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Workshop 1. Innate Immunity and
Inflammation
WS1.1
Granulocyte Reactivity is Associated with
Cartilage Destruction in Patients with
Anti-collagen Antibodies
Vivek Anand Manivel1, Azita Sohrabian1, Maurius
C. Wick2, Lena Hakansson3 & Johan R€onnelid1
1Immunology Genetics and Pathology IGP, Uppsala, Sweden, 2Department
of Radiology, Karolinska University Hospital, Stockholm, Stockholm,
Sweden, 3Department of Medical Sciences, Uppsala University, Uppsala,
Sweden
Objective: RA patients with anticollagen antibodies (anti-
CII) are characterized by acute RA onset and early joint
erosions as well as increased production of TNF by peripheral
blood mononuclear cells (PBMC) stimulated by anti-CII
immune complexes (IC) in vitro. The aim was to investigate
whether polymorphonuclear neutrophil granulocytes
(PMN) react towards anti-CII IC and whether such responses
are associated with the clinical acute-onset RA phenotype.
Methods: A set of 72 baseline patient sera (24 anti-CII
positive, 24 anti-CII negative/RF positive and 24 anti-CII
negative/RF negative) was chosen from a clinically well-
characterized RA cohort with 2-year radiological follow-up
(Larsen score). PMN and PBMC isolated fromhealthy donors
were stimulatedwith anti-CII IC prepared with sera from the
patients. PMN expression of CD11b, CD66b, CD16 and
CD32 was measured by flow cytometry, whereas PMN
production of myeloperoxidase (MPO) and IL-17, and
PBMC production of TNF, was measured with ELISA.
Results: CD11b, CD66b and MPO were upregulated,
whereas CD16 and CD32 were downregulated by anti-CII
IC.Therewere correlations betweenCD16,CD66b andMPO
production in relation to anti-CII levels (r = 0.3152,
0.6755 and 0.2532, respectively). CD16 was associated with
early joint erosion (P = 0.024,0.034,0.046atbaseline, 1 and
2 years), and CD66b was associated with changes in joint
erosion (P = 0.017 and 0.016, at 1 and 2 years compared to
baseline, respectively). CD66b was associated with baseline
CRP and PBMC production of TNF was associated with
baseline ESR, in accordance with our earlier findings. No
clinical associations were observed for MPO or IL-17.
Conclusion: PMN reactivity against anti-CII IC is
associated with Larsen score and may contribute to joint
destruction in newly diagnosed RA patients with high
levels of anti-CII.
WS1.2
Increased IRAK-M in Peritoneal
Macrophages of NOD Mice Suggests In
Vivo Exposure to Bacterial Endotoxins
from the Gut
Rohini Emani1, Catharina Alam2 & Arno
Haninnen1
1Turku University, Turku, Finland, 2Abo Akademi University, Turku, Finland
Macrophages play an important role in innate immune
reactions, and peritoneal macrophages guard the sterility of
this compartment mainly against microbial threat from the
gut. Type-1 diabetes (T1D) is an autoimmune disease in
which gut microbiota and gut immune system appear to
contribute to disease pathogenesis. We have observed
increased permeability and free radical production of gut
epithelium in non-obese diabetic (NOD) mice. Impaired
barrier function could lead to bacterial endotoxin leakage to
peritoneal cavity. To seek for extraintestinal consequences of
impaired barrier function, we characterized peritoneal lavage
cells from young NOD mice after weaning. We detected a
rapid increase in the number of macrophages in 1–2 weeks
from weaning in NOD mice compared to C57BL/6 and
BALB/c mice, and toNODmice fed an antidiabetogenic diet
(ProSobee) which improves gut barrier function. Upon LPS
stimulation ex vivo, macrophages produced low amounts of
TNF-a and showed reduced expression of CD40. Expression
of TLR signalling pathway negative regulator, interleukin-1-
associated kinase-M (IRAK-M), was increased, indicating
prior in vivo exposure to TLR-4 ligand(s). Upon further
phenotyping, increased levels of ARG1 were observed
suggesting in vivo differentiation towards M2-like pheno-
type. Bacterial endotoxins in peritoneal cavity may contrib-
ute to autoreactive T cell activation by increased production
of cytokines and activation of antigen-presenting cells in
pancreatic lymph nodes.
WS1.3
Roles for Microglia Subsets in
Neuroinflammation
Agnieszka Wlodarczyk, Morten Løbner, Oriane
Cedile & Trevor Owens
IMM, SDU, Odense, Denmark
Experimental autoimmune encephalomyelitis (EAE) is a
mouse model for the inflammatory demyelinating disease –
multiple sclerosis (MS). MS is considered to be mediated by
autoreactive myelin-specific T cells. The crucial event in
generating autoimmunity in the central nervous system
(CNS) is presentation of autoantigen to na€ıve T cells in
lymph nodes and their reactivation in the CNS by infiltrat-
ing or resident antigen-presenting cells (APC). Dendritic
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cells (DC) are themajor APC in the periphery but in the CNS
they likely contribute to control of T cell entry.Microglia are
CNS-resident cells and are considered to act as APC.
In this work, we compared antigen-presenting capacity of
CD11c+ and CD11c microglia subsets with infiltrating
CD11c+ APC, which include DC. Two subpopulations of
microglia (CD11c CD45dim CD11b+) and (CD11c+
CD45dim CD11b+), as well as CD11c+ CD45high cells,
were sorted from CNS of C57BL/6 mice with EAE. Sorted
cells were characterized by flow cytometry for surface
phenotype and by qRT-PCR for cytokine expression. They
were co-cultured with primed T cells to measure the
induction of T cell proliferation and cytokine response.
Our results show that the number of CD11c+ microglia
cells significantly increases during EAE. This population of
cells unlike CD45high CD11c+ cells express almost no
CCR2 and express CX3CR1. CD11c+ microglia differ
significantly from blood-derived CD11c+ cells also in their
cytokine profile, expressing no detectable IL-6, IL-12 or IL-
23, low levels of IL-1b and high levels of IGF1. By
contrast, CD11c microglia express low but detectable
levels of all these cytokines. Although CNS-resident and
blood-derived CD11c+ cells show equivalent ability to
induce proliferation of primed T cells, CD11c+ microglia
induce lower levels of Th1 and Th17 cytokines.
Our findings show distinct subtypes of APC in the
inflamed CNS, with a hierarchy of functional competence
for the induction of T cell responses.
WS1.4
Notch Enhances the Endothelial
Inflammatory Response
Eirik Sundlisæter1, Reidunn Jetne Edelmann1,
Johanna Hol1, Stig Kr€uger1, Junbai Wang1,
Monika Kasprzycka1, Espen Bækkevold1, Ian
Donaldson1, Helge Scott1, Manuel Ehling2, Ralf H.
Adams2, Christian W. Siebel3, Rui Benedito4 &
Guttorm Haraldsen1
1University of Oslo, Oslo, Norway, 2Max Planck Institute for Molecular
Biomedicine, M€unster, Germany, 3Genentech Inc, San Francisco, CA, USA,
4CNIC, Madrid, Spain
Vascular endothelial cells (ECs) upregulate the Notch
ligand Jagged1 when exposed to pro-inflammatory stimuli.
We found that inhibition of Jagged1 or Notch1 in ECs
impaired their inflammatory response to IL-1, including
reduced expression of adhesion molecules, chemokines and
the chemokine transcytosis receptor DARC. Furthermore,
EC-targeted inducible knockout of the canonical Notch
transcription factor RBPJ/CSL reduced inflammation in a
mouse model of 2,4-dinitrofluorobenzene-induced contact
dermatitis. A similar trend was seen when endothelial
JAG1 was deleted. Conversely, transgenic overexpression of
active Notch1 in ECs enhanced the inflammatory response.
In conclusion, we show for the first time that Notch
signalling modulates gene expression in activated ECs,
sharpening the inflammatory profile of the vasculature and
giving it an edge towards leucocyte recruitment.
WS1.5
Type I Interferon Expressed by Glial Cells
in the Central Nervous System Plays a
Protective Role in EAE
Reza Khorooshi1, Thomas Hellesøe Holm2, Carsten
Tue Berg1, Marlene Thorsen Mørch1, Ruthe
Truong Dieu1, Dina Dræby1, Siegfried Weiss3,
Stefan Lienenklaus3 & Trevor Owens1
1Institute of molecular medicine, Odense, Denmark, 2Department of
Biomedicine Aarhus University,Arhus, Denmark, 3Molecular Immunology,
Helmholtz Centre for Infection Research, Braunschweig, Germany
Interferon beta (IFN-b) is used to treat patients with
multiple sclerosis (MS). IFN-b is a member of the type I
IFN family, which share a common receptor (IFNAR), and
is induced by stimulation of innate receptors. Type I IFNs
are increased in the CNS during experimental autoimmune
encephalomyelitis (EAE), an animal model for MS, and
lack of IFN-b and type I IFN signalling worsens EAE,
suggesting an important role for endogenous IFN-b in the
CNS. The aim of this study was to identify the cellular
source and role of endogenous type I IFN in the CNS. Mice
were administered poly I:C into the cerebrospinal fluid via
the cisterna magna and induction of IFN-b was demon-
strated by in vivo imaging of a luciferase/IFN-b reporter
mouse. Intrathecal administration of poly I:C transiently
induced IFN-b in the brain and spinal cord, and microglia
and astrocytes were implicated as cell source. EAE was
induced in C57BL/6- and IFNAR-deficient mice by
immunization with myelin oligodendrocyte glycoprotein
35–55. At onset of EAE, mice received a single intrathecal
injection of poly I:C. This transiently prevented EAE
progression. In contrast, intrathecal administration of poly
I:C had no effect on progression of EAE in IFNAR-
deficient mice, indicating type I IFN-mediated poly I:C-
induced suppression of EAE. These results suggest that
type I IFN induced within the CNS by glial cells plays a
protective role in EAE. This underscores the role of
endogenous type I IFN in mediating neuroprotection.
Abstracts 425
..................................................................................................................................................................
 2014 John Wiley & Sons Ltd
WS1.6
Examination of Intestinal Eosinophil
Phenotype and Function During
Inflammation and Steady State
Daniel Sorobetea, Jan Marsal & Marcus
Svensson-Frej
Lund University, Lund, Sweden
The intestinal lamina propria contains relatively high
numbers of eosinophils during steady state as well as
inflammation. Eosinophil accumulation during inflam-
mation is particularly pronounced during parasitic infec-
tions and certain inflammatory diseases of the
gastrointestinal tract, such as eosinophilic oesophagitis
and inflammatory bowel disease (IBD). Despite this fact,
the function of gastrointestinal eosinophils remains
largely unknown.
We have isolated and purified eosinophils from the large
and small intestine of both mice and humans in healthy as
well as in diseased states by MACS and FACS. Our
preliminary data suggest that there is much more plasticity
among eosinophils with regard to phenotype, localization
and function than previously believed. Indeed, eosinophils
appear to be localized to different anatomical compart-
ments in patients with IBD, and express different surface
receptors than their blood-borne counterparts. Thus, it
appears that both mouse and human eosinophils are far
more varied than the dogma portrays them to be.
WS1.7
IL-1β Stabilizes Human S100A9 by
Ca2+- and P38 MAPK-Dependent
Phosphorylation
Zhifei He1, Matteo Riva2, Tomas Leanderson1 &
Fredrik Ivars1
1Lund University, Lund, Sweden, 2Active Biotech AB, Lund, Sweden
S100A8 and S100A9 are cytosolic Ca2+-binding proteins
that are associated with acute and chronic inflammation
and cancer. S100A9 predominantly forms heterodimers
with S100A8, but there are data showing that S100A9 can
also form homodimers. We have investigated the stability
of human S100A8 and S100A9 proteins using transfected
COS cells. Our data showed that, in single transfected
cells, the S100A8 protein decayed within 24 h, while
S100A9 was completely unstable. However, S100A9
protein expression could be rescued upon co-expression
with S100A8 or inhibition of proteasomal activity.
Interestingly, incubation of S100A9-transfected COS cells
with proteasomal inhibitor or IL-1b led to the formation
of protease-resistant S100A9 homodimers. It is known that
IL-1b stimulation causes Ca2+ influx into the cells and we
found that addition of a membrane-permeable Ca2+
chelator (BAPTA-AM) inhibited the stabilization of
S100A9. Further, IL-1b stimulation can also induce the
activation of the Ser/Thr kinase P38 MAPK, which can
phosphorylate S100A9 at Thr-113. We could show that
addition of the P38 MAPK inhibitor SB-203580 to IL-1b-
stimulated cells reduced the stabilization of S100A9.
Finally, using site-directed mutagenesis, we changed Thr-
113 to Ala-113 and found that this mutant S100A9
protein could no longer be stabilized by IL-1b.
In summary, our data indicate that the human S100A9
protein can be stabilized by inflammatory stimuli that
cause Ca2+- and P38 MAPK-dependent phosphorylation of
the protein. Because S100A9 is a ligand of TLR4, this
mechanism may constitute an amplification step during an
inflammatory reaction.
WS1.8
Understanding the LACC1 Biological
Function and its Role in IBD Pathogenesis
Ghazaleh Assadi, Lina Cordeddu & Mauro
D’Amato
Karolinska Institutet, Stockholm, Sweden
Introduction: Several GWA studies conducted in various
populations have consistently identified LACC1 as a
Crohn’s disease risk gene. LACC1 (previously called
chromosome 13 open reading frame 31, C13orf31) is
located on chromosome 13q14.11, and its product consists
of 430 amino acids and has a mass of 47.780 kDa. At
present, its biological function is unknown as well as its
pathogenic role in Crohn’s disease. The fact that LACC1
predicted protein sequence is highly conserved across
species calls for an important function; however, it is
puzzling to observe that LACC1 homology is with laccase
proteins that are uniquely found in bacteria.
Material and methods: For functional characterization of
LACC1, HeLa, THP-1 and U937 cell lines were utilized.
Additionally, immunofluorescence, Western blot and
luciferase assay were conducted.
Results: From the real-time PCR and Western blot
analyses, we identified that LACC1 was endogenously
regulated in THP-1 and U937 cell line upon PMA-driven
differentiation and particularly under LPS stimulation. The
Western blot results indicated a cleavage of the protein
when HeLa cells were transfected with the LACC1-wt
construct and a N-terminus GFP-tagged protein. Interest-
ingly, the immunofluorescence experiments on the THP-1
cells revealed partial co-localization with endomembrane
structures and ER compartments. The luciferase assay
conducted to investigate LACC1 involvement in unfolded
protein response showed an increased luciferase activity in
LACC1+ versus LACC1 tunicamycin-treated HeLa cells.
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Moreover, the laccase assays demonstrated that LACC1 is
not a conventional laccase.
Conclusion: Preliminary experiments performed on
LACC1 show possible co-localization of LACC1 in the
endomembrane structures and its endogenous expression in
macrophages; however, further experiments need to be
designed in order to define its functionality.
WS1.9
The Salivary Scavenger and Agglutinin
(SALSA) in Early Life: Diverse Roles in
Amniotic Fluid and Intestine
Martin Reichhardt1, Hanna Jarva1,2, Mark De
Been3,4, Juan Rodriguez5, Esther Jimenez
Quintana5, Vuokko Loimaranta6, Willem De
Vos1,3,7 & Seppo Meri1,2
1Department of Bacteriology and Immunology, University of Helsinki,
Helsinki, Finland, 2Helsinki University Central Hospital Laboratory HUSLAB,
Helsinki, Finland, 3Department of Veterinary Biosciences, University of
Helsinki, Helsinki, Finland, 4Department of Medical Microbiology, University
Medical Center Utrecht, Utrecht, the Netherlands, 5Department of
Nutrition, Food Science and Food Technology, Complutense University,
Madrid, Spain, 6Department of Medical Biochemistry and Genetics,
University of Turku, Turku, Finland, 7Laboratory of Microbiology,
Wageningen University, Wageningen, the Netherlands
The salivary scavenger and agglutinin (SALSA), also
known as gp340 and dmbt1, is produced by mucosal
tissues throughout the body. SALSA is an antimicrobial
and inflammation regulating molecule located at the
mucosal surfaces. It has also been suggested to play a
role in both cell differentiation and epithelial polariza-
tion. In the present study, a general screen of body
secretions for SALSA revealed that SALSA was present in
amniotic fluid (AF) and exceptionally abundant in both
meconium and faeces of infants. SALSA constituted up
to 6–10% of the total protein amount in meconium,
thus making it one of the most abundant proteins.
Innate immunity is extremely important for both the
mother in the course of maintaining a healthy pregnancy
and for the infant in the very early stages of life. The
high levels of SALSA in AF, and especially in the
meconium and faeces, suggest a robust and important
function for SALSA both during the foetal development
and in the innate immune defence of infants. SALSA
proteins in the AF and intestinal samples were poly-
morphic and exhibited varying peptide compositions. In
particular, a different abundance of peptides correspond-
ing to functionally important structures was found in AF
and intestinal SALSA. Peptides within the bacterial-
binding part of the scavenger receptor cysteine-rich
domains were more abundant in the intestinal SALSA.
In contrast, SALSA present in the AF contained
relatively more peptides from the zona pellucida (ZP)
domain, which is involved in cell differentiation. Our
results have thus identified body compartments, where
SALSA is particularly abundant, and suggest that SALSA
exhibits varying functions in the different locations.
WS1.10
CD11c/CD18 Phosphorylation on Alpha
Chain Regulates Integrin Functions
Liisa Uotila, Maria Aatonen & Carl Gahmberg
University of Helsinki, Helsinki, Finland
CD11c/CD18 (or complement receptor 4, aXb2, or
p150/95) is a leucocyte integrin expressed especially on
monocytes, macrophages, dendritic cells as well as on
some subsets of T and B cells. It binds to a variety of
extracellular matrix molecules, soluble ligands and cell
surface Ig-superfamily proteins. The broad spectrum of
the binding partners is reflected on the functions of
CD11c/CD18: one of its first reported functions was the
function as a complement receptor, hence the name.
Other suggested roles include dendritic cell antigen
uptake and presentation, generating CD4 and CD8 T
cell-mediated responses and providing a useful approach
for antitumour vaccine development. Recently, CD11c/
cD18 has also been shown to have a role in the
transendothelial migration of macrophages to atheroscle-
rotic plaques in hypercholesterolaemic mice. Yet another
suggested role could be the removal of senescent red cells
from the bloodstream through the interactions between
red cell ICAM-4 and CD11c/CD18 on spleen macro-
phages.
The phosphorylation of the cytoplasmic parts of integrin a
and b chains has been shown to be of pivotal importance in
the regulation of the integrin activities like adhesion. Here,
we identify the phosphorylation site of CD11c as serine
1158 and show that it is pivotal for adhesion and
phagocytosis, but not for outside-in activation.
In general, it may be that the role of the CD11c/CD18 is
relevant also outside the circulation, as it is enriched in
macrophages and dendritic cells and binds to several
extracellular matrix ligands. All the suggested functions
involve adhesion, and understanding the regulation of
CD11c/CD18 is a prerequisite for further elucidation of
this complex integrin.
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WS1.11
Neutrophils from Patients with ANCA-
Associated Vasculitis Exhibit an Increased
Propensity to Undergo Neutrophil
Extracellular Trap (NET) Formation and/or
Necrosis
Daniel So¨derberg, Tino Kurz, Maria Weiner, Per
Eriksson & Marten Segelmark
Link€oping University, Link€oping, Sweden
Background: Dying neutrophils surrounding small ves-
sels, the histological hallmark of antineutrophil cytoplas-
mic antibody (ANCA)-associated vasculitis (AAV), may
provide the source of antigens for the generation of ANCA.
We have previously shown that AAV neutrophils are less
prone to undergo cell death from apoptosis. Neutrophil
extracellular traps (NETs), released in a pathway of
programmed cell death called NET-osis, have recently
been visualized at vasculitic lesions in patients and have
also been shown to be important in AAV rodent model.
Methods: Neutrophils were isolated by Percoll centrifu-
gation from 24 AAV patients (5 active/19 remission) and
15 healthy controls (HC). Neutrophils were exposed to
10 nM phorbol 12-myristate 13-acetate (PMA), 2 or 8 ng/
ml TNF-a, 10 or 100 nM dexamethasone or left untreated.
DNA was quantified in a microplate fluorescence reader
using Sytox Green, and the results were expressed as
percentage of total DNA (lysis with 1% Triton X-100).
Neutrophil cell death was also visualized by fluorescence
microscopy.
Results: PMA, also at moderate doses (10 nM), efficiently
induced NET-osis but no difference was seen between
neutrophils from AAV patients and HC. However,
unstimulated neutrophils of AAV patients showed an
increased propensity for cell death after 4 h compared to
HC (P < 0.05). Stimulation of neutrophils with a high
dose of TNF-a (8 ng/ml) abolished the difference in cell
death between patients and controls, while a difference
could still be detected after co-incubation with a low TNF-
a dose (2 ng/ml). About 100 nM dexamethasone decreased
PMA-induced NET-osis, while it increased spontaneous
cell death.
Conclusions: Neutrophils from AAV patients show an
increased propensity for spontaneous NET formation and/
or necrosis in vitro. However, these differences can be
abolished by the addition of inflammatory cytokines (i.e.
TNF-a) or high doses of anti-inflammatory drugs. Further
and more intricate studies are needed to reveal the
significance of these findings.
WS1.12
Polysaccharide from Achillea millefolium
has Anti-Inflammatory Effects in THP-1
Monocytes
Oddny Logadottir1,2,3, Sesselja Omarsdottir4,
Arnor Vikingsson3, Jona Freysdottir1,2,3 &
Ingibjorg Hardardottir1
1Faculty of Medicine, Biomedical Center, University of Iceland, Reykjavik,
Iceland, 2Department of Immunology, Landspitali, Reykjavik, Iceland,
3Centre for Rheumatology Research, Landspitali, Reykjavik, Iceland,
4Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavik,
Iceland
Background: Achillea millefolium has been used in tradi-
tional medicine to heal inflamed cuts and alleviate
rheumatism. Aqueous extract from Achillea millefolium
has been shown to have anti-inflammatory effects on
dendritic cells in vitro. Several compounds have been
isolated from Achillea millefolium, but only a few have been
tested for their immunological effects.
Objectives: To use bioguided fractionation to isolate a
polysaccharide fromAchillea millefolium that has anti-inflam-
matoryeffectsonTHP-1monocytes andtodeterminehowthe
polysaccharide affects intracellular signalling in the cells.
Methods: Bioguided fractionation using ion-exchange
chromatography was used to isolate a polysaccharide from
Achillea millefolium. THP-1 monocytes were primed with
IFN-c and then stimulated with LPS in the absence or
presence of the polysaccharide. The cells were cultured for
48 h, and cytokine concentration in the supernatant was
determined by ELISA. Phosphorylation of several intracel-
lular kinases will be determined byWestern blotting after 1-
h stimulation of the cells in the presence or absence of the
polysaccharide.
Results: The water-soluble compound isolated from
Achillea millefolium is most likely a polysaccharide with a
molecular weight <20 kDa. THP-1 cells incubated with
the polysaccharide increased IL-12 secretion by around
80% but increased IL-10 secretion by around threefold,
thus decreasing the IL-12/IL-10 ratio around 40%. The
effect of the polysaccharide on phosphorylation of intra-
cellular kinases is currently being investigated.
Conclusions: A polysaccharide isolated from Achillea
millefolium has anti-inflammatory effects on cytokine secre-
tion by THP-1 monocytes.
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WS1.13
Heightened Antibody Response to
Porphyromonas gingivalis Detected in
ACPA+ RA, Suggesting a Role for this Oral
Bacteria in the Aetiopathogenesis of RA
Nastya Kharlamova1, Natalia Sherina1, Xia Jiang1,
Ann Marry Quirke2, Lena Israelsson1, Jan
Potempa3, Patric Venables2, Tulay Lindberg1 &
Karin Lundberg1
1Karolinska Institutet, Stockholm, Sweden, 2Kennedy Institute of
Rheumatology, London, UK, 3Jagiellonian University, Krakow, Poland
Introduction: Porphyromonas gingivalis is a major cause of
chronic periodontitis (PD) and the only known pathogen to
express a peptidyl arginine deiminase (PAD) enzyme,
therefore potentially contributing to the aetiopathogenesis
of rheumatoid arthritis (RA), by triggering anticitrulli-
nated protein antibody (ACPA) production. The overall
aim of this study was to investigate whether P. gingivalis is
an aetiological risk factor for the development of RA,
specifically ACPA-positive RA, and specifically to deter-
mine whether ACPA+ RA patients have an heightened
immune response to P. gingivalis-specific virulence factor,
arginine gingipain B (RgpB).
Methods: Sera from 66 patients with chronic PD, 60 non-
PD controls, 1974 RA cases and 383 non-RA controls were
screened by ELISA for the presence of antibodies to RgpB.
For statistical analyses, Mann–Whitney U-test and an
unconditional logistic regression analysis were used.
Results: Significantly higher anti-RgpB antibody levels
were detected in the PD subset, compared to the non-PD
controls. However, the correlation coefficient for being
anti-RgpB IgG positive and having PD was weak
(r = 0.37, P < 0.001). Significantly elevated anti-RgpB
IgG levels were also detected in RA compared to non-RA
controls, and in ACPA+ RA compared to ACPA RA.
Regression analysis revealed significant associations
between anti-RgpB IgG status and RA, with an OR of
3.3 for ACPA+ RA and 2.4 for ACPA RA. Moreover,
there was an interaction between anti-RgpB IgG and
smoking, and between anti-RgpB IgG and SE, in ACPA+
RA, but not in ACPA RA.
Conclusion: Anti-RgpB IgG should not be used as a
surrogate marker for PD. However, our data suggest a role
for the oral bacteria P. gingivalis in the aetiology of RA,
because a heightened antibody response to RgpB was
strongly associated with RA, specifically ACPA+ RA, and
because we could observe a (biological) interaction between
anti-RgpB IgG and risk factors for RA, HLA-DRB1 SE
and smoking.
WS1.14
Increase in Acute-Phase Proteins in Early
Life Predicts Reduced Growth Rate of
Beef Calves at 6 Months of Age
Leena Seppa¨-Lassila1, Heidi H€artel2, Ulla Eerola3,
Toomas Orro4, Heli Simojoki1 & Timo Soveri1
1University of Helsinki, Helsinki, Finland, 2HK Agri & Satafood Development
Association, Huittinen, Finland, 3Private practician, Lammi, Finland,
4Estonian University of Life Sciences, Tartu, Estonia
Parts of the innate immunity are activated after birth,
manifested as elevated levels of the acute-phase proteins in
clinically healthy animals for 2–3 weeks after birth. In the
current study, we explored the use of the acute-phase
response as a long-term prognostic marker for growth in
beef calves.
Thirty-seven calves from six herds were visited three
times at intervals of approximately 13 days, when calves
were (mean  S.D.) 3.3  1.1, 16.4  1.4 and
30.2  1.2 days of age. On each visit, calves were
clinically examined and weighed. Blood samples were
collected and analysed for acute-phase proteins: haptoglo-
bin, serum amyloid-A (SAA) and fibrinogen. Association
between acute-phase proteins at different age groups and
weight gain was explored by linear mixed models.
In general, the calves were healthy, and only sporadic
health problems were detected. The haptoglobin concen-
trations over the reference value (obtained from samples of
120 healthy dairy calves) of 196 mg/l were observed six
times, in five calves. Fibrinogen concentrations over the
reference value of 5.9 g/l were observed on 20 measure-
ments, in 12 calves. None of the calves had SAA
concentration over the reference value of 178 mg/l.
However, the linear mixed model showed that calves with
higher SAA concentrations on the visit at approximately
2 weeks of age had lower growth rate from the first visit to
the last weighing at 210 days of age.
Similar phenomenon at the second week of age – the
innate immune response when no signs of inflammation
can be observed associated with retarded growth in long
term – has been detected in lambs and in reindeer calves
(Orro et al. 2011, Comp Immunol Microbiol Infect Dis),
but mechanisms for this interplay between growth and
the activated innate immune system is yet to be solved.
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WS1.15
Periodontitis Enhances Inflammatory
Cytokine Response in Rats with Pristane-
Induced Arthritis
Erik Lo¨nnblom1, Kaja Eriksson2, Gregory Tour2,
Anna Kats2, Catharina Hultgren3, Pierre
Georgsson1, Annelie Hellvard4, Piotr Mydel4,
Rikard Holmdahl5 & T€ulay Yucel-Lindberg2
1Karolinska Institute, Stockholm, Sweden, 2Department of Dental Medicine,
Division of periodontology, Karolinska Institute, Huddinge, Sweden,
3Department of Laboratory Medicine, Karolinska Institute, Huddinge,
Sweden, 4BroegelmannResearchLaboratory,TheGadeInstitute,Universityof
Bergen, Bergen, Norway, 5Department of Medical Biochemistry Biophysics,
Karolinska Institute, Stockholm, Sweden
There is growing evidence of a link between rheumatoid
arthritis (RA) and periodontitis reflected in shared chronic
nature of the inflammatory responses and a number of
environmental factors including smoking and periodontal
pathogens. Objectives: This study aimed to further under-
stand mechanisms underlying the infection-immune associ-
ation of periodontal niche with RA inflammatory events,
related to the ability of the major periodontal pathogens to
contribute to the loss of self-tolerance and development of
RA. Methods: We examined Porfyromonas gingivalis and
Fusobacterium nucleatum ligature-induced periodontitis
and pristane-induced arthritis (PIA) interaction in rats by
monitoring the disease progression and severity with clinical
assessment, micro-CT and cytokine multiplex profiling at
different time intervals after induction. Results: Experi-
mentally induced periodontitis manifested clinically in all
investigated subjects as severe localized form by week 6
following induction and resulted in significant alveolar bone
loss that progressed further by week 15. Arthritis induction
at week 8 was associated with a significant animal weight
decrease followed by severe arthritic changes in all limbs.
Endpoint analysis revealed a trend towards increased pro-
inflammatory cytokine levels (IL-1b, IL-2, TNF-a and
RANTES) in serum of periodontitis-challenged PIA rats.
Conclusions: Periodontitis enhanced systemic inflammatory
response in experimental arthritis in rats compared to their
counterparts with no periodontal disease.
WS1.16
Comparison of the Ability of Clinical and
Dairy Strains of Lactobacillus rhamnosus
to Activate the Complement System
Eija Nissila¨, Karita Haapasalo-Tuomainen, Hanna
Jarva, Seppo Meri & Willem De Vos
University of Helsinki, Helsinki, Finland
Introduction: The complement system is a central part of
innate immunity defending us against invading pathogens.
Lactobacillus rhamnosus GG (LGG) is one of the most widely
used probiotics in the world. However, several strains of
L. rhamnosus have been isolated from various types of
infections including bacteraemic sepsis. Earlier studies have
found genomic and phenotypic differences between
L. rhamnosus strains from various origins. The aim of this
study was to analyse how different L. rhamnosus strains
from clinical samples and dairy products activate or escape
complement in vitro.
Methods: The clinical isolates of L. rhamnosus were
collected at the Helsinki University Central Hospital
laboratory. To study complement activation, L. rhamnosus
strains were incubated with normal human serum at
+37 °C for 30 min. Complement activation was analysed
by measuring C3a and terminal pathway complex (TCC)
formation by ELISA. The binding of complement regula-
tors factor H and C4bp was analysed using a radioligand
assay.
Results: All the studied strains activated complement as
judged by the formation of C3a and TCC. The level of
activation varied between the strains only to a limited
extent. None of the L. rhamnosus strains bound comple-
ment inhibitors factor H or C4bp.
Conclusion: All tested strains of L. rhamnosus, including
strain LGG, activated complement. No biologically rele-
vant differences in complement-activating capacity or
binding of the studied complement regulators were found
between the L. rhamnosus strains from clinical or dairy
origin.
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WS1.17
The Human Cathelicidin LL-37 in the Skin
of Individuals with Psoriasis
Gudmundur Bergsson1, Eva €Osp Bj€ornsdottir1,
Jenna Huld Eysteinsdottir1,2, Bjarni A.
Agnarsson3,4, Jon Hjaltalın Olafsson4,5,6, Barður
Sigurgeirsson6, Asa Brynjolfsdottir2, Steingrımur
Davıðsson2,5 & Bj€orn Runar Luðvıkssson1,6
1Department of Immunology, Landspitali University Hospital, Reykjavik,
Iceland, 2The Blue Lagoon Clinic, Grindavik, Iceland, 3Department of
Pathology, Landspitali University Hospital, Reykjavik, Iceland, 4Department
of Dermatology, Landspitali University Hospital, Reykjavik, Iceland,
5Huðlæknast€oðin, Kopavogur, Iceland, 6Faculty of Medicine, University of
Iceland, Reykjavik, Iceland
Psoriasis is a common chronic skin disease associated with
high degree of morbidity and low quality of life. Although
a number of treatment options are available, psoriasis is
linked to high cost and major impact on healthcare system
and society. Induction of antimicrobial peptides and
changes in proteolytic balance are characteristic of psoriatic
skin. Furthermore, the human cathelicidin LL-37 has been
linked to the pathogenesis of psoriasis, either as a trigger or
by facilitating the maintenance of the disease. Therefore,
understanding the role of this peptide of host defence can
aid effective development of psoriasis treatment. Our
previous data demonstrate that a controlled balneotherapy
in the Blue Lagoon can suppress circulating and epidermal
T lymphocytes, reduce skin inflammation and improve
quality of life. Here, we hypothesize components of a
combined balneo- and narrowband ultraviolet B (NB-
UVB) therapy to positively affect the proteolytic imbalance
and the high levels of antimicrobial and antiproteolytic
peptides involved in the pathogenesis of psoriasis. In order
to address this issue, we collected punch biopsies from
psoriatic skin lesions before and after 6-week daily
treatment involving bathing in geothermal seawater
combined with NB-UVB therapy. Punches were sliced,
and sections were fluorostained using an LL-37-specific
antibody. Our results indicate that LL-37 levels are higher
in samples collected from individuals after successful
balneotherapy, particularly in the upper cell layers, that
is, stratum granulosum and lucidum. In conclusion, the
increased levels, stability and location of LL-37 after
therapy are surprising, particularly because the location
corresponds to the location of proteases, which degrade and
inactivate LL-37. The data indicate an unknown homeo-
static mechanism of LL-37 in the suppression of pathogenic
skin infiltrating T effector cells.
WS1.18
Dendritic Cells Matured in the Presence of
the Lycopodium Alkaloid Annotine Direct
T Cell Responses Towards a Th2/Treg
Phenotype
Ingibjorg Hardardottir1, Brianna Blomqvist2,3,
Sigrun Hauksdottir2,3, Elin Olafsdottir2 & Jona
Freysdottir1,3
1Faculty of Medicine, Biomedical Center, University of Iceland, Reykjavik,
Iceland, 2Faculty of Pharmaceutical Sciences, University of Iceland,
Reykjavik, Iceland, 3Centre for Rheumatology Research and Department
of Immunology, Landspitali, Reykjavik, Iceland
Annotine is a lycopodane-type alkaloid that does not
inhibit acetylcholinesterase, as some other lycopodium
alkaloids do. It has not been investigated for other
bioactivity. The aim of this study was to determine
whether annotine affects immune responses by dendritic
cells (DCs).
Annotine was isolated from Icelandic Lycopodium annotinum
ssp. alpestre. Human monocytes were differentiated into
immature DCs (imDCs) by incubating them with GM-CSF
and IL-4 for 7 days. The imDCs were matured with TNF-
a and IL-1b and stimulated with LPS for 48 h in the
presence or absence of annotine at a concentration of 1, 10
or 100 lg/ml. The effect of the annotine on maturation of
the DCs was determined by measuring concentration of
cytokines in culture supernatant by ELISA and expression
of surface markers by flow cytometry. DCs matured and
stimulated in the absence or presence of annotine at
100 lg/ml were also co-cultured with allogeneic CD4+ T
cells for 6 days, and concentration of cytokines in super-
natant was determined by ELISA.
DCs matured and stimulated in the presence of annotine
secreted less IL-10, IL-12 and IL-23 than DCs matured and
stimulated in the absence of annotine. However, annotine
reduced IL-10 secretion more than IL-12 secretion, making
the ratio of IL-12/IL-10 in medium from DCs cultured
with annotine higher than that in medium from DCs
cultured without annotine. Allogeneic CD4+ T cells co-
cultured with DCs matured and stimulated in the presence
of annotine secreted more IL-10 and IL-13 than T cells co-
cultured with DCs matured and stimulated in the absence
of annotine.
Although annotine had a pro-inflammatory effect on
cytokine secretion by DCs, DCs matured and stimulated
in the presence of annotine had a greater potential to direct
the differentiation of T cells into a Th2/Treg pathway than
DCs matured and stimulated in the absence of annotine.
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WS1.19
Cytotoxic Peptides from S. aureus Cause
Neutrophil Cell Death with NET-like
Features
Halla Bjo¨rnsdottir1, Karin Christenson1, Huamei
Forsman1, Marios Stylianou2, Constantin Urban2,
Claes Dahlgren1, Anna Karlsson1 & Johan Bylund1
1University of Gothenburg, Gothenburg, Sweden, 2Umea University, Umea,
Sweden
Community-associated methicillin-resistant Staphylococcus
aureus (CA-MRSA) are antibiotic-resistant strains with
high virulence that cause severe infections in humans.
These strains secrete a group of virulence factors called
phenol-soluble modulins (PSMs) which are peptides capa-
ble of activating neutrophils to produce reactive oxygen
species (ROS) through the chemoattractant receptor FPR2,
but also to possess cytotoxic properties at higher concen-
trations.
We found that PSM peptides (PSMa2 and PSMa3) were
cytotoxic to isolated human neutrophils and moreover that
the neutrophils formed neutrophil extracellular trap
(NET)-like structures after treatment with the peptides.
NET-like structures were not induced by other cytotoxic
peptides (e.g. high doses of LL-37), and the PSM-triggered
NET-like structures were morphologically indistinguish-
able from NETs induced by conventional stimuli, such as
phorbol myristate acetate (PMA), in that they contained
extracellular DNA, histones and granule proteins. The
NET-like structures induced by PSM were also potently
antifungal and capable of inhibiting Candida albicans
growth in vitro. The cytotoxic effect of the PSM peptides
was not mediated via FPR2 and in contrast to NET
formation by PMA, the PSM-triggered process induced
very rapid expulsion of the DNA structures (within
minutes). NET formation by PMA has been shown to be
dependent on ROS production, but the NET-like struc-
tures induced by PSM peptides were independent of radical
formation.
Our data reveal an unusual cytotoxic effect by PSM
peptides resulting in a type of cell death that morpholog-
ically resembles NETosis very closely. Thus, these findings
are the basis for further studies on the role of these NET-
like structures for the pathogenesis of CA-MRSA.
WS1.20
Boosting Innate Immunity with New
Potent Inducers of Antimicrobial Peptide
Expression
Roger Stro¨mberg1, Hakan Ottosson1, Erica
Miraglia1, Frank Nylen1, Gudmundur
Gudmundsson2 & Birgitta Agerberth1
1Karolinska Institutet, Huddinge, Sweden, 2University of Iceland, Reykjavik,
Iceland
The continual emergence of antibiotic resistance among
bacterial pathogens poses a great challenge to the public
health. The pipeline of new antibiotics in drug develop-
ment has yet to match this threat, because only few novel
agents have been developed in the last decades. Strength-
ening immune defences against pathogens by boosting the
expression of our own ‘natural antibiotics’ may represent a
novel or complementary pharmaceutical intervention in
infectious diseases. Importantly, the multiplicity of anti-
microbial peptides (AMPs) with overlapping antibacterial
mechanisms secures minimal risk of microbial resistance.
AMPs can be induced by certain compounds, as exempli-
fied by butyrate and 4-phenylbutyrate (PBA). In a rabbit
model of shigellosis, oral administration of PBA has been
shown to eliminate the pathogen in rectum and colon and
recovery from the symptoms of the disease.
We here present a new class of compounds that are
considerably more powerful inducers of the human AMP
LL-37 (even at down to 800 times lower concentration
compared to PBA). Furthermore, a synergistic effect is
obtained when these compounds are used in combination
with vitamin D. These results were demonstrated both in a
reporter cell line containing a construct with luciferase
coupled to the human CAMP gene encoding LL-37 (Nylen
et al. 2013) and confirmed in the parental colonic epithelial
cell line HT-29. The new class of compounds is aroylated
phenylenediamines or derivatives or analogs thereof.
The effectiveness of this new class of inducers is unexpected
and implies that these compounds may work via different
or additional stimulatory mechanisms compared to previ-
ously identified inducers. Although some of the new
inducers are known to be histone deacetylase (HDAC)
inhibitors, no clear relationship between effectiveness
(IC50) for HDAC inhibition and stimulation of LL-37
expression is found, suggesting that the induction occurs
mainly through another mechanism.
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WS1.21
Distribution of the 1637delC Allele
Among MBL2 Genotypes
Helga Bjarnado´ttir, Margret Arnardottir & Bj€orn
Runar Luðvıksson
The National University Hospital of Iceland, Reykjavik, Iceland
Activation of complements via the lectin pathway (LP) is
mediated by five separate pattern recognition proteins
(PRPs). These are mannan-binding lectin (MBL), collectin-
11 (CL-11), ficolin-1, ficolin-2 and ficolin-3. MBL insuf-
ficiency is associated with susceptibility to infectious
diseases. The frequency of MBL insufficiency (defined as
AX/O and O/O genotypes) has been determined to be 7.9%
among Icelandic blood donors (IBD). This is relatively
high among healthy individuals and suggests that MBL
might be a redundant molecule. Ficolin-3 is the most
abundant of the PRPs in serum. The 1637delC mutation
(allele frequency 0.01) in the FCN3 gene causes ficolin-3
deficiency in a gene dose-dependent manner.
If MBL insufficiency is compensated for by, for example,
ficolin-3, then it is conceivable that ficolin-3 levels in MBL
insufficiency are higher than in sufficient cases. Therefore,
we hypothesize that the 1637delC allele should be rare or
not found among AX/O and O/O genotypes. The aim was to
investigate the distribution of the 1637delC allele among
MBL2 genotypes.
The cohort consisted of blood donors and individuals that
had been referred to our laboratory for MBL evaluations
(n = 637). MBL deficiency variants in exon 1 (B–D) were
determined in addition to the downregulating allele X in
the MBL2 promoter using melting curve analysis on the
LightCycler. The 1637delC allele was determined by
RFLP-PCR.
The resulting MBL2 genotypes were grouped into insuf-
ficient producers of MBL (AX/O and O/O; n = 106) and
sufficient (A/A and AY/O; n = 531). Twenty 1637delC
heterozygotes were detected in the sufficient group (3.8%),
whereas the allele was not found in the insufficient group
(P = 0.0426).
The results support our hypothesis that MBL-insufficient
individuals are not carriers of the 1637delC allele. This
could be explained by natural selection and reveals the
importance of this defence system.
WS1.22
Bronchial Epithelial Model VA10 and
Analyses of the Mechanism for
Phenylbutyrate-Induced Defences
Nikhil Kulkarni1, Zhiqian Yi1, Carolin Huehnken1,
Ulrich Zugel2, Birgitta Agerberth3 & Guðmundur
Guðmundsson1
1University of Iceland, Reykjavik, Iceland, 2Bayer Schering Pharma, Berlin,
Germany, 3Department of Medicinal biochemistry and biophysics,
Karolinska Instituet, Stockholm, Sweden
Antimicrobial peptides (AMPs) form an important part of
innate immunity in humans and constitute the first line
of defensive barrier against the invading microbes
preventing infections. In our current study, we looked
at the effect of histone deacetylase inhibitor 4-phenyl
butyric acid (PBA) on innate immune effectors and
associated regulatory pathways in a human bronchial
epithelial cell line VA10. PBA significantly induced
expressions of several innate effectors pro-LL-37 (cathelic-
idin), DEFB1 (human beta defensin 1) and others in a
time- and dose-dependent manner. In addition, PBA
significantly enhanced Toll-like receptor 5 ligand flagel-
lin-mediated pro-inflammatory cytokine expression. This
activation was shown dependent on activation of MAP
kinases. Further modulation of nuclear receptors differen-
tially affected PBA induction of CAMP expression in an
unexpected way. We also show the effect of PBA on
enzymes of the vitamin D metabolic pathway affecting
cathelicidin regulation. Antimicrobial peptides have been
indicated as effectors of wound healing. TGFB1, EGFR
and transcription factors of cell differentiation affected
PBA-induced LL-37 expression. This indicates a cross-talk
between pathways involved in growth and differentiation
with innate immune regulation. Finally, we have shown
PBA- and vitamin D3-induced antibacterial activity. Our
future goal is to understand detailed mechanism behind
PBA-induced antimicrobial effectors identifying both cis
and trans factors involved in regulation and ultimately
strengthening the use of PBA as a therapeutic drug
against infections.
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WS1.23
Frequency of Lectin Pathway Components
Deficiency Alleles and Genotypes in
Icelandic Blood Donors
Margret Arnardottir1,2, Helga Bjarnado´ttir1 &
Bj€orn Runar Luðvıksson1,2
1Department of Immunology, Landspitali – The National University
Hospital of Iceland Reykjavik, Iceland, 2Faculty of Medicine, University of
Iceland, Reykjavik, Iceland
The lectin pathway (LP) of complement activation is
initiated by five separate pattern recognition proteins
(PRPs) that can either be mannan-binding lectin (MBL),
ficolin (1–3) or collectin-11 (CL-11). Each of these PRPs is
complexed with serine proteases (MASP-1–3) and non-
enzymatic proteins (MAP1 and sMAP). Several mutations
cause deficiency in the LP components. Individuals with
the MBL2 genotypes O/O or XA/O have been defined as
MBL insufficient. The effect of the D120G allele in the
MASP2 gene and the 1637delC allele in the FCN3 gene is
gene dose dependent and homozygotes have no detectable
MASP-2 and ficolin-3 in serum.
Our aim was to evaluate the frequency of these deficiency
alleles and genotypes in Icelandic blood donors.
EDTA blood samples were collected from 500 blood
donors from the Icelandic Blood Bank and DNA isolated
using high salting-out procedure. A multiplex real-time
PCR assay with subsequent melting curve analysis was
performed to detect variants in the MBL2 gene (X/A/B/C/
D). To detect the 1637delC mutation, RFLP-PCR was
performed. Genotyping for the D120G mutation was
carried out using PCR-SSP.
A total of 498 blood donors were genotyped for the
1637delC and D120G alleles. Fifteen (3%) individuals
were found to be heterozygous for 1637delC and 39 (7.8%)
were found to be heterozygous for D120G. A total of 494
individuals were MBL2 genotyped. The frequency of MBL-
sufficient genotypes (YA/YA, XA/XA and YA/O) and
MBL-insufficient genotypes (XA/O and O/O) was 92.1%
and 7.9%, respectively.
Estimated allele frequencies of 1637delC and D120G are
0.015 and 0.041, respectively. We can therefore expect
approximately 1:4500 to be ficolin-3 deficient (~70
individuals) and 1:640 to be MASP-2 deficient (~500) in
the Icelandic population. These results are comparable to
population studies in other Caucasian populations. How-
ever, the frequency of MBL insufficiency is considerably
lower than found elsewhere in European Caucasians (7.9%
versus 16%).
WS1.24
The Effects of Carbamylated LL-37
Catalin Koro1, Brith Bergum1, Annelie Hellvard1,
Roland Jonsson1, Jan Potempa2 & Piotr Mydel1
1University of Bergen, Bergen, Norway, 2Jagiellonian University, Krakow,
Poland
Background: Non-enzymatic conversion of lysine residues
to homocitrulline (carbamylation) is a common post-
translational modification (PTM) of proteins and peptides,
which occurs in inflammatory foci. The process of lysine
carbamylation is mediated by the myeloperoxidase (MPO)
system (MPO/H2O2/SCN
-) employed by neutrophils to
kill bacteria. Thus, MPO has recently attracted a lot of
attention as a potential trigger factor for atherogenesis and
inflammation.
Upon infection, immune cells and endothelial cells start to
secrete the antimicrobial and immune modulatory peptide
LL-37 in order to fight invading pathogens. Thus, LL-37 is
mainly present in an inflammatory milieu where it is
frequently exposed to carbamylation. In this context, the
aim of our study was to analyse the effects of carbamylated
LL-37 in the interaction with human and bacterial cells.
Materials and methods: Synthetic LL-37 peptides with
lysine residues replaced with homocitrulline at sites that
we found to be vulnerable to carbamylation were used. The
bactericidal capacity of carbamylated LL-37 was investi-
gated in liquid cultures of B. subtilis, E. coli and S. aureus.
Transmigration assay was performed using 6.5-mm tran-
swell plates with 3 lm pore size. PMNs and erythrocytes
were used in lysing assays.
Results: Carbamylation has profound impact on LL-37
bactericidal and immunomodulatory activities. We found
that carbamylation decreases bactericidal capacity of LL-37
against B. subtilis and E. coli. Interestingly, LL-37 carbam-
ylated at positions 12 and 15 was strongly lytic to PMN, but
had no effect on erythrocytes. Additionally, LL-37 with
lysine carbamylated at positions 12 and 15 acted as strong
chemoattractant for PMNs as compared to native peptide.
Conclusions: Taken together, our data suggest that
carbamylation has a profound impact on the activity of
the LL-37 and may be detrimental to the host. Modified
LL-37 exerted strong pro-inflammatory activity that may
lead to exacerbation of inflammation with concomitant
collateral host tissue damage.
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WS1.25
M2-Macrophages to Clear Amyloid Beta
Oligomers in Alzheimer’s Disease Mice
Harald Lund & Robert Harris
Karolinska Institutet, Stockholm, Sweden
In Alzheimer’s disease (AD) transgenic mice, a pro-
inflammatory activation of microglia/macrophages in the
brain contributes to amyloid beta buildup and cognitive
decline. Reversal of this effect, by switching of the
microglial phenotype from pro-inflammatory (M1) to
anti-inflammatory (M2), is associated with better clearance
of amyloid beta deposits. In this study, we wanted to test
the hypothesis that in vitro-generated M2 macrophages
could phagocytose and clear amyloid beta in transgenic AD
mice. We show that M1 and M2-activations have opposite
effects on the ability of macrophages to phagocytose
amyloid beta oligomers, with M2 increasing and M1
decreasing phagocytosis. Interestingly, when macrophages
are transplanted into the hippocampus of aged transgenic
AD mice, they retain the ability to migrate to plaques and
phagocytose amyloid beta. Furthermore, we show that this
beneficial response towards amyloid beta is associated with
an upregulation of scavenger receptors, because both broad
pharmacological inhibition and scavenger receptor null
mice inhibited phagocytosis.
WS1.26
Effects of Dietary Gluten on Murine
Natural Killer Cell Activity
Jesper Larsen, Morten Dall, Kare Engkilde, Julie
Christine Antvorskov, Christian Weile, Knud
Josefsen & Karsten Buschard
Rigshospitalet, Copenhagen N, Denmark
Dietary gluten influences the development of type 1
diabetes (T1D) in non-obese diabetic (NOD) mice and
biobreeding (BB) rats and has been shown to influence a
wide range of immunological factors in the pancreas and
gut. A recently published case report describes a boy with
T1D, who was able to maintain a low fasting blood glucose
level without insulin therapy for more than 20 months,
while adhering to a gluten-free diet since the time of
diagnosis. In this study, the effect of gluten on NK cells in
vitro and in vivo was studied.
In vitro gliadin increased direct cytotoxicity and IFN-c
secretion from C57/BL6 splenocytes against MIN6 cells,
and gliadin preincubation of MIN6 cells led to a
significantly increased proportion of degranulating C57/
BL6 CD107a+ NK cells. Stimulation of C57/BL6-purified
NK cells with gliadin increased secretion of TNF-a, IL-2
and IL-10 after only 2 h of preincubation with MIN6 cells.
In vivo the standard gluten-containing diet led to an
increase in NKp46+ cells in BALB/c pancreatic lymph
nodes (PLN) compared to a GF diet. Finally, we found
higher expression of the proliferation marker CD71 and
activating receptor NKG2D on NKp46+ cells in all
lymphoid organs in BALB/c and NOD mice receiving the
gluten-containing diet.
We suggest that gluten peptides may activate NK cells
locally in the pancreas or gut, which may be important
during onset of T1D. These results represent a possible
mechanism for the effect of gluten on T1D and may help to
understand the beneficial effects of a GF diet seen in human
disease and animal models of T1D.
WS1.27
Cholera Toxin Selectively Blocks TLR7
Expression in Human Lymphocytes
Lucija Zenic, Inger Nordstro¨m & Kristina Eriksson
University of Gothenburg, Sweden, G€oteborg, Sweden
Cholera toxin (CT) is an enterotoxin from Vibrio cholera, the
causative agent of cholera disease in humans. Toll-like
receptors (TLR) are a family of pathogen-recognition
receptors sensing a variety of pathogens, critical for the
effective innate immune response to infection. The regu-
lation of TLR expression depends on a variety of stimuli
such as microbial components and cytokines. In this study,
we investigated whether CT could modulate TLR expres-
sion and thus interfere with the TLR-mediated response.
We found that CT specifically inhibited TLR7 mRNA
expression in peripheral blood mononuclear cells (PBMC)
as well as in TLR7-expressing plasmacytoid dendritic cells
and B cells. The TLR7 downregulation was mediated
through the catalytic CTA portion but was independent of
cAMP induction and consequent PKA activation. Further-
more, although a PKC activator mimicked the results
obtained by CT, the PKC inhibitors could not reverse the
CT-mediated downregulation of TLR7. However, we
found that CT induced the secretion of IL-6 and IL-8
and these cytokines promoted the inhibition of TLR7
expression in PBMC. This implies that CT induces
downregulation of TLR7 via an autocrine induction of
inflammatory cytokines.
 2014 John Wiley & Sons Ltd
Workshop 2. Immune Cells, Development
and Differentiation/Lymphocyte
Activation and Function
WS2.1
Differential Expression of TIM-2 During B
Cell Development
Riikka Syrja¨nen, Petar Petrov, Virpi Glumoff, Olli
Vainio & Tatsuya Uchida
University of Oulu, Oulu, Finland
Transmembrane (or T cell) immunoglobulin and mucin
domain containing molecule 2 (TIM-2) is expressed by
mature TH2 and B cells in mouse. Interestingly, our
recent report has shown that TIM-family molecules are
also expressed during embryonic haematopoiesis in mouse
and chicken; TIM-1 is expressed in embryonic para-
aortic/aorta-gonads-mesonephros region and TIM-4 by
foetal liver myeloid progenitor cells. Here, we investi-
gated the role of TIM-2 in haematopoiesis. Our results
show that TIM-2 is expressed in foetal liver and adult
bone marrow by common lymphoid progenitor, but not
by myeloid progenitor cells. Furthermore, foetal liver
CD45+TIM-2+ cells have in vitro B lymphoid but not
myeloid potential. During B cell differentiation, large
pro-B and large pre-B cells express TIM-2 in both foetal
liver and adult bone marrow. However, the subsequent
small pre-B and immature B cells do not express TIM-2
until differentiation into transitional B cells. Because
earlier studies have reported TIM-2 to function in the
inhibition of cell proliferation, the possible role of TIM-2
during B cell proliferation is discussed.
WS2.2
Prospective Isolation of Committed Mast
Cell Progenitors from Mouse Blood
Joakim Dahlin, Birgitta Heyman & Jenny Hallgren
Uppsala University, Uppsala, Sweden
Introduction: Mast cell progenitors develop from hae-
matopoietic stem cells in the bone marrow. Progenitors
committed to the mast cell lineage are postulated to
circulate through the blood and mature when reaching the
peripheral organs. However, committed mast cell
progenitors in the blood have not been found in mice
or humans.
Methods: Prospective mast cell progenitor populations
from mouse blood were isolated using gradient centrifu-
gation and two rounds of fluorescent-activated cell sorts.
The sorted cells were cultured in a cytokine cocktail,
which allowed differentiation into all myeloerythroid
lineages.
Results: We isolated a population of lineage- c-kithi IL-
33R+ integrin b7hi CD16/32hi progenitors from blood,
constituting 0.0045% of the mononuclear cells, which
gave rise to a pure population of mature mast cells when
cultured. The blood mast cell progenitors expressed higher
levels of FceRI in Th2-prone BALB/c mice than in Th1-
prone C57BL/6 mice.
Conclusions: We have identified a population of commit-
ted mast cell progenitors in mouse blood. These cells were
more mature in Th2-prone than in Th1-prone mice based
on the expression of FceRI.
WS2.3
Trojan, a Possible Regulator of Apoptosis,
Belongs to a Novel Protein Family
Petar Petrov1, David Burt2, Riikka Syrj€anen1,
Tatsuya Uchida1 & Olli Vainio1
1University of Oulu, Oulu, Finland, 2Roslin Institute, University of
Edinburgh, Edinburgh, UK
Trojan is a novel transmembrane protein, cloned from
chicken embryonic cDNA library that belongs to a yet
uncharacterized family of proteins. The molecule is
predicted to have an extracellular CCP domain, followed
by two FN3 domains and a short cytoplasmic tail with
several overlapping short functional motifs.
Trojan is expressed specifically in lymphoid tissues, where
its expression pattern is similar to that of IL-7Ra and the
antiapoptotic Bcl-2 on developing thymocytes. In vitro
studies showed that upon apoptosis induction, Trojan
expression rises on the surface of surviving cells and
gradually decreases towards its normal levels as cells
recover and proliferate. This similar expression, supported
by our current functional analyses, makes Trojan an
attractive candidate of having an antiapoptotic or prolif-
erative role. Stimulation through Trojan has yielded
controversial results that tend to show a slight rise in the
intracellular Ca++. We are aiming to mimic cell–cell and
ligand binding interactions in order to acquire conclusive
results.
The family of Trojan includes two other members. One is a
receptor type protein tyrosine phosphatase and the other is
a membrane protein having an ITAM within its cytoplas-
mic tail. By doing phylogenetic analyses, we determined
that the three family members had been subject to positive
evolutionary selection.
In the present study, we characterize a novel avian leucocyte
protein and its family evolution. From the data acquired, we
expect Trojan to serve as an apoptosis regulator.
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WS2.4
Improving the Quality of Dendritic Cells
to be Used in Immunotherapy
Dag Heiro Yi & Silke Appel
University of Bergen, Bergen, Norway
Therapeutic vaccinations of patients with malignant
diseases are based on the stimulation of their own immune
systems in order to get an antitumour response. Therapeu-
tic vaccines using dendritic cells (DC) have been shown to
be well tolerated and safe. However, this method requires
an improvement, as only few clinical relevant responses
could be documented so far. OK432 (picibanil) is an
immunotherapeutic agent derived from penicillin-killed
Streptococcus pyogenes that has been used effectively to
treat a variety of tumours. It has been shown previously
that OK432-stimulated DC produce large amounts of IL-
12. We here investigated the possibility to reduce the time
used to generate monocyte-derived DC (moDC) using
OK432 in combination with TLR ligands and PGE2 to
stimulate the cells. 6-day DC cultures and 3-day DC
stimulated with a cytokine cocktail consisting of IL-1beta,
TNF-alpha, IL-6 and PGE2 were used as controls. The
combination of OK432, TLR ligands and PGE2 used to
stimulate moDC after 3 days of culture resulted in
phenotypically mature cells expressing high amounts of
co-stimulatory molecules, MHC class II and CCR7. These
cells performed at least equally well in an MLR as 3-day
moDC cultures stimulated with the cytokine cocktail.
Moreover, preliminary data suggest that these cells
produced considerable amounts of IL-12. These results
make 3-day moDC stimulated with a combination of
OK432, TLR agonists and PGE2 a promising alternative
to be used for moDC-based cancer vaccines.
WS2.5
Structural Biology Reveals Binding Modes
of Superantigen SEE to TCR
Paulina Regenthal, Karin R€odstr€om & Karin
Lindkvist-Petersson
Lund University, Lund, Sweden
Superantigens (SAgs) are bacterial toxins that are able to
cause a massive immune response, which may lead to food
poisoning and toxic shock syndrome. Staphylococcus aureus is a
bacterium that can produce a broad range of SAgs, that is,
staphylococcal enterotoxins. A deeper insight into how
bacteria act on humans is necessary, because bacteria are
constantly developing resistance against antibiotics, whereas
not as many novel antibiotics are discovered. SAgs are
capable of cross-linking T cell receptors (TCRs) and major
histocompatibility complex (MHC) class II. They bind to
TCR variable a domain (Va) or b domain (Vb). Most SAgs
utilize the TCR Vb, although there are differences in
binding specificity. The staphylococcal SAgs are classified
into five different taxonomic groups (I-V), based on their
protein sequences. SAg-TCR structures with SAgs from
group I, II, IV and V are available. We have determined the
X-ray structure of staphylococcal enterotoxin E (SEE), from
group III, in complex with its TCR to 2.5 A resolution. The
TCR-SAg structure shows how SEE binds specifically to Vb
of the TCR, via extended loops. Many hydrogen bonds are
observed between the SEE andTCR. Structural knowledge of
SAgs in complex with TCR helps in understanding how
SAgs cause massive immune responses.
WS2.6
Lipid Subdomains and the Actin
Cytoskeleton in B Cell Receptor
Organization and Signalling
Sustar Vid & Pieta Mattila
University of Turku, Turku, Finland
B lymphocytes are responsible for humoral immunity, one
of the main components of the immune system protecting
the individual from pathogens. Binding of antigen with B
cell receptor (BCR) starts an intracellular signalling cascade
ultimately leading to antibody production. Aberrant B cell
activation plays a role in several diseases, such as immun-
odeficiencies, autoimmunity disorders and cancer.
Recently, it was demonstrated that the compartmentaliza-
tion of BCR, regulated by underlying actin cytoskeleton,
controls the receptor signalling even bypassing the need of
ligand binding. An outstanding and completely unresolved
question is how the lipid microenvironment contributes to
this behaviour of BCR and how the actin cytoskeleton and
plasma membrane interact to provide optimal regulation
for signalling. Advanced super-resolution optical micro-
scopic techniques enable unprecedented observations of
these nanodomains in live cells. Our aims are:
1 to determine the direct role of Lo membrane domains
in mediation of B cell receptor organization, activa-
tion, dynamics and signalling.
2 to determine the interaction between the different
plasma membrane domains and cortical actin cyto-
skeleton.
At the moment, we are setting up live cell imaging
techniques including super-resolution microscopy such as
single-particle tracking and dSTORM. In our study, a novel
specific Lo domain binder is used. Ostreolysin (Oly) is a 16-
kDa cytolytic protein specifically expressed in Pleurotus
ostreatus. Oly binds only to membrane containing equimo-
lar sphingomyelin and cholesterol in Lo phase, where
cholesterol concentration is over 30% of all lipids. As such,
modified non-lytic Oly is ideal marker for Lo domains
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suitable for live cell imaging. In addition, we are using
laurdan two-photon microscopy and lipid domains markers
based on differentially lipidated GFPs, as well as phospho-
inositide markers. With the combination of mentioned
techniques, we are able to study the role of different lipid
compartments and plasma membrane microdomains in
receptor signalling, actin cortex and cell activation.
WS2.7
Identification of Novel Regulators of B
Cell Receptor Signalling
Luqman Awoniyi, Elina Kuokkanen & Pieta Mattila
University of Turku, Turku, Finland
The protection of individual from surrounding pathogens
requires coordinated action of the innate and adaptive arms
of the immune system. B lymphocytes play a crucial role in
adaptive immune system by producing antibodies that
neutralize bacteria and toxins and target infected or
malignant cells for destruction. B cells recognize patho-
gens, or pathogen-derived antigens, by their B cell receptor
(BCR), which then triggers intricate downstream signal-
ling pathways and ultimately leads to cell differentiation
and antibody production. Strikingly, almost nothing is
known how the signals are transmitted in space and time in
the cell to trigger subsequent and necessary physical
changes, like antigen internalization and processing, and
cellular morphology changes. To understand the molecular
mechanisms governing B cell activation, it is essential to
understand the functional significance and the interaction
between BCR and various signalling pathways and to
identify the major players at different stages of activation
(i.e. early BCR signalling, internalization, antigen pro-
cessing). To this end, we use newly established techniques,
called BioID and APEX, which allow identification of
novel proteins that interact with or are in the close vicinity
of BCR during the different stages of cell activation. As the
methods are based on biotinylation inside intact cells and
are highly controllable in time, we gain unprecedented
insight into the molecular mechanisms of BCR signal
transmission with high spatial and temporal precision.
Currently, we are validating our BioID and APEX
constructs and estimate to get first results of the BCR
proximity interactome in 6 months.
WS2.8
GSH and Trx Can Substitute for Each
Other During dNTP Synthesis in Human
CD4+ T cells
Trine Levring, Martin Kongsbak & Carsten Geisler
University of Copenhagen, Copenhagen N, Denmark
CD4+ T cells play a very central role in the immune
system, as they modulate the response to a particular
pathogen. When the immune system is activated, the T
cells recognizing the specific antigen need to be activated
and expand in numbers. Expansion requires that the cells
are activated, grow, replicate their DNA and divide.
We have previously shown that T cells express transporters
for the amino acid cysteine when activated and that the
uptake of cysteine is required for DNA synthesis. In this
study, we show that cysteine is needed for glutathione
(GSH) synthesis and that in the absence of cysteine in the
medium, activated T cells fail to synthesize GSH. The
synthesized GSH is needed for DNA synthesis, which
explains why T cells depend on cysteine uptake to be able
to synthesize DNA. Some residual DNA synthesis can take
place in cells depleted of GSH. However, this residual
DNA synthesis could be abrogated by the inhibition of
thioredoxin (Trx), showing that Trx can substitute for
GSH during DNA synthesis in CD4+ T cells.
In other organisms, GSH and Trx have been shown to be
electron donors for the enzyme RNR during synthesis of
the DNA building blocks, dNTPs. The failure to reduce
RNR causes DNA synthesis to stop. In this study, we
show that inhibition of both Trx and GSH reduces dNTP
levels compared to cells in which only one of these
antioxidants is inhibited and untreated cells. These data
provide evidence of GSH and Trx being needed for dNTP
synthesis, most likely by acting as electron donors for
RNR.
WS2.9
A Ternary Complex of the T Cell-Specific
Adapter Protein (TSAd), Lck and IL-2
Inducible Kinase (Itk) is Maintained by
Mutual Phosphorylation Events
Ramakrishna Prabhu Gopalakrishnan, Stine
Granum, Greger Abrahamsen, Anne Spurkland &
Vibeke Sundvold-Gjerstad
University of Oslo, Oslo, Norway
T cells play a major role in adaptive immune response,
protecting the host from infections and cancer. Activation
of T cells is tightly controlled by kinases, phosphatases and
adapter proteins. Crucial steps in T cell activation is the
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activation of the kinases Lck and Itk. The T cell-specific
adaptor protein (TSAd) is expressed predominantly in
activated T cells and interacts with both Lck and Itk. We
have previously shown that Lck-mediated phosphorylation
of Itk is promoted by TSAd. Moreover, TSAd also
promotes phosphorylation of Lck-Y192, which changes
the binding affinity of the Lck-SH2 domain and results in
increased binding of Lck to TSAd. Here, we use a
combination of siRNA-mediated suppression of TSAd in
Jurkat T cells as well as transient transfections in 293T
cells and Jurkat T cells, and report that TSAd promotes
Lck-Itk interaction. Tyr to Phe mutants of either TSAd or
Lck point to critical roles for Lck-Y192 and TSAd-Y290 in
maintaining the three-molecular complex of TSAd, Itk and
Lck. TSAd-Y290 is indispensable for TSAd’s effect on Lck-
mediated Itk phosphorylation. The emerging picture is
thus that interaction of TSAd with Lck and Itk may be
reinforced by reciprocal phosphorylations. The role of this
ternary complex in events downstream of TCR activation is
currently under investigation in our laboratory.
WS2.10
Colon Draining Lymph Nodes Act as
Secondary Sites of Activation for
Autoreactive BDC2.5 T Cells in NOD Mice
Raine Toivonen & Arno H€anninen
University of Turku, Turku, Finland
The studies on lymphatic system and activation of specific
immune responses are extensive; however, little effort has
been put on structural studies of lymphatic vasculature.
Nevertheless, this question is of paramount importance
when making claims on activation of cell populations due
to occurrences in specific organs. Here, we concentrate on
the colon draining lymphatic system and the mesenteric
lymph nodes (MLN), and how the lymph veins collect
lymphatic fluids from different parts of the colon to specific
LNs. To visualize lymphatics and primary LNs, we injected
fluorescein isothiocyanate-labelled dextran (FITC-Dx) sub-
serosally to various sites of colon. The ascending, transverse
and descending colon each drain to individual LNs
embedded in the mesenterium. The activation of plasma-
cytoid and CD103+ dendritic cells was found to be
activated at these sites after the induction of colitis,
whereas the major part of MLN did not show activation of
these cell populations. We also saw a significant activation
of autoreactive BDC2.5 T cells in colon draining LNs
(coLNs), but not in MLN. These results underline the
importance of recognizing the relevant lymphatic sites
according to the primary organ which is to be studied.
WS2.11
The Role of Pro-Inflammatory Cytokines
upon the Differentiation and Function of
In Vitro-Induced CD8+ Tregs
Una Bjarnado´ttir1, Andri Leo Lemarquis2,
Snæfrıður Halldorsdottir1,2, Jona Freysdottir1,2,3 &
Bj€orn Runar Luðvıksson1,2
1Department of Immunology, Landspitali, The National University Hospital
of Iceland, Reykjavik, Iceland, 2Faculty of Medicine, Biomedical Center,
University of Iceland, Reykjavik, Iceland, 3Centre for Rheumatology
Research, Landspitali, National University Hospital of Iceland, Reykjavik,
Iceland
Introduction: CD8+ Tregs may play an essential role in
the immunopathology of various autoimmune diseases.
Therefore, they have a great potential as therapeutic agents
and further studies on their behaviour are essential to
enhance our understanding regarding their function. The
aim of this study was to evaluate the role of the innate
immune system on in vitro-induced CD8+ Treg differen-
tiation and function. Furthermore, their cytokine profile
was investigated.
Material and methods: Naive human
CD8+CD25CD45RA+ T cells were selected from PBMCs
isolated from healthy blood donors and cultured in Treg-
inducing conditions with or without IL-1b, TNF-a or
monocyte-derived DCs. Their cytokine profile was analysed
using ELISA and Luminex assay.
Results: CD8+CD127CD25hiFoxP3hi Tregs (CD8+ iT-
regs) were induced in vitro in the presence of TGF-b1 and
IL-2, which had a synergistic effect (P < 0.0001) upon
their differentiation. Various concentrations of IL-1b and
TNF-a were added to the CD8+ T cell inducing cultures.
IL-1b significantly suppresses the differentiation of human
CD8+ iTregs at high concentration (P < 0.01). Further-
more, IL-1b (10 ng/ml) and TNF-a (50 ng/mL) reduced
the CD8+ iTreg-mediated suppression on both CD4+ and
CD8+ effector T cells. This may be linked to the reduction
in IL-10 and TGF-b1 secretion (P < 0.05/0.01) in the
presence of IL-1b and TNF-a. Finally, the role of innate
immunity in the differentiation and function of CD8+
iTregs was further verified in the presence of mDCs. In
addition, their function was possibly associated with TGF-
b1 secretion.
Conclusion: The generation of functional CD8+ iTregs is
IL-2 and TGF-b1 dependent under both anti-CD3- and
mDC-driven stimulatory conditions. In addition, TNF-a
and IL-1b reduce their suppressive function, which might
be IL-10 and TGF-b1 driven. Thus, this study provides
clear evidence that cells and molecules of the innate
immune system have a great influence upon the differen-
tiation and function of human CD8+ iTregs.
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WS2.12
Differences in the Autoreactive T Cell
Pool When Restricted by the Highly
Related Rheumatoid Arthritis-Associated
HLA-DRB1 Alleles *04:01, *04:04 and
*01:01
Charlotta Sandin1, Christina Gerstner1, Hannes
Uchtenhagen2, Eddie James3, Jennifer Pieper2,
Mary Rieck3, Adnane Achour2, Jane Buckner3,
Tatiana Sandalova2 & Vivianne Malmstr€om2
1Department of Medicine, Karolinska Institutet, Stockholm, Sweden,,
2Karolinska Institutet, Stockholm, Sweden, 3Benaroya Research Institute
at Virginia Mason, Seattle, WA, USA
The shared epitope (SE) alleles HLA-DRB1*04:01, *04:04
and *01:01 are associated with risk for rheumatoid arthritis
(RA) positive for autoantibodies against citrullinated
proteins, for example a-enolase. Recent studies identified
specific citrullinated epitopes presented by *0401 that are
associated with disease and provided molecular evidence for
how citrullination could break tolerance. So far, the risk
conferred by *04:04 and *01:01 is less well characterized.
Here, we aimed at the identification and functional
characterization of citrullinated a-enolase T cell epitopes
presented by these alleles.
Overlapping peptides were screened and several novel a-
enolase epitope candidates identified. A large, but not
complete, overlap was observed between *0401, *0404 and
*0101. Surprisingly, the binding of native and citrullinat-
ed epitopes indicated that the bias for citrullinated epitopes
of *04:01 appears less pronounced in *0404 or *0101. In
vitro stimulation of peripheral blood mononuclear cells
(PBMCs) demonstrated that a number of the epitope
candidates are indeed immunogenic in RA patients and
elicit a pro-inflammatory cytokine response. However, and
in agreement with the peptide binding, a significant
preference for citrullinated epitopes was only observed for
*04:01.
While this study confirms the compelling bias of *04:01
for citrullinated epitopes, it demonstrates its absence in
*0404 and *0101. Our data suggest that, despite their
name and shared amino acids, significant differences exist
in how these HLA-DR alleles confer risk to RA.
Altogether, this demonstrates how even subtle changes in
the MHC peptide-binding groove can have significant
immunological impacts and has prompted ongoing struc-
tural characterization of the different properties of *04:01
versus *01:01 and *04:04.
WS2.13
Retinoic Acid Modulates the Early
Expansion and Differentiation of CD4+
T Cells During the Development of
Intestinal Inflammation
Aymeric Rivollier1, Lieneke Pool1, Kerstin
Wendland2 & William Agace2
1National Veterinary Institute, Danish Technical University, Frederiksberg C,
Denmark, 2Department of Experimental Medical Sciences, Lund University,
Lund, Sweden
Epidemiological studies of vitamin A-deficient populations
have illustrated the importance of vitamin A and its
metabolite all-trans retinoic acid (RA) in mucosal immune
responses. In support of that finding, we and others have
shown that RA produced by intestinal dendritic cells is
required for the generation of gut-tropic T cells and IgA-
secreting plasma cells. Evidences from the literature
suggest antagonistic roles for RA in intestinal T cell
biology. In the homeostatic intestine, RA plays anti-
inflammatory functions, sustaining the development of
foxp3+ regulatory T cells, while restraining Th17 effector
T cell differentiation. In contrast, RA has pro-inflamma-
tory functions, promoting Th1/Th17 effector T cell
responses, in the gut upon pathogen exposure. Therefore,
the circumstances in which RA plays pro- or anti-
inflammatory roles and the target T cell populations
remain to be more clearly defined.
RA has been shown to control the CD4+ T cell compart-
ment by signalling through the RA receptor RARa. We
therefore took advantage of mice expressing a dominant
negative form of the RARa, specifically in the CD4 T cell
compartment (RARfl/wt CD4Cre+ mice), in order to
conditionally ablate RA signalling in CD4+ T cells during
the development of intestinal inflammation in the T cell
transfer colitis model.
Histological, flow cytometry and real-time PCR analyses
indicate that RA signalling modulates the early expansion
and differentiation of CD4+ T cells following their transfer
into RAG/mice. Indeed, RA signalling-deficient CD4+T
cells selectively accumulate and showed capacities to differ-
entiate into IL-17+, IL-17+IFN-c+ and foxp3+ cells, but
reduced capacities to differentiate into IFN-c+ cells and were
less potent at inducing intestinal inflammation. RA signal-
ling-deficient CD4+ T cells were also unable to differentiate
into cytotoxic T lymphocyte (CTL)-like cells within the
intraepithelial lymphocyte compartment of the colon.
We are currently deciphering the mechanisms of these
effects of RA on T cells.
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WS2.14
Abolishing Riboflavinkinase Activity
Massively Impairs a T Cell-Mediated
Antiviral Immune Response
Andrew Berdel, Kristin Jakobshagen, Beate Ward,
Martin Kr€onke & Olaf Uterm€ohlen
Institute for Medical Microbiology, Immunology and Hygiene, Cologne,
Germany
Riboflavinkinase (RFK) activity generates FMN, which is
also the substrate for synthesis of FAD. Both FMN and
FAD are essentially required by flavoenzymes in a multi-
tude of metabolic pathways. The consequences of RFK
deficiency during the immune response against the lym-
phocytic choriomeningitis virus (LCMV) were character-
ized in conditionally (RFK(fl/fl)/MxCre) or cell specifically
(RFK(fl/fl)/CD11cCre or CD4Cre) RFK-deficient mice.
Systemic levels of type I IFN early after infection of mice
with LCMV effectively induced Cre expression in RFK(fl/
fl)/MxCre mice as judged by rapid deletion of floxed RFK
alleles and, consequently, complete knockdown of RFK at
the protein level by day 4 post-infection. As a consequence,
proliferation and maturation of LCMV-specific CD8+ T
cells were massively impaired. This resulted in significantly
delayed elimination of LCMV from the organs of RFK(fl/
fl)/MxCre mice.
To reveal in which cell type(s) RFK activity is required to
generate antiviral CD8+ T cells, the LCMV-specific immune
response was characterized in mice with cell type-specific
deletions of RFK either in dendritic cells (RFK(fl/fl)/
CD11cCre) or in T lymphocytes (RFK(fl/fl)/CD4Cre). In
RFK(fl/fl)/CD11c Cre mice, the generation and antiviral
activity of LCMV-specific CD8+ T cells were not signif-
icantly impaired. In sharp contrast, in RFK(fl/fl)/CD4Cre
mice, the expansion andmaturation of LCMV-specific CD8+
T cells were almost abolished. Consequently, the LCMV was
not eliminated from the organs of these mice.
Taken together, deletion of RFK activity even during an
ongoing virus infection significantly suppresses the virus-
specific immune response. Therefore, inhibition of RFK
activity might be a promising approach for immunosup-
pressive therapy in future.
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Workshop 3. Immune Regulation
WS3.1
Divergent Regulation of B and T Cell
Responses by Complement-Activating
IgM
Zhoujie Ding1, Anna Bergman1, Christian
Rutemark1, Rika Ouchida2, Hiroshi Ohno2, Ji-Yang
Wang3,4 & Birgitta Heyman1
1Department of Medical Biochemistry and Microbiology, Uppsala
University, Uppsala, Sweden, 2RIKEN Research Center for Allergy and
Immunology, Yokohama, Japan, 3Medical Research Institute, Tokyo
Medical and Dental University, Tokyo, Japan, 4Department of
Immunology, Shanghai Medical College, Fudan University, SHANGHAI,
China
Complement is important for immune responses and IgM
is a potent activator of the complement system. However,
knockin mice of the Cl13 strain, producing IgM unable to
activate complement due to a point mutation on the l-
heavy chain, have normal primary antibody responses. This
suggests that natural IgM capable of activating comple-
ment does not play a key role in inducing normal antibody
response. This puzzling finding promoted our investigation
of whether the ability of IgM to activate complement is
indeed required in specific IgM-mediated enhancement of
immune responses. We first compared the binding ability
of the mutant Cl13 IgM and WT IgM to the recently
discovered murine IgM Fc receptor (FclR) and demon-
strated that both of them bind equally well to the FclR. In
spite of this, WT IgM enhanced antibody and germinal
centre responses after immunization together with sheep
red blood cells (SRBC) or keyhole limpet hemocyanine
(KLH), whereas Cl13 IgM failed to do so. In addition, it
has been reported that IgM cannot enhance antibody
responses in T cell-deficient nude mice and thus does not
substitute for T cell help. Interestingly, we found that WT
IgM anti-SRBC administered with SRBC-OVA had no
effect on the activation or proliferation of OVA-specific
CD4+ T cells although it efficiently enhanced the T-
dependent antibody responses against both SRBC and
OVA. In conclusion, our study emphasizes the importance
of complement-activating ability of specific IgM to
enhance B cell responses and also reveals a divergent
regulation of T and B cell responses by IgM.
WS3.2
Antigen-Specific IgM Causes Deposition
of C3 on Sheep Red Blood Cells Within
Seconds After Immunization
Anna Bergman, Zhoujie Ding & Birgitta Heyman
Uppsala University, Uppsala, Sweden
C1q, the initiator of the classical pathway, is primarily
activated by antibody–antigen complexes (immune com-
plexes, ICs). Deficiency of classical complement factors
results in impaired antibody responses. This may seem as a
paradox, because there are no, or are least very low,
antigen-specific antibodies (forming the ICs that activate
C1q) prior to the antibody response. Nonetheless, if
antigen-specific IgM is administered before the antigen,
the antibody response will be enhanced: IgM-mediated
enhancement – a phenomenon dependent on IgM being
able to activate complement. It was thus hypothesized that
natural IgM would bind an antigen with enough affinity to
form the ICs C1q needed for activation. However, this was
proven wrong when it was shown that Cl13 mice
(producing IgM unable to activate complement) have
normal antibody responses. This prompted the investiga-
tion of whether the antigen itself, in this case sheep red
blood cells (SRBC), was able to activate complement. C3
deposition on SRBCs incubated 30 min with fresh mouse
plasma did not differ from SRBC incubated with PBS.
Only after adding IgM anti-SRBC to the mixture, there
was a marked C3 deposition on the SRBC. In vivo,
immunization with SRBC together with specific IgM
resulted in C3 deposition on the antigen within seconds in
the blood. SRBC administered alone had no detectable C3
on their surface. Thirty minutes after immunization with
SRBC alone, C3-coated SRBC were found in the marginal
zone. In conclusion, SRBC alone are able to activate
complement in vivo, although specific IgM markedly
increases the efficiency of C3 deposition.
WS3.3
MZ B Cells Transport IgG3-Ag to Splenic
Follicles and Induce Germinal Centres
Lu Zhang, Zhoujie Ding, Hui Xu, Frida
Henningsson & Birgitta Heyman
Uppsala University, Uppsala, Sweden
IgG3–antigen complexes can cause enhancement of the
antigen-specific antibody response compared to what is
seen when the antigens are administered alone. According
to our in vivo study, IgG3 increases antigen binding to
marginal zone (MZ) B cells, but not to peripheral B cells.
The binding is mediated through complement receptors 1
and 2 (CR1/2, encoded by Cr2). Within 2 h of immuni-
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zation, antigen complexed to IgG3 can be detected in
splenic B cell follicles. This is followed by an increased
germinal centre formation compared to that seen in mice
immunized with antigens alone. Experiments with Cr2
KO mice show that the IgG3-mediated effects depend on
CR1/2. Studies in bone marrow chimeric mice demonstrate
that CR1/2 must be expressed on both follicular dendritic
cells (FDC) and B cells in order for an optimal IgG3-
mediated enhancement of antibody responses. Thus, these
data suggest that CR1/2+ MZ B cells transport IgG3–
antigen immune complexes to B cell follicles, thereby
increasing the concentration of antigen as well as the
germinal centre formation, which leads to the enhancement
of antibody responses.
WS3.4
Anti-CD23–Antigen Conjugates Localize
Antigen to Splenic Follicles and Enhance
Specific Ab Response
Hui Xu, Lenny Mechelen, Frida Henningsson &
Birgitta Heyman
Uppsala University, Uppsala, Sweden
Antigen transported to lymphoid B cell follicles is the
initial step of adaptive immune responses. Follicular B cells
(FOBs) circulate from peripheral blood through the
secondary lymphoid organs. Therefore, they are ideal
transporters of antigens as they have access to splenic
follicles. Here, we report that targeting antigens to CD23,
a receptor on FOBs, is followed by rapid transport of the
antigens to follicles. Anti-CD23 mAb (or an isotype
control) were covalently linked to OVA and administered
i.v. to mice. The antigen binds to FOBs in peripheral blood
10 min after immunization and is localized in splenic
follicles after 30 min. Specific Ab responses were also
enhanced in mice immunized with anti-CD23-antigen as
compared to isotype control antigen or antigen alone.
Moreover, anti-CD23–antigen conjugates did not enhance
specific antibody responses or localization of antigen to
splenic follicles in CD23 KO mice, demonstrating that
these processes are CD23 dependent. Our data suggest a
possible way to enhance specific antibody responses and
may be useful for therapeutic vaccination.
WS3.5
IgG-Mediated Suppression of Primary IgG
Anti-SRBC Responses is not Dependent
on FccR or Complement
Joakim J.E. Bergstro¨m, Annika Grahn Westin &
Birgitta Heyman
Department of Medical Biochemistry and Microbiology, Uppsala
University, Uppsala, Sweden
Antibodies administered with the antigen to which they
bind can profoundly influence the resulting antigen-
specific humoral immune response, a phenomenon known
as antibody feedback regulation. This regulatory capacity
can result in 99% suppression or 1000-fold enhancement of
the specific antibody response and is dependent on antigen
and antibody isotype. Passively administered IgG can
suppress the specific antibody response against large
particulate antigens such as erythrocytes. This is used to
prevent haemolytic disease in newborns by so-called Rh(D)
prophylaxis. The mechanism behind IgG-mediated sup-
pression is not very well understood. One possibility would
be that IgG could interact with the inhibitory Fc-gamma
receptor (FccR) on B cells (FccRIIB) and/or other FccR
and exert its suppressive function via these. Alternatively,
the complement system could be involved. Earlier studies
have shown that suppression of the IgM response does not
require FccR. The aim of the present study was to
investigate whether IgG could suppress IgG responses,
whether this required FccR, and whether IgG could
suppress in mice lacking CR1 and CR2 or C1q.
Mice (BALB/c, FcRc/, FccRIIB/, Cr2/, C1q/)
were immunized i.v. with IgG anti-SRBC (sheep red blood
cells) and SRBC or with SRBC or IgG alone. IgM (direct
plaque-forming cells, PFC) and IgG (ELISA) responses
were analysed and, as expected, IgG suppressed these
responses dramatically. The suppressive capacity of IgG
was not affected by the absence of FcRc, FccRIIB, CR1/
CR2 or C1q.
WS3.6
Studies on the Human Primary Amine
Oxidase/Sialic Acid Binding Ig-Like
Lectin-9 Interaction
Heli Elovaara1, Vimal Parkash2, Ruth Fair-M€akel€a1,
Eva Bligt-Linden2, Tiina Salminen2 & Sirpa
Jalkanen2
1University of Turku, Turku, Finland, 2Division of Biochemistry, Department
of Biosciences,Abo Akademi University, Turku, Finland
Leucocyte trafficking fromblood vessels into inflamed tissues
is essential in maintaining health. Human primary amine
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oxidase (hAOC3) on the endothelium is a significant player
in the trafficking with a still unknown mechanism. The first
hAOC3 counter molecules have been identified being sialic
acid binding Ig-like lectins-9 and -10 [SIGLEC-9 and -10;
Kivi et al. (2009) Blood 114:5385; Aalto et al. (2011) Blood
118: 3725]. Our objective is to characterize the mechanisms
of hAOC3 in the leucocyte trafficking by studying its
interaction with SIGLEC-9 and -10.
For the interaction studies, we have put up an insect cell
production system and purified the protein by chromato-
graphic methods. The binding constants for hAOC3/
SIGLEC interaction were determined by a surface plasmon
resonance (SPR). The mutagenesis of specific arginine
residues of SIGLECs was performed to study the impor-
tance of these residues in the interaction. We also studied
the activity of hAOC3 towards the recombinant SIGLECs.
We will aim for detailed characterization of the interaction
via the co-crystallization of hAOC3/SIGLEC complex.
Finally, we will test whether hAOC3/SIGLEC interaction
influences SIGLEC signalling in neutrophils.
We have been able to produce a soluble extracellular part of
SIGLEC-9. The SPR studies indicate specific binding of
SIGLECs to the immobilized hAOC3, with Kd of about 1
micromolar. The arginine residues, which were shown by
peptide studies to be important for the binding, do not affect
significantly the binding at the protein level. However, we
have demonstrated that the binding of SIGLEC-9 to hAOC3
is dramatically affected by the addition of sialic acid to the
binding assay. This implies that also sialic acid-binding V-
domain is involved in the SIGLEC-9/hAOC3 interaction. In
addition, we have demonstrated that SIGLEC-9 may
interfere the activity of hACO3.
WS3.7
Modulation of Dendritic Cells by
Exosomes Derived from Breast Milk and
Plasma
Pia Larssen, Maria Eldh & Susanne Gabrielsson
Karolinska Institutet, Stockholm, Sweden
Exosomes are small extracellular vesicles, 30–100 nm in
diameter, produced and secreted by most cells including
immune cells. They play a role in a variety of biological
systems and are capable of both immune activation and
tolerance induction. Breast feeding has been suggested to
decrease the risk of allergy development in the newborn
child. Breast milk contains exosomes that can induce
regulatory T cells in a mixed peripheral blood mononuclear
cell culture. However, it is not known whether milk
exosomes exert a direct effect shifting na€ıve T cells to a
regulatory phenotype or whether exosomes induce a
tolerogenic dendritic cell phenotype that in turn regulates
the T cell profile. In contrast to milk exosomes, we
speculate that plasma exosomes are more pro-inflamma-
tory. Therefore, we compared these two exosomal sources to
explore whether they have different immune modulatory
properties. Exosomes were isolated by differential ultra-
centrifugation and captured on anti-CD63-coated latex
beads for phenotype analysis using flow cytometry. Mono-
cyte-derived dendritic cells (MDDCs) were incubated for
24 h with exosomes from milk or plasma, respectively,
followed by phenotyping using flow cytometry. Milk and
plasma exosomes expressed similar surface markers such as
the tetraspanins, CD9, CD63 and CD81 but had low HLA-
ABC and HLA-DR levels. In spite similar levels of surface
molecules, plasma-derived exosomes, but not milk derived,
strongly increased HLA-DR expression on MDDCs. These
data indicate that exosomes of different origin carry diverse
biological functions. While plasma exosomes seem to be
more immune stimulatory, we are currently investigating
the tolerogenic capacity of the milk exosomes.
WS3.8
Requirement for IRF4-Dependent DCs
for the Generation of Th2 Responses
During Infection with the Murine
Gastrointestinal Nematode Trichuris
muris
Mimoza Demiri, Emma Persson, William Agace &
Marcus Svensson-Frej
Lund University, Lund, Sweden
The nature of adaptive CD4+ T cell responses is controlled
by the antigen-presenting DC and environmental factors
present during activation. While the requirements for the
induction of Th1, Th17 and regulatory T cells are
relatively well defined, comparably little is known with
regard to how CD4+T cells are directed to become Th2
cells, including the involvement of specific DC subsets.
Trichuris muris is a large intestinal nematode frequently
used to study Th2 responses. Here, we investigate the role
of DC subsets during T. muris infection, utilizing
wild-type mice and CD11cCRE 9 IRF4flox mice
that have specific reduction in CD103+CD11b+ and
CD103CD11b+ DCs in the mesenteric lymph nodes
(MLN) and intestine. Preliminary results show an aberrant
Th2 cytokine profile in MLNs and increased worm burden
in infected mice with IRF4-deficient DCs, suggesting an
impaired Th2 response in these mice. This suggests that
IRF4-dependent DCs are important for the generation of
optimal Th2 responses during intestinal helminth infec-
tion. We are currently utilizing in vitro models to further
investigate DC subsets and mechanisms involved during
Th2 induction.
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WS3.9
Interferon Regulatory Factor 4 Expression
in Thymic Epithelium Regulates
Peripheral Tolerance by Controlling
Thymic Regulatory T Cell Output
Uku Haljasorg1, James Dooley2, Martti Laan1, Kai
Kisand1, Rudolf Bichele1, Adrian Liston2 & P€art
Peterson1
1University of Tartu, Tartu, Estonia, 2Autoimmune Genetics Laboratory,
University of Leuven, Leuven, Belgium
Interferon regulatory factor 4 (Irf4) has been shown to
play a critical role in the differentiation and function of a
diverse group of peripheral immune cell populations
including B cells, macrophages, dendritic cells and several
T cell subpopulations. Despite its high expression levels
in thymic epithelial cells (TECs), Irf4 has not been
studied in the context of thymic microenvironment and
its consequent effect on the generation of an immuno-
competent set of peripheral T cells. To address this issue,
we crossed Irf4 flox/flox mice with FoxN1-Cre mice
eventually resulting in TEC-specific Irf4-deficient progeny
(Irf4/). Here, we show that the morphology of Irf4-
deficient thymi is in general unaffected and the numbers
and phenotype of a majority of T cell populations
originating from the thymus appear to be comparable to
the control mice. We witnessed, however, a 50% decrease
in the numbers and percentages in regulatory T (Treg)
cells in the thymi of 2-month-old Irf4/ mice. This
decrease was also present in the periphery where Irf4/
mice had a 20% decrease in the splenic Treg cell
population. Aged Irf4/ mice also showed an increased
incidence of autoimmune infiltrations in the salivary
glands compared to the controls. Altogether, these results
indicate a role for TEC-specific Irf4 expression in avoiding
peripheral autoimmunity by regulating the maturation
process of thymic regulatory T cells.
WS3.10
CD1d Expression on Pancreatic β-Cells as
a Target for the β-Cell-Specific
Autoantibody IC2
Christina Engmose1, Kathrine Jensen1, Kare
Engkilde1, Thomas Herrmann2 & Carl-Henrik
Brogren1
1Rigshospitalet, Copenhagen N, Denmark, 2Institute f€ur Virologie und
Immunbiologie, W€urzburg, Germany
Natural killer T (NKT) cells play a regulatory role in the
immune system and are stimulated by binding to glyco-
lipid–CD1d complexes. The autoantibody IC2 seems to
have a strong inhibitory function on the cytokine release
from NKT cells in vitro. Therefore, we searched for CD1d
expression on pancreatic tumour b-cell line (b-TC-tet) and
on primary mouse b-cells in order to clarify the presence of
CD1d b-cell expression.
Flow cytometry was performed on spleen and pancreatic
cells from NOD, NOD CD1d and C57Bl/6 CD1d-
knockout mice. Staining for b-cell, CD45+, CD1d+ and
IC2+ cells was performed. For confocal microscopy studies,
the IC2+, CD1d+ and insulin were used. The staining was
performed according to the standard protocols. Classical
iNKT functional assays with IL-2 release were used to
elucidate IC2 inhibition. The hybridoma cell line NKT-
1.2 functions as responder cell with CD1d-coated plates
uploaded with aGalCer.
Flow cytometric analysis of both b-TC-tet and primary b-
cells from the three mice types demonstrated CD1d on
their surface. Expression of CD1d on b-cells was observed
to be significantly higher, compared to the expression on
CD45+ cells from pancreas and spleen. Furthermore, IC2
binding is shown on b-TC-tet and primary b-cells both in
flow cytometry and in confocal microscopy. Flow cytomet-
ric data indicate CD1d expression on b-cells from the two
CD1d-knockout mice strains.
These observations indicate that CD1d molecules are
expressed not only on antigen-presenting cells but also
strongly by pancreatic b-cells. The b-cell themselves can
therefore contribute to the maintenance of normal NKT
cells regulation. The inhibitory IC2-binding to CD1d is
dependent on certain glycolipids in the cleft of CD1d, and
if these lipids are not present, IC2 will not bind. We are
currently searching for a CD1d glycolipid specific for b-cell
and IC2 binding.
WS3.11
T Regulatory Cells Ameliorate Joint
Destruction in Staphylococcus
aureus-Induced Arthritis
Berglind Bergmann1, Pernilla Jirholt1, Inga-Lill
Martensson1, David Klatzmann2 & Inger
Gjertsson1
1Institute of Medicine, University of Gothenburg, Gothenburg, Sweden,
2Department of Inflammation, Immunopathology and Biotherapy, The
Pierre-and-Marie-Curie University, Paris, France
Background: Staphylococcus aureus is a common cause of
bacterial arthritis, characterized by a severe destruction of
the affected joints, often followed by permanent articular
damage. It has proven difficult to effectively treat this type
of infection due to the necessity of a maintaining a strong
immune response for bacterial elimination, and concomi-
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tant downregulation of the exaggerated immune response
that contributes to the tissue destruction. Regulatory T
cells (Tregs), defined by the expression of CD4, CD25 and
FOXP3, limit immune responses and have also been shown
to inhibit the formation of bone-resorbing osteoclasts.
Interleukin 2 (IL-2) is essential for the homeostasis and
maintenance of Tregs in the periphery and has been shown
to be of therapeutic value in treating hepatitis C-induced
vasculitis by increasing and modulating Tregs. This study
was performed to assess the role of Tregs in the outcome of
S. aureus-induced arthritis.
Methods: Adeno-associated virus (AAV) vector, encoding
for IL-2 or luciferase, was injected intraperitoneally into
C57Bl/6 mice 19 days prior to intravenous inoculation of
TSST-1-producing S. aureus.
Results: The IL-2-treated mice showed a profound increase
in the frequency of CD4+CD25+FOXP3+ cells (Tregs) in
the blood and spleen both before and 10 days after
bacterial inoculation. The IL-2-treated group lost signif-
icantly less weight and displayed an increased ability to
clear the bacteria compared to the control group. Moreover,
the IL-2-treated mice developed significantly decreased
joint destruction and synovitis compared to the control
group. These findings coincided with a significant decrease
in serum levels of IL-6 in the IL-2 treated group. In
addition, similar results were obtained after adoptive
transfer of Tregs.
Conclusions: An increased proportion of Tregs limits the
S. aureus-induced immune response without hampering
bacterial clearance and general disease.
WS3.12
The Role of CD73 in Macrophage
Polarization
Dominik Eichin1, Juha Laurila2, Sirpa Jalkanen2,3 &
Marko Salmi2,4
1University of Turku, Turku, Finland, 2MediCity Research Laboratory,
University of Turku, Turku, Finland, 3Department of Medical Microbiology
and Immunology, University of Turku, Turku, Finland, 4Department of
Medical Biochemistry and Genetics, University of Turku, Turku, Finland
The ectoenzyme CD73 is a potent producer of extracellular
adenosine as it dephosphorylates adenosine monophosphate
(AMP). While CD73 can exert enzymatic-independent
effects such as promoting angiogenesis, many of its functions
are related to this enzymatic activity. This activity cannot
only play a role in lymphocyte migration, but it can also be
involved in downregulation of antitumour immunity, as the
produced adenosine is highly anti-inflammatory. Due to the
influence of CD73 on inflammation, its overexpression in
several cancer types and its effect on cell trafficking, CD73 is
an important player in the immune system.
While research on several aspects of the immune system
concerning CD73 has been carried out, macrophages have
so far not been studied very intensively. Macrophages can
be separated into a pro- and an anti-inflammatory pheno-
type, also called M1 and M2. As both CD73 and
macrophages are involved in (anti)-inflammatory processes,
our aim was to find and characterize a connection between
them. We therefore were focusing to determine whether
CD73 is differently expressed on M1 and M2 macrophages
and to analyse whether CD73 is required for macrophage
polarization towards either phenotype.
In order to answer these questions, humanmacrophages were
cultured and polarized towards M1 or M2 in vitro. In
addition, mouse macrophages were polarized towards the
same phenotype in vivo. After a successful polarization, the
macrophage populations were compared by applying differ-
ent techniques such as flow cytometry, qPCR andmultiplex.
We could clearly detect the expression of CD73 on in vitro
M1 polarized human monocytes/macrophages, while no
expression on unpolarized or M2 macrophages could be
found. Furthermore, we could neither detect any difference
in the CD73 expression of polarized mouse macrophages
nor could we see any effect of CD73 on the polarization
ability of those cells.
WS3.13
Vagus Nerve Stimulation Decreases T Cell
Activation in Immune Organs
Johanna Estelius, Erwan Le Ma^ıtre & Jon Lampa
Karolinska Institutet, Stockholm, Sweden
Vagus nerve stimulation (VNS) is known to decrease the
effects of an inflammatory response prompting investiga-
tions of its potential therapeutic role in chronic inflam-
matory conditions. The anti-inflammatory effect of VNS is
mediated via interactions between neurons and T cells, as
well as TNF-a-producing macrophages mainly in the
spleen. However, it is still largely unknown how VNS
affects the different immunologically active cell popula-
tions. Here, we aim to investigate the effect of VNS on
different pro- and anti-inflammatory cell populations of the
immune system, providing insight into how the anti-
inflammatory properties of VNS are orchestrated.
VNS (1 V at 1 Hz for 5 min) or sham operation was
performed on anesthetized male C57BL/6 mice injected
intraperitoneally with 2 mg/kg LPS, respectively. After
6 h, mice were sacrificed and cells from whole blood,
spleen and mesenteric lymph nodes (MLN) were acquired
and stained for markers representing key lymphocytic and
myeloid cell populations and their activation status.
Multicolour flow cytometry analysis revealed no differences
between VNS and sham-treated mice concerning percent-
ages of general CD8+ and CD4+ T cell populations as well
as neutrophil and macrophage populations in the studied
organs, suggesting that these populations remain
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unchanged in their respective compartments after VNS.
Interestingly, in MLN, we detected a significant decrease in
activated CD69+ CD4+ T cell population in VNS-treated
mice compared to sham (3.44  0.09% VNS versus
5.30  0.39% sham; P < 0.05). Additionally, these
results were in line with a decrease in activated CD69+
IFN-c+ Th1 cells in MLN after VNS (13.55  0.10%
VNS versus 27.11  6.83% sham; non-significant). Sim-
ilar tendencies were noted in both spleen and blood,
respectively. Taken together, these data suggest that VNS
may have suppressive effects on T cell activation in
immune organs without changes in T cell trafficking;
moreover, MLN seem to be an important site for neuro-
immune interaction.
WS3.14
The Kinetics of Thymic-Derived and
Peripherally Induced Regulatory T Cell
Response in Early Development of Type 1
Diabetes in a Murine Experimental Model
Kailash Singh, Marcus Lundberg, Lina Thorvaldson
& Stellan Sandler
Uppsala University, Uppsala, Sweden
Background: Type 1 diabetes (T1D) has been accepted as
an autoimmune disease leading to destruction of the b-
cells. Despite extensive research in the field of T1D, the
kinetics of the regulatory T cell (Tregs) response in early
development of T1D is not yet clear. Tregs are character-
ized by the expression of CD4, CD25 and Foxp3 in na€ıve
conditions. Furthermore, Helios can be used as a marker for
distinguishing thymic-derived Tregs (tTregs) from periph-
erally induced Tregs (pTregs).
Aim: The aim of this study was to elucidate the dynamics
of Tregs in the early development of T1D in the none obese
diabetic (NOD) murine model.
Methods: In this study, we have examined the proportion
of the Tregs subsets; CD4+CD25+Foxp3+ (Tregs),
CD4+CD25+Foxp3+Helios+ (tTregs) and CD4+CD25+
Foxp3+Helios (pTregs) in pancreatic draining lymph
nodes (PDLNs) of 8-, 13- and 20- to 21-week-old NOD
female and male mice by flow cytometry. Pancreatic tissue
of mice was also investigated for insulitis. The results
obtained from NOD mice were compared to wild-type (wt)
CD-1 mice.
Results: The proportion of Tregs was increased in both
female and male NOD mice compared to wt mice.
Interestingly, the proportion of IFN-c+ cells was increased
in Tregs, tTregs and pTregs in both female and male NOD
mice compared to wt mice. The degree of insulitis was
higher in female compared to male NOD mice on weeks 13
and 20–21.
Conclusion: Thus, we conclude that Tregs are increased in
early development of T1D. However, the upregulation does
not protect from the autoimmune diabetes, possibly
because of a phenotypic shift in the tTregs and pTregs
population in the NOD murine model of T1D.
WS3.15
IRF4-Dependent Dendritic Cells Regulate
CD4+ T Cell Responses to Soluble Oral
Antigens
Emma Persson1, Katarzyna Luda1, Allan Mowat2,
Knut Kotarsky1 & William Agace1
1Lund University, Lund, Sweden, 2University of Glasgow, Glasgow, UK
Dendritic cells (DCs) that migrate from the intestines to
the mesenteric lymph nodes are believed to be play key
roles in the initiation and regulation of adaptive immune
responses to orally administered antigen; however, the in
vivo functionality of individual DC subsets remains to be
established. We and others previously showed that
intestinal CD103+CD11b+ DCs are dependent on the
transcription factor interferon regulatory factor (IRF)4
and are depleted in the mesenteric lymph nodes (MLNs)
of mice lacking IRF4 in DCs. Using this mouse model,
we here address the role of IRF4-dependent DCs in the
initiation and regulation of CD4+ T cell responses to
soluble luminal antigen. Our results suggest that IRF4-
dependent DCs are not critical for the priming of OT-II
cell responses to orally administered ovalbumin (OVA).
This is in contrast to our findings that IRF4 expression
by DCs is required for efficient OT-II responses
following intraperitoneal OVA administration. Moreover,
IRF4-dependent DCs are not required for the develop-
ment of induced Tregs in the MLNs or for the
establishment of oral tolerance. In contrast, IRF4-
dependent DCs appear to play key roles in regulating
gut homing receptor expression and IL-10 production by
CD4+ T cells in the MLNs. In summary, our data point
to an important role for IRF4-dependent DCs in the
regulation of immune responses to orally administered
soluble antigen.
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WS3.16
Role of Intestinal IRF8-Dependent
CD103+CD11b DCs in Intestinal Immune
Homeostasis
Katarzyna Maria Luda, Emma Persson & William
Agace
Lund University, Lund, Sweden
CD103+ dendritic cells (DCs) represent the major
migratory DC subset in the small intestinal lamina
propria (LP) and play a key role in the transport and
presentation of luminal antigen to adaptive immune cells
in intestinal draining mesenteric lymph nodes (MLN).
CD103+ DCs can be subdivided into two distinct
subsets: CD103+CD11b and CD103+CD11b+ DC that
have distinct transcription factor requirements for their
development. We have recently shown that
CD103+CD11b+ DCs are dependent on the transcription
factor IRF4 for their survival and appear important in
the generation of mucosal Th17 responses (Persson et al.
Immunity 2013). In contrast, CD103+CD11b DCs are
dependent on the transcription factor IRF8 (Edelson
et al. 2010, JEM) and thus appear developmentally
related to lymph node-resident CD8+ DCs that are
particularly efficient in cross-presenting antigen to CD8
T cells (Pooley et al. JI 2001, Dudziak et al. Science
2007). The role of intestinal CD103+CD11bDCs in
intestinal homeostasis remains, however, unclear. Here,
we have generated mice with a specific deletion of IRF8
in their DC compartment CD11c-Cre.IRF8fl/fl. In
preliminary analysis, we have found that CD11c-
Cre.IRF8fl/fl mice have a specific deletion of
CD103+CD11b DCs within the intestinal LP and
MLN. We are currently assessing the impact of loss of
this DC subset has on intestinal immune compartments
and intestinal adaptive immune responses.
448 Abstracts
..................................................................................................................................................................
Scandinavian Journal of Immunology, 2014, 79, 424–478
Workshop 4. Tolerance, Autoimmunity
and Transplantation
WS4.1
A Novel Connection of Autophagy-
Related Gene 7 to Multiple Sclerosis and
Experimental Autoimmune
Encephalomyelitis
Rasmus Berglund, Tomas Olsson, Maja Jagodic,
Melanie Thessen Hedreul & Roham Parsa
Karolinska Institute, Stockholm, Sweden
Introduction: The autophagocytic process is linked to
both innate and adaptive immunity and is implicated in
neurodegeneration and autoimmunity, which are proper-
ties of multiple sclerosis (MS) and its animal model
experimental autoimmune encephalomyelitis (EAE). Gen-
ome-wide expression analysis in a backcross (BC)
population of rats induced with EAE revealed a regulation
of autophagy-related gene 7 (Atg7) expression. Therefore,
we aimed to investigate the involvement of Atg7 in EAE
and MS.
Methods: Cellular source and kinetics of Atg7 expression
was studied with quantitative PCR and Western blot in
sorted cells from rats. The impact of Atg7 on the immune
system and EAE development was characterized in mice
with a conditional Atg7 deletion in T cells resp. myeloid
cells. Atg7 expression was investigated in samples from
MS patients and controls, and the genetic association of
autophagy genes was investigated in a Swedish cohort.
Results: In rat strains, we identified Atg7 as an EAE-
associated gene and further showed that higher Atg7
expression correlates with less severe EAE. The mouse
strain with conditional Atg7 deletion in myeloid shows
aggravated EAE. In PBMC and sorted immune cells from
MS patients and controls, we detected altered mRNA
expression patterns. Furthermore, we observed an associa-
tion of Atg7 to MS in a Swedish population.
Conclusions: In conclusion, we demonstrate a regulation
of Atg7 expression in MS and EAE immune cells and an
impact on EAE disease phenotypes. To elucidate the
molecular impact of Atg7 and autophagy in neuroinflam-
matory disease, further functional studies are required.
Based on our findings, the primary focus is on myeloid
cells targeting autophagy, regulatory and executive
properties.
WS4.2
To Which Extent May the Familial Risk of
RA be Explained by Established RA Risk
Factors?
Xia Jiang1, Thomas Frisell1, Johan Askling2,
Elizabeth Karlson3, Lars Klareskog2, Lars
Alfredsson1 & Henrik K€allberg1
1Karolinska Institutet, Stockholm, Sweden, 2Karolinska Institutet Hospital,
Stockholm, Sweden, 3Harvard University, Brigham and Women’s hospital,
Boston, MA, USA
Objectives: Family history of rheumatoid arthritis (RA)
may be seen as an easily obtained aggregate of an
individual’s genetic risk and shared environmental risk
factors may be seen as an easily obtained aggregate of an
individual’s genetic risk and shared environmental risk
factors, and is accepted to be important in clinical
diagnosis. It has been claimed that identified genetic
factors explain 50% of RA heritability. We wished to test
how much of the RA familial risk can be explained by
established genetic and non-genetic risk factors.
Methods: RA disease history in first-degree relatives of
individuals in the Swedish Epidemiological Investigation
of rheumatoid arthritis (EIRA) case–control study was
assessed through linkage to the Swedish multigeneration
and patient registers. The influence of non-genetic (smok-
ing, alcohol intake, silica exposure, BMI, fatty fish
consumption, socioeconomic status) and genetic (shared
epitope and 46 SNPs identified by Immunochip consor-
tium) risk factors was assessed through logistic regression
after multiple imputation.
Results: Established non-genetic risk factors did not
explain any significant part of the familial risk in either
anticitrullinated protein/peptide antibody (ACPA)-positive
or -negative RA. Genetic risk factors explained a limited
proportion of the familial risk for ACPA-positive RA
(ORCrude = 4.09, ORAdjust for S.E. = 3.72, ORAdjust for
46SNPs = 3.44, ORAdjust for both = 3.34).
Conclusion: We found that established risk factors did not
explain much of the familial aggregation of RA, suggesting
that most heritability remains to be elucidated. In
particular for ACPA-negative RA, it seems that we have
only found factors responsible for a very minor (or no) part
of the familial aggregation. Family history of RA remains
an important risk factor for RA, and there is a need for
aetiologic studies focusing specifically on ACPA-negative
RA.
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WS4.3
B Regulatory Cells are Functionally
Impaired in Patients with Rheumatoid
Arthritis and in Their First-Degree
Relatives Compared with Controls
Mikael Brink, Lisbeth €Arlestig, Solbritt Rantap€a€a
Dahlqvist & Kristina Lejon
Umea University, Umea, Sweden
Introduction: B regulatory cells have been suggested to
play a role in the development of various autoimmune
diseases including rheumatoid arthritis (RA). In this study,
the functionality of B regulatory cells in the blood from
RA patients, their first-degree relatives (FDR) at risk of
developing RA and healthy controls was investigated.
Methods: Mononuclear cells were isolated from 26 patients
with RA, 23 FDR and 11 healthy controls from northern
Sweden. Cells were analysed by flow cytometry for the
expression of STAT-3, with and without anti-CD40-anti-
body stimulation in CD19+CD20+ CD24hiCD38hi cells (B
regulatory cells/Bregs). T regulatory (CD4+CD25+FoxP3+),
CD4+ and CD8+ cells were analysed for their expression of
activation markers, such as CD69 and CD25. Seven
cytokines, that is, eotaxin, interleukin (IL)-1b, IL-10, IL-
12(p70), IL-6, MCP-1 and IL-17A, were analysed in plasma
samples using a Luminex 200 Labmap system.
Results: When comparing the STAT-3 levels of B regula-
tory cells, with and without stimulation of CD40, at an
individual level, a significant increase was found in controls
(P = 0.018), while no change was found in cells from the
FDR or RA patients. The cytokines IL-1b, IL-10, IL-12
(p70), IL-6, MCP-1 and IL-17A were found to be altered in
RA patients as well as in FDR compared with controls.
Conclusion: The response of Bregs following stimulation
was not only decreased in patients with RA but also in
unaffected FDR from multicase families, with both groups
differing significantly from healthy controls. This indicates
that additional immunological mechanisms, and/or genetic
or environmental factors, contribute to the development of
rheumatoid arthritis.
WS4.4
Human Leucocyte Antigen Genes and
Interferon Beta Preparations Influence
Risk of Developing Neutralizing Antidrug
Antibodies in Multiple Sclerosis
Malin Lundkvist Ryner, Jenny Link, Katharina Fink,
Christina Hermanrud, Izaura Lima, Boel Brynedal,
Ingrid Kockum, Jan Hillert & Anna Fogdell-Hahn
Karolinska Institutet, Stockholm, Sweden
Introduction: Development of antidrug antibodies (ADA)
is a clinical problem associated with the use of different
biological therapeutics. A significant proportion of patients
with multiple sclerosis (MS) who receive therapy with
interferon beta (IFN-b) develop neutralizing ADA (NAbs)
that reduce drug efficacy. However, only a subset of treated
patients develop NAbs, and thus, other factors are likely to
influence the risk of developing NAbs. The objective of
this study was to investigate whether HLA class I and II
alleles are associated with the development of NAbs against
IFN-b.
Methods: HLA-genotyped patients were cross-referenced to
patients who had been analysed routinely for NAbs using an
in vitro IFN-b-induced gene expression assay, resulting in a
cohort of 903 patients with MS of Scandinavian origin with
knownHLA genotype andNAb status. Patients were treated
with intramuscular IFN-b-1a, subcutaneous IFN-b-1a or
subcutaneous IFN-b-1b. NAb status and development of
NAb titres high enough to be biologically relevant (>150
ten-fold reduction units/ml) was correlated with HLA allele
group carriage.
Results: Carriage of HLA-DRB1*15 was associated with
an increased risk of developing NAbs and high NAb titres.
After stratification based on type of IFN-b preparation,
HLA-DRB1*15 carriage was shown to increase the risk of
developing NAbs and high NAb titres against both
subcutaneous and intramuscular IFN-b-1a. Additionally,
in patients receiving subcutaneous IFN-b-1a, carriage of
HLA-DQA1*05 decreased the risk for high NAb titres. In
IFN-b-1b-treated patients, HLA-DRB1*04 increased the
risk of developing high NAb titres, and in a subgroup
analysis of DRB1*04 alleles, the risk for NAbs was
increased in DRB1*04:01 carriers.
Conclusions: There is a preparation-specific genetically
determined risk to develop NAbs against IFN-b. However,
choice of IFN-b preparation still remains the single most
significant determinant for the risk of developing NAbs.
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WS4.5
Regulation of Autoimmunity by Reactive
Oxygen Species in SKG Arthritis
Simon Guerard, Rikard Holmdahl & Kajsa Wing
Karolinska Institutet, Stockholm, Sweden
Introduction: To dissect the mechanisms that underlie
autoimmune diseases, various rodent models have been
developed. In collagen-induced arthritis (CIA), it was
previously demonstrated that lack of reactive oxygen
species (ROS) burst by phagocytes increases susceptibility
to arthritis.
Method: To further investigate the role of ROS in
autoimmunity, ROS-deficient Ncf1*/* mice were crossed
with SKG mice. SKG mice are susceptible to chronic T
cell-driven arthritis following activation of innate immu-
nity by a single injection of mannan, a polysaccharide
extracted from yeast. This susceptibility is caused by a
point mutation in ZAP70 that decreases TCR signalling
and thus alters thymic selection, leading to a more self-
reactive T cells repertoire. Hence, this model does not rely
on immunization with specific antigens, unlike in CIA,
and therefore allows the study of ROS in spontaneous self-
reactivity.
Results: The ROS deficiency made SKG mice more
susceptible to arthritis. The disease onset and incidence
were similar to SKG controls; however, the severity was
much higher in SKG.Ncf1*/* mice especially in the
chronic phase. Using in vivo imaging, a very high spike of
ROS was detected in arthritic joints of regular SKG mice
at the disease onset, which was then followed by a lower yet
constantly higher level of ROS in comparison with wild
type, which suggests a correlation between disease pro-
gression and ROS concentration in joints. However,
SKG.Ncf1*/* mice, which have no detectable ROS
production in joints, developed a much more severe
disease. To better understand how ROS from phagocytes
can limit arthritis severity in SKG mice cell and serum
transfer experiments are under way, as well as thorough
characterization of T cell and B cell responses.
Conclusion: Altogether, these results demonstrate the role
of ROS in autoimmunity, which, as opposed to traditional
belief, has a regulatory function by limiting tissue damage
and improving clinical outcome.
WS4.6
Altered Phenotype and Stat1 Expression
in TLR7/8-Stimulated Monocyte-Derived
Dendritic Cells from Patients with Primary
Sj€ogren’s Syndrome
Petra Vogelsang1, Marie Karlsen1, Johan G. Brun2,
Jonsson Roland1 & Silke Appel1
1University of Bergen, Bergen, Norway, 2Department of Rheumatology,
Haukeland University Hospital, Bergen, Norway
Introduction: Dendritic cells (DC) are the most potent
antigen-presenting cells of the immune system, involved in
both initiating immune responses and maintaining toler-
ance. Dysfunctional and via toll-like receptor (TLR)
ligands activated DC have been implicated in the devel-
opment of autoimmune diseases. Therefore, we analysed
the phenotype and functional properties of immature and
TLR7/8-stimulated monocyte-derived DC (moDC) from
patients with primary Sj€ogren’s syndrome (pSS), a chronic
inflammatory autoimmune disease characterized by pro-
gressive mononuclear cell infiltration in the exocrine
glands.
Methods: The phenotype, apoptosis susceptibility and
endocytic capacity of moDC were analysed by flow
cytometry. Secretion of cytokines was measured by ELISA
and multiplex analyses in moDC cell culture supernatants.
The expression of TLR7 was analysed by flow cytometry
and RT-PCR. Expression of Ro52/SSA, IRF-8, Bim, Stat1,
p-Stat1 (Tyr701), p-Stat1 (Ser727), Stat3, pStat3 and
GAPDH was measured by Western blotting. NF-kB
family members (p50, p65, c-Rel, p52 and RelB) were
quantified using the ELISA-based TransAM NF-kB family
kit.
Results: We could not detect differences in expression of
co-stimulatory molecules and maturation markers such as
CD86, CD80, CD40 or CD83 on moDC from patients
compared to healthy controls. Moreover, we could not
observe variations in apoptosis susceptibility, Bim and
Ro52 expression and the endocytic capacity of the moDC.
However, we found that moDC from pSS patients
expressed increased levels of the MHC class II molecule
HLA-DR. We also found significant differences in cytokine
production by moDC, whereas increased IL-12p40 secre-
tion in mature pSS moDC correlated with increased RelB
expression. Strikingly, moDC from pSS patients matured
for 48 h with TLR7/8 ligand CL097 expressed signifi-
cantly less Stat1.
Conclusion: Our results suggest a role for moDC in the
pathogenesis of Sj€ogren’s syndrome.
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WS4.7
B Cells and IgE in Type 1 Diabetes
Radha Thyagarajan & Kristina Lejon
Umea University, Umea, Sweden
B cells contribute to the pathogenesis in type 1 diabetes
(T1D), a chronic autoimmune disease in which the insulin-
producing beta cells are destroyed leading to hyperglyca-
emia. Autoantibodies against b-cells precede disease
development in susceptible individuals and are good
diagnostic markers for screening patients. In addition,
anti-CD20 treatment in prediabetic individuals has been
shown to delay T1D onset. The non-obese diabetic (NOD)
mouse is extensively used to study the pathogenesis of T1D
and develops the disease in two phases – insulitis and overt
diabetes, similar to humans. Previously, our laboratory has
established that NOD B cells incongruously capture IgM
and IgG molecules on the surface, promoting enhanced
immune complex trapping. This has also been observed for
IgE. IgE is usually associated with allergy. Interestingly,
several studies have shown that presence of IgE autoanti-
bodies in autoimmune patients, including T1D, is linked
to poor disease prognosis. In our study, we aimed to
elucidate the role/importance of IgE in T1D using the
NOD mouse. Age-matched NOD and C57BL/6 (B6)
female mice were used for the study. Flow cytometric
analysis of splenic B cells from NOD and B6 revealed
increased IgE levels on both CD23 high and CD23 dim
NOD B cells, indicating that additional molecules can
bind IgE. Immunohistochemical analysis of the spleen
confirmed increased IgE level in NOD. Levels of IgE in the
serum did not correlate with the surface levels on B cells as
observed on an individual basis, possibly due to capture on
B cell surface. IgE was also observed in the vicinity of the
pancreatic islets, indicating its role in autoimmunity.
However, the target for IgE is yet to be determined. We
have planned to eliminate IgE from the NOD mouse
system using anti-IgE to determine whether this leads to
decreased T1D development.
WS4.8
Dysregulated Responses to Interferons in
Autoimmune Addison’s Disease
Kine Edvardsen1, Trine Bjanesøy2, Alexander
Hellesen3, Lars Breivik3, Marit Bakke2, Eystein S.
Husebye3 & Eirik Bratland3
1University of Bergen, Bergen, Norway, 2Department of Biomedicine,
University of Bergen, Bergen, Norway, 3Department of Clinical Science,
University of Bergen, Bergen, Norway
Autoimmune Addison’s disease (AAD), or primary adreno-
cortical insufficiency, is a classic organ-specific autoimmune
disorder with poorly described pathogenesis. Genetic asso-
ciations with HLA variants and immune responses against
specific adrenal antigens point to a well-coordinated immu-
nological attack on steroidogenic cells of the adrenal cortex,
but the actual triggers of this attack remain completely
unknown. In particular, knowledge about the roles played by
innate immunity and the adrenocortical cells themselves is
lacking. The interferon-inducible chemokine CXCL10 is
elevated in the serum of patients with AAD and can also be
induced at high levels in adrenocortical cells stimulated with
interferons or pathogen-associated molecular patterns.
However, it is also possible that this chemokine is produced
by activated immune cells in the patients. In the present
study, we have investigated whether peripheral blood
mononuclear cells (PBMC) from AAD patients display an
enhanced propensity to produce CXCL10 after direct or
indirect stimulation with type I or -II interferons. Surpris-
ingly, although serum levels of CXCL10 and CXCL9 were
significantly higher in patients than in controls, patient
PBMC produced significantly less CXCL10 and CXCL9
than healthy controls after stimulation with interferon-a, -b
and -c. This phenomenon was not evident when CXCL10
production was induced indirectly by stimulating PBMC
with poly (I:C). We therefore conclude that PBMC from
patients with AAD are deficient in their response to
interferons. This might be related to their substitution
therapywith glucocorticoids, but this should be investigated
on the molecular level. Furthermore, the aforementioned
observations suggest that the adrenal cortex itself is
responsible for the increased serum levels of CXCL10 in
the AAD patients.
WS4.9
CCL2 Chemokine in Central Tolerance
Oriane Cedile1, Morten Løbner1, Henrik Toft-
Hansen1, Ida Frank1, Agnieszka Wlodarczyk1,
Magali Irla2 & Trevor Owens1
1Institute of Molecular Medicine, University of Southern Denmark, Odense,
Denmark, 2Centre d’Immunologie de Marseille-Luminy, Marseilles, France
CCL2 is an inflammation-associated chemokine that
induces the recruitment of immune cells in tissues. CCL2
and its receptor CCR2 are implicated in promoting
experimental autoimmune encephalomyelitis (EAE), a
mouse model of multiple sclerosis. However, we observed
that transgenic mice expressing CCL2 in central nervous
system (MBP/CCL2) were resistant to EAE. MBP/CCL2
mice crossed with 2D2 mice, whose T cells express a
transgenic T cell receptors (TCR) specific for the self-
antigen myelin oligodendrocyte glycoprotein (MOG), were
also resistant to EAE. Both MBP/CCL2 and 2D2 9 CCL2
mice showed ectopic expression of CCL2 in thymus.
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T cell development is guided by interactions with thymic
stromal cells. Among them, dendritic cells (DC) delete or
anergize CD4+ and CD8+ thymocytes whose TCR recog-
nize a complex of self-peptide + major histocompatibility
complex, so that only T cells tolerant to self-peptides leave
the thymus. Three subsets of DC have been identified in
mouse thymus. They all express CCR2 and two of the DC
subtypes can take up antigens in periphery and migrate
into the thymus to mediate tolerance.
We thus investigated whether thymic expression of CCL2
could tolerize encephalitogenic T cells and inhibit EAE
development.
We showed that ectopic expression of CCL2 in thymus of
MOG-TCR transgenic mice induced a massive deletion of
MOG-specific T cells. CD4-expressing MOG-specific T
cells were not detected in thymus or lymph nodes. Thymus
weight and thymus cell number were also strongly
decreased. The ectopic expression of CCL2 in thymus was
accompanied by increased number of plasmacytoid DC
(pDC) in thymus and we showed that pDC expressed
CCR2. We also identified stromal cells that constitutively
expressed CCL2 in B6 mouse thymus.
Based on these results, we propose that overexpression of
CCL2 in thymus recruits pDC which delete encephalito-
genic T cells, thereby inhibiting EAE development. This
identifies a novel role for CCL2 in T cell tolerance.
WS4.10
Profiling of Intestinal Microbiota of
Paediatric Patients After Stem Cell
Transplantation
Kaarina La¨hteenma¨ki1, Pirjo Wacklin1, Elina
Tuovinen1, Mervi Taskinen2, Jukka Partanen1, Kim
Vettenranta2 & Jaana M€att€o1
1Finnish Red Cross Blood Service, Helsinki, Finland, 2Children’s Hospital,
Helsinki University Central Hospital, Helsinki, Finland
Background: Gastrointestinal complications constitute a
major problem in allogeneic haematopoietic stem cell
transplantation (HSCT). Intensive pretransplantation con-
ditioning contributes to intestinal complications by dis-
rupting the integrity of the intestinal epithelium. This can
lead to translocation of intestinal microbes and microbial
structures into tissues. Lipopolysaccharide (LPS) of Gram-
negative bacteria is a strong inducer of pro-inflammatory
cytokines and found in serum in graft-versus-host disease
(GvHD), which is a severe immunological complication of
HSCT and also contributes to damage of intestinal mucosa.
Intestinal microbiota in healthy individuals is highly diverse
and estimated to consist of at least 1000 different bacterial
species. In our ongoing study, we follow the composition of
intestinal microbiota in paediatric patients after HSCT. We
also study roles of immunological responses towards micro-
bial structures in transplantation complications.
Methods: From faeces samples collected before and during
a 6-month period after transplantation, microbial profiles
have been analysed by PCR-DGGE (denaturing gradient
gel electrophoresis) and by 16S rRNA pyrosequencing. We
have also measured LPS-induced cytokine production from
peripheral blood mononuclear cells (PBMC) obtained from
sibling donors of the grafts.
Results and conclusions: Preliminary results indicate a
significant disturbance of the intestinal microbiota in many
patients. This was seen as high dominance of single
bacterial genera following the immediate post-transplant
phase. Recovery of microbiota, indicated by re-appearance
of common intestinal bacterial genera and increased
diversity of microbiota, could be seen 4–6 months post-
transplantation. The results suggest that profiling of
intestinal microbiota can be a useful tool in patient
follow-up after transplantation.
WS4.11
Ro52/TRIM21 Expression is Decreased in
Malignant B Cells
Margarita Ivanchenko1, Susanna Brauner1,
Gunilla Enblad2, Christer Sundstr€om2,
Carin Backlin2, Eva Baecklund2 &
Marie Wahren-Herlenius1
1Karolinska Institutet, Stockholm, Sweden, 2Uppsala University, Uppsala,
Sweden
Introduction: TRIM21 (Ro52) is a rheumatic autoantigen
predominantly expressed in leucocytes. Several members of
the TRIM (tripartite motif) protein family regulate basic
cellular processes, including proliferation and apoptosis.
Interestingly, high expression of TRIM21 is associated
with decreased proliferation and increased apoptosis in vitro
and the Trim21 gene is located in a tumour suppressor
locus. Rheumatic patients are prone to developing B cell
lymphomas, especially diffuse large B cell lymphoma
(DLBCL). Hypothesizing that TRIM21 expression may be
altered in lymphoma cells, we investigated TRIM21
expression in tumour tissue and several human cell lines.
Methods: Lymphoma biopsies obtained from patients with
DLBCL with and without a history of rheumatic disease
were investigated for TRIM21 expression by immunohis-
tochemistry using two different TRIM21 monoclonal
antibodies. TRIM21 mRNA contents was analysed by
qPCR in six human B cell lines (FLEB14-4, KM3, Daudi,
Raji, U266 and NALM-6), a T cell line (Jurkat) and
CD19+ B cells from a healthy donor.
Results: We observed that loss of TRIM21 expression in
lymphoma tissue significantly correlated with shorter
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overall and progression-free survival in DLBCL patients.
This association was independent of rheumatic disease and
autoantibody status. TRIM21 mRNA expression was
considerably lower in all investigated B cell lymphoma
lines as well as Jurkat cells (0,3–4,8 relative normalized
expression units) compared to normal human B lympho-
cytes (7,1 relative normalized expression units).
Conclusion: Our data indicate that TRIM21 expression is
deficient in both DLBCL and B cell lymphoma-derived cell
lines compared to normal lymphoid cells. Further,
TRIM21 expression associates with a more aggressive
course of lymphoma. Analysis of TRIM21 expression in
DLBCL may thus have an additional value in clinical
assessments of the prognosis.
WS4.12
Profiling of Peripheral Blood Cells in
Patients with Rheumatic Diseases Using
TruCount Technology
Silke Appel1, Richard Davies1, Daniel
Hammenfors2, Brith Bergum1, Kjerstin Jakobsen1,
Petra Vogelsang1, Johan Brun2, Yenan Bryceson3
& Roland Jonsson1
1University of Bergen, Bergen, Norway, 2Haukeland University Hospital,
Bergen, Norway, 3Karolinska University Hospital Huddinge, Stockholm,
Sweden
Objectives: We analysed the cellular profile of peripheral
blood leucocytes in patients with three different autoim-
mune diseases, primary Sj€ogren’s syndrome (pSS), systemic
lupus erythematosus (SLE) and rheumatoid arthritis (RA),
and healthy controls, to determine whether this could be
used to differentiate between patient groups and to get
more insight into the pathogenesis of these diseases.
Methods: Peripheral blood from healthy controls (n = 20),
patients with pSS (n = 27), SLE (n = 13) and RA (n = 14)
was collected into heparin tubes, and 50 ll was transferred
to a TruCount tube (BD Bioscience), containing titrated
amounts of antibodies, to determine the absolute number
of different leucocyte populations. After 15-min incuba-
tion, erythrocyte lysis buffer was added to remove red
blood cells. The cells were analysed within 4 h on a
BDFortessa flow cytometer (BD Bioscience). Antibodies
used were CD45 Qdot 605, CD3 Horizon V500, CD56
PE-Cy7, CD4 Pacific blue, CD20 Alexa Fluor 647, CD8
PerCP-Cy5.5. Analyses were performed using FlowJo
software (Treestar).
Results: The cellular profile of peripheral blood of the
different patient groups varied significantly from each
other and the healthy controls. Patients with RA had
significantly increased amounts of granulocytes and mono-
cytes compared to healthy controls, while the amount of
lymphocytes was similar in all analysed groups. SLE
patients had significantly reduced numbers of CD20+ B
cells compared to healthy controls. The number of CD3+ T
cells and CD8+ T cells was similar in all subgroups, but
CD4+ T cells were significantly increased in RA patients
compared to SLE patients. CD56+ NK cells were signif-
icantly increased in RA patients compared to patients with
pSS and SLE.
Conclusion: TruCount analyses resulted in distinct cellu-
lar profiles of peripheral blood leucocytes in the three
analysed patient groups and might help to understand
underlying defects in these autoimmune diseases.
WS4.13
Characterization of the Sj€ogren’s
Syndrome Susceptibility Genes
Fam167/Blk
Gudny Ella Thorlacius, Thomas Bergman, Susanna
Brauner, Alexander Espinosa & Marie
Wahren-Herlenius
Karolinska Institutet, Stockholm, Sweden
Sj€ogren’s syndrome is a common autoimmune disease,
primarily affecting exocrine glands, particularly salivary
and lacrimal glands. Sj€ogren’s syndrome primarily involves
B cells which show defective differentiation patterns
resulting in altered activation and trafficking. A genome-
wide association study of genetic polymorphisms in
Sj€ogren’s syndrome identified six novel non-HLA gene
loci as associated with Sj€ogren’s syndrome. The FAM167A/
BLK locus on chromosome 8 was one of the identified loci,
with a P < 5 9 1010 for the most significant SNP. The
Sj€ogren’s associated genotype in the FAM167A/BLK locus
regulated increased expression of the FAM167A gene and
decreased expression of BLK. BLK functions in signalling
downstream of the B cell receptor, while FAM167A has no
known function.
To begin understanding the function of fam167a, the
expression pattern of fam167a was characterized in organ
samples collected fromC57BL/6mice, including skin, brain,
lung, salivary gland, lymph node, thymus, heart, skeletal
muscle, intestine, kidney, spleen and liver. Lymphocyte
subtypes sorted from lymph nodes, spleen and thymus from
mice were also collected. RNAwas isolated using an RNeasy
isolation kit (Qiagen), cDNA was generated using iScript
(BioRad), and the presence of fam167a expression was
measured in comparison with housekeeping genes (GAPDH
and HPRT) using a SYBR green-based qPCR. To assess the
intracellular localization of fam167a, the gene was cloned
using the Gateway system (Invitrogen) and a YFP-tagged
expression clone transfected into 3T3 cells.
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Mouse skin, lungs, spleen and lymph nodes all showed
expression of fam167a, as well as sorted double negative T
cells (CD3+CD4CD8) and marginal zone B cells. After
transfection of YFP-tagged fam167a, punctuate dot-like
cytoplasmic fluorescence was observed in 3T3 cells.
Fam167a thus appears to have a potentially cytoplasmic
function in lymphocytes and epithelium.
WS4.14
Cardiopathogenic Role of Human RO/SSA
and LA/SSA Antibodies in a Novel Animal
Model of Congenital Heart Block
Vijole Ottosson1, Ariela Hoxha2, Amelia Ruffatti2,
Lars Ottosson3, Malin Hedlund1, T. Del Ross2,
L. Punzi2, Sven-Erik Sonesson3 & Marie
Wahren-Herlenius1
1Karolinska Institutet, Stockholm, Sweden, 2Department of Medicine,
Rheumatology Unit, University of Padua, Padua, Italy, 3Department of
Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden
Background: Congenital heart block (CHB) develops in
children of Ro/SSA- and/or La/SSB-positive mothers.
However, the mechanism behind the disease remains
unknown.
Objectives: To study the effect on cardiac conduction of
purified human IgG antibodies from a CHB patient
mother in an animal model.
Methods: Pregnant adult female Dark Agouti rats
(Charles-Rivers, Germany) were injected intraperitoneally
with 4 mg of IgG purified from a CHB anti-Ro52-p200
antibody-positive mother, a healthy control or vehicle. The
assessment of foetal cardiac function during pregnancy was
performed by foetal echocardiography/Doppler recordings.
Neonatal cardiac function after birth was assessed by ECG
recordings within 24 h after birth.
Results: Performing echocardiography/Doppler, we
observed significant bradycardia and AV time prolongation
in the group injected with 4 mg patient IgG compared to
other groups (P = 0.0004; P = 0.001) as well as a
significant prolongation of isovolumetric contraction time
(ICT) and ejection time (ET) time (P = 0.01; P = 0.007).
Furthermore, pups in the group injected with patient IgG
had a significantly higher myocardial performance index
(MPI; P = 0.002) than in the group injected with control
IgG.
The ECG recordings showed that the pups from the group
injected with patient IgG have a significant reduction in
mean heart rate (P < 0.0001) as well as a significant
prolongation of the PR and RR intervals compared to the
group injected with IgG control sera (P < 0.0001).
Conclusions: Our data suggest that maternal autoanti-
bodies induce foetal bradycardia, AV time prolongation
and decrease cardiac performance, mimicking features of
the human disease and confirming a role for the autoan-
tibodies in disease pathogenesis. The data also suggest that
an animal model for CHB can be established by a simple
technique of passive transfer of human IgG from a mother
with a child with CHB. This model will be highly relevant
for investigating the pathogenesis of CHB and evaluating
novel therapeutic approaches and drugs.
WS4.15
Evidence of Marginal Zone B Cells in the
Lymph Nodes Presenting Autoantigen to
T Cells in a Model of Autoimmune
Arthritis
Anna-Karin Palm1, Heike Friedrich1, Linda Myers2
& Sandra Kleinau1
1Uppsala University, Uppsala, Sweden, 2Department of Pediatrics,
University of Tennessee Health Science Center, Memphis, TN, USA
B cells play a major role in the pathogenesis of many
autoimmune disorders, including rheumatoid arthritis
(RA). However, it is not fully known how the B cells
contribute to arthritis. A significant fraction of B cells in
the peripheral repertoire express self-reactivity, and many
of these B cells belong to innate-like subsets such as the
marginal zone (MZ) B cells. We show here that MZ B cells
in the spleen have natural self-reactivity to type II collagen
(CII) and initiate an early response to CII during the
induction of collagen-induced arthritis, a mouse model for
RA. Furthermore, the MZ B cells were very potent CII-
presenting cells inducing proliferation of CII-specific T
cells ex vivo. Notably, an expansion of a small MZ B cell-
like (MZBL) population was also evident in the lymph
nodes following immunization with CII but not with a
control protein or the adjuvant alone. The MZBL cells
displayed MZ B cell characteristics and had an antigen-
activated phenotype with high surface expression of CD80
and CD86 and could present CII to T cells.
We show here that self-reactive MZ B cells that are
retained in the repertoire can be activated in the spleen and
lymph nodes to promote autoimmune arthritis by breaking
T cell tolerance. This may then allow autoreactive T cells to
assist follicular B cells in the production of pathogenic
autoantibodies.
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The Telomeric End of MHC Class III
Regulates Experimental Arthritis in Rats
Anthony C.Y. Yau, Jonatan Tuncel, Ulrika Norin,
Sabrina Haag & Rikard Holmdahl
Medical Inflammation Research, Karolinska Institutet, Stockholm, Sweden
Rheumatoid arthritis (RA) is a multifactorial, chronic
inflammatory joint disease with the strongest association in
the HLA-DRB1 locus within the major histocompatibility
complex (MHC). In addition to the DRB1 locus, human
genetic association studies have suggested the disease
association of MHC class III region. However, MHC class
III is a region difficult to study in human due to its high
gene density and strong linkage disequilibrium. MHC
class III contains many candidate genes in RA, including
tumour necrosis factor (TNF), lymphotoxin-alpha (LTa)
and allograft-inflammatory factor (AIF-1).
Previous linkage analysis showed the association of MHC
Pia1 with both pristane-induced arthritis (PIA) and oil-
induced arthritis (OIA) in rats. Disease-phenotyping intra-
MHC recombinant inbred strains covering different parts
of MHC revealed two arthritis regulation loci within the
Pia1 locus, one in MHC class II and one in MHC class III.
For MHC class III, we have further mapped arthritis
susceptibility to a minimal interval of around 40–60 kb in
the telomeric end of MHC class III. Compared to the DA
rats control, the MHC class III congenic rats developed less
severe PIA and OIA with less weight loss and a later day of
disease onset, and also less damaged joints with signifi-
cantly less bone erosion and cartilage destruction. Adoptive
transfer of oil-primed T cells showed that the locus
controlled immune priming of the disease. Furthermore,
quantitative real-time PCR revealed the differential
expression of two genes in the region, and sequence
analysis showed a number of genetic variants in the region
which could be important in understanding the disease
regulation.
In conclusion, we showed that telomeric end of MHC class
III regulates experimental arthritis and controls immune
priming of arthritis in rats. Identification of the disease
regulation gene in MHC class III may provide novel target
in treatment aimed at reducing disease severity and joint
damage.
WS4.17
Pregnancy Induces a Reduction of CCL25
and CXCL12 Expression in Thymic Cortical
Epithelial Cells and Fibroblasts
Martti Laan, Uku Haljasorg, Kai Kisand &
P€art Peterson
Department of Molecular Pathology, Tartu University, Tartu, Estonia
During normal pregnancy, the thymus undergoes severe
reduction in size and thymocyte output, which may
contribute to the maternal–foetal tolerance. The mecha-
nisms behind this pregnancy-induced thymic involution,
however, are presently unknown. The aim of the study was
to characterize changes in different thymocyte subpopula-
tions in pregnancy to detect a possible block in their
development. In addition, the study aimed to determine
pregnancy-induced changes in thymic chemokine produc-
tion by thymic stromal cells to determine a possible defect
in seeding of the thymocyte progenitors.
Thymocyte subpopulations were analysed by FACS in mice
thymi at three time points of normal pregnancy. In
addition, the thymic medullary epithelial cells, cortical
epithelial cells, fibroblasts and dendritic cells were FACS-
sorted, followed by the expression analysis by qPCR for the
key chemokines behind the seeding of thymocyte progen-
itors.
Although pregnancy induced a progressive reduction in
thymocyte numbers, the proportion of their major sub-
populations remained unchanged. However, in cortical
epithelial cells and thymic fibroblasts, pregnancy induced a
substantial reduction in the expression level of CCL25 and
CXCL12.
The data indicate a role for cortical epithelial cells and
fibroblasts, which via reduced expression of CCL25 and
CXCL12 may play a role in the pregnancy-induced thymic
involution. The resulting changes in recruitment of
thymocyte progenitors and sequential changes in thymic
output may contribute to the immune tolerance in
pregnancy.
456 Abstracts
..................................................................................................................................................................
Scandinavian Journal of Immunology, 2014, 79, 424–478
WS4.18
Thymic Export of T Cells During
Pregnancy: Can Differential Regulation of
T Cell Populations Contribute to Foetal
Tolerance?
Sandra Hellberg1, Ratnesh Mehta1, Mans
Edstr€om1, Anna Forsberg1, G€oran Berg1, Ola
Winqvist2, Maria Jenmalm1 & Jan Ernerudh1
1Link€oping University, Link€oping, Sweden, 2Karolinska Institutet,
Stockholm, Sweden
Despite the prominent role of thymus in T cell-mediated
immunity, there is little knowledge regarding its function
in human pregnancy and pregnancy-associated tolerance
towards the semi-allogenic foetus. In this exploratory
study, we investigated the function of thymus during
pregnancy by analysing the output of T helper cells from
thymus. DNA from isolated CD4+ blood cells from 26
healthy second-trimester pregnant and 20 age-matched
non-pregnant women were analysed for the content of T
cell receptor excision circles (TRECs), which are enriched
in newly synthesized T cells. In addition, the frequency of
recent thymic emigrant (RTE) T helper subsets was
assessed in whole blood from pregnant (n = 10) and non-
pregnant women (n = 8) by flow cytometry, utilizing
CD31 and CD45RA as markers of recent thymic exposure
and na€ıve phenotype, respectively. Pregnant women
showed significantly reduced levels of TREC in the
CD4+ population as compared to non-pregnant women
(P = 0.041), which indicates a reduced output of CD4+ T
helper cells from the thymus, being in line with the
observed shrinkage of thymus in mouse pregnancy.
Further, we attempted to determine whether the output
of the regulatory T cell (Treg) subpopulation was also
decreased during pregnancy or whether it was differen-
tially regulated. Preliminary results suggest an increased
thymic output of Tregs during pregnancy as measured by
the frequency of CD31+CD45RA+Tregs (P = 0.018). In
conclusion, we show reduced TREC levels in CD4+ cells
in pregnant women, likely reflecting a reduced output of
the whole T helper cell population from thymus which
could be of importance for limiting the entry of potential
allogenic antifoetal T cells into the periphery. However,
the output of Tregs may be differentially regulated,
thereby further contributing to the establishment and
maintenance of the foetal-tolerant environment required
for successful pregnancy.
WS4.19
Alternative Splicing of FOXP3 is
Associated with Atherosclerotic Plaque
Instability
Anne-Laure Joly, Sang Liu, Reiner Mailer & John
Andersson
Karolinska Institutet, Stockholm, Sweden
Atherosclerosis, a chronic inflammatory disease of arteries,
is the leading cause of cardiovascular diseases. Atheroscle-
rosis is initiated when low-density lipoprotein is retained
in the subendothelial space of arteries resulting in
pathological immune responses and formation of an
atherosclerotic plaque. The main clinical complication
occurs when a plaque ruptures causing formation of a
thrombus that can further induce life-threatening vascular
events. Previous studies have demonstrated that effector T
cells contribute to atherogenesis. In contrast, it has become
clear that immunosuppressive CD4+FOXP3+ regulatory T
(TReg) cells have an atheroprotective role in experimental
models of atherosclerosis. Yet, it remains to be determined
how TRegs modulate clinical atherosclerosis. The tran-
scription factor Forkhead box P3 (FOXP3) protein defines
the lineage of TRegs and plays a critical role in upholding
their suppressive activity. Three splice forms of FOXP3
mRNA exist in humans, which gives rise to protein
isoforms with different functional properties. Full-length
FOXP3 and FOXP3d2 confer a suppressive phenotype to
TReg cells, whereas FOXP3d2d7 inhibits the function of
the other FOXP3 isoforms in a dominant negative manner.
Herein, we have analysed FOXP3 splice variants expression
in more than 200 blood samples and 200 atherosclerotic
plaques in relation to plaque stability and effect of HMG-
CoA reductase inhibitors treatment. We have observed that
while the total amount of FOXP3 transcripts stay stable
between symptomatic versus asymptomatic plaques, there
is a shift in the isoform ratio where relatively low levels of
FOXP3d2 are found in symptomatic plaques.
It is well established that TReg cells have the capacity to
suppress immune responses. However, in order to harness
their full clinical potential, we need to fully understand
how they function. Our results highlight the importance of
characterizing FOXP3 expression on an isoform basis and
suggest that immune responses may be manipulated by
modulating the expression of FOXP3 isoforms.
 2014 John Wiley & Sons Ltd
WS4.20
Amino Acids Situated in NLS Domain of
AIRE Protein are Required for DNA
Binding
Julia Maslovskaja & P€art Peterson
University of Tartu, Tartu, Estonia
The autoimmune regulator (AIRE) is a transcriptional
regulator expressed in a specific subset of thymic epithelial
cells and promoting activation of thousands genes there. It
is established that AIRE influences transcription in
elongation stage by releasing stalled RNA polymerase.
Despite many exciting hypotheses, the recruitment of
AIRE to its target genes and the mechanism of genes to be
activated are not completely understood at the moment.
The interaction of PHD1 domain of AIRE with non-
methylated H3 was demonstrated in previous years and its
importance for target gene activation by AIRE was shown.
In our experiments, we observed even stronger binding of
AIRE to episomal plasmids than to chromatin despite low
histone content of plasmids. There are different reports
about SAND domain role in mediating DNA binding of
AIRE as well as DNA-PK participation in this process. We
performed EMSA and agarose gel shift assays to determine
that part of NLS domain is responsible for AIRE binding
to oligos and plasmids. Our ChIP experiments with specific
amino acids mutated confirmed our finding that amino
acids situated in NLS domain but not crucial for nuclear
localization are responsible for binding to plasmids. The
dimerization of AIRE through CARD domain is also
important for DNA binding as the mutations disrupting
dimerization prevent also binding in ChIP experiments.
There is possible interplay between domains in AIRE
recruitment with NLS playing major role in the case of
more open DNA and PHD1 taking over in the case of
chromatin coated with histones.
WS4.21
Characteristics of T Cell Subsets in
Smokers and Multiple Sclerosis Patients’
Lungs
Michael Hagemann-Jensen1, Johan €Ockinger1,
Susanna Kullberg1, Frederik Piehl2, Thomas
Olsson2, Anders Eklund1, Johan Grunewald1 &
Jan Wahlstr€om1
1Respiratory Medicine Unit, Department of Medicine, Solna, Karolinska
Institutet, Stockholm, Sweden, 2Neuroimmunology Unit, Department of
Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
Background: Smoking has been shown to be a consider-
able risk factor for various autoimmune diseases, especially
in combination with certain genetic variants. With regard
to multiple sclerosis (MS), a recent study found a strong
gene–environment interaction, because expression of HLA-
DRB1*15 and absence of HLA-A*02 was associated with a
16-fold increase in risk of disease. Recent studies in the
EAE model of MS have further shown that prior to
entering the CNS, T cells migrate to the lung, where
extensive activation and reprogramming of autoreactive T
cells occur in the lung-associated lymphoid tissues. This
indicates that important immunological events in the
lungs could contribute in a regulatory manner, as a
prerequisite for autoreactive T cells to enter their target
tissues and induce autoimmunity.
Methods: Bronchoalveolar lavage (BAL) fluid and periph-
eral blood from healthy non-smoking controls, healthy
smokers and MS patients (smoking and non-smoking/ex-
smokers) with normal lung function are obtained for this
ongoing study. Ex vivo investigation of samples is carried
out by staining with panels of antibodies against selectively
chosen activation/regulatory/migratory markers followed
by flow cytometric analysis.
Results: Preliminary data from healthy non-smoking
controls (N = 7), smokers (N = 10) and MS non-smoking
patients (N = 8) and MS smoking patients (N = 3) show
increased expression of the activation marker CD40L
(suggesting recent antigen encounter) on CD4+ T cells
from MS BAL fluid compared to BAL fluid from smoker
sand non-smokers. Proliferation of CD4+ and CD8+ T cells
in MS BAL fluid as well as smoking controls is also higher,
than non-smoking patients. Additionally, BAL samples
from MS patients, smoking and non-smoking, have
higher frequencies of Helios-positive CD4+CD25+ and
CD4+FOXP3+ cells compared to healthy smokers and
non-smokers.
Conclusion: From the preliminary data, it seems there are
interesting differences between the various subject groups.
It is, however, too early to make full conclusions as the
study is ongoing.
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WS4.22
Importance of Indirect
Immunofluorescence Methodology in
Antinuclear Antibody Screening
A´sa Jacobsen1, Anna Guðrun Viðarsdottir2,
Dagrun Inga Þorsteinsdottir1 & Bj€orn Runar
Luðvıksson2
1Department of Immunology, Landspitali-University Hospital, University of
Iceland, Reykjavık, Iceland, 2Department of Immunology, Landspitali-
University Hospital, Reykjavık, Iceland
Introduction: The importance of antinuclear antibody
(ANA) screening in diagnostic workup of autoimmune
disease is well known. The rate of positive screening is
about 0.5% in the general population and up to 90% in
patients with systemic lupus erythematosus (SLE). Today
several methodologies are commonly used for ANA
screening. The methodology recommended by the ACR
and EULAR is indirect immunofluorescence (IIF). How-
ever, some laboratories use ENA-ELISA for the same
purpose. The aim of this study was to evaluate the strength
of the above methodologies in the routine use of ANA in
Iceland.
Methods: The rate of positive ANA test was evaluated for
1-year time. We evaluated these different methodologies
used for ANA screening including IIF on rodent tissue and
HEp-2000 cells and ENA-ELISA. All samples that were
ENA positive were evaluated for specific ENA profile (Sm,
nRNP, SSA, SSB, Scl-70, Jo-1 and dsDNA).
Results: For a 1-year time, 3556 samples were evaluated of
whom 42.4% were positive. Of the ANA positive, only
12.6% were ENA positive. To evaluate the strength of the
various ANA screening methods, we analysed additional
196 samples further. Of the 196 samples, 79.6% were
positive in ANA screen test on rodent tissue and 91.3% on
HEp-2000 cells. On rodent tissue, 25% had positive ENA
profile and 22.3% on HEp-2000 cells. Out of the samples
that were ANA positive and ENA negative, 82.9% on
rodent tissue and 79.5% on HEp-2000 cells had joint pain
or arthritis. From these ANA-positive and ENA-negative
samples, 21% had been diagnosed of SLE, 20% with
rheumatoid arthritis and about 30% were strongly
suspected to suffer from other autoimmune diseases.
Conclusion: The results clearly demonstrate the impor-
tance of IIF methodologies in ANA screening, given their
significant accretion with an underlying autoimmune
disease even in ENA-negative individuals.
WS4.23
CD8+ T Cells, Not HLA Class II Risk
Allele-Restricted CD4+ T Cells, Mediate
Transfer Autoimmune Pancreatitis in
HLA-DRB1*0405 Transgenic Ab0
Rag1/ NOD Mice
Tobias Freitag1, Salil Patel2, Grete Sonderstrup2 &
Seppo Meri1
1Haartman Institute, University of Helsinki, Helsinki, Finland, 2Department
of Microbiology and Immunology, Stanford University School of Medicine,
Stanford, CA, USA
Background: Autoimmune diseases are frequently associ-
ated with specific HLA class II risk alleles. The isolation
from autoimmune disease patients of risk allele-restricted,
self-antigen-specific CD4+ effector T cells suggests that
pathogenic T cells may recognize self-antigens presented
on HLA class II risk alleles. This mechanism could lead to
CD4+ T cell activation, inflammatory cytokine secretion
and organ damage in autoimmune diseases.
Autoimmune pancreatitis (AIP) in humans is associated
with the HLA-DRB1*0405/DQB1*0401 haplotype. We
recently described a model of AIP in HLA-DRB1*0405
transgenic Ab0 NOD mice (Freitag TL et al.; Gastroen-
terology 2010). Contrary to HLA class II transgenic control
strains, these mice develop spontaneous AIP, characterized
by destructive infiltration of the exocrine pancreas with
CD4+ and CD8+ T cells, B cells and macrophages.
Objectives: To identify the pathogenic lymphocyte pop-
ulation causing AIP in HLA-DRB1*0405-transgenic Ab0
NOD mice.
Methods: T and B cell-deficient, HLA-DRB1*0405
transgenic Ab0 Rag1/ NOD recipient mice were
adoptively transferred with CD4+ T cells, CD8+ T cells
or CD19+ B cells i.v., from HLA-DRB1*0405/huCD4
transgenic Ab0 NOD donor mice. Recipients were mon-
itored for up to 16 weeks post-transfer.
Results: Only adoptive transfers with CD8+ T cells, but
not with CD4+ T cells or CD19+ B cells, resulted in AIP
and pancreatic atrophy in recipient mice. This was
associated with significant body weight loss and reductions
in pancreas weight versus controls.
Conclusions: CD8+ T cell transfer, not HLA class II-
restricted CD4+ T cell transfer, causes AIP in HLA-
DRB1*0405-transgenic Ab0 Rag1/ NOD mice. This
suggests that in immunocompetent mice HLA class II risk
allele expression fails to protect from CD8+ T cell-
mediated AIP, likely due to defects in organ-specific self-
tolerance maintained by regulatory CD4+ T cells (Treg).
This model can be used to explore the functional roles of
HLA class II alleles in human autoimmune diseases.
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WS4.24
Autoantibodies Against Ganglioside GM3
are Associated with Narcolepsy–
Cataplexy Developing After Pandemrix
Vaccination Against 2009 Pandemic
H1N1-Type Influenza Virus
Anna-Helena Saariaho1, Arja Vuorela2, Tobias
Freitag1, Giuseppe Plazzi3, Markku Partinen4, Ilkka
Julkunen5, Outi Vaarala2 & Seppo Meri1
1Research Program in Immunobiology, Haartman Institute, University of
Helsinki, Helsinki, Finland, 2Department of Vaccines and Immune
Protection, National Institute of Health, Helsinki, Finland, 3Department
of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna,
Bologna, Italy, 4Helsinki Sleep Clinic Finnish Narcolepsy research Centre
Vitalmed Research Centre, Helsinki, Finland, 5National Institute of Health,
Helsinki, Finland
After the mass vaccinations against the pandemic H1N1
influenza virus, a sudden increase in juvenile narcolepsy
was reported in six European countries where AS03-
adjuvanted Pandemrix vaccine was used.
Narcolepsy with cataplexy (NC) is a chronic neurological
disease characterized by an excessive daytime sleepiness,
hallucinations and cataplexy. In NC, the hypocretin 1-
producing neurons in the hypothalamus are destroyed,
most probably by an autoimmune reaction. Both genetic
(e.g. HLA-DQB1*0602) and environmental risk factors
(e.g. Pandemrix) contribute to the disease development,
but the underlying autoimmune mechanisms are largely
unknown.
Because influenza virus haemagglutinin is known to bind
gangliosides, which serve as virus receptors, we screened
the sera of NC patients and controls for IgG antiganglio-
side antibodies (AGAs) against 11 human brain ganglio-
sides (GM1, GM2, GM3, GM4, GD1a, GD1b, GD2,
GD3, GT1a, GT1b, GQ1b) and a sulfatide. Samples from
173 children were analysed: 48 with post-Pandemrix NC,
20 with NC without Pandemrix association, 57 Pan-
demrix-vaccinated and 48 unvaccinated children. We
found that anti-GM3 antibodies were significantly associ-
ated (P < 0.05) with post-Pandemrix NC (15% of patients
versus 4% of vaccinated controls). In general, AGAs were
more frequent in vaccinated (18%) than in unvaccinated
(7%) individuals. Our data suggest that autoimmunity
against GM3 is a feature of Pandemrix-triggered NC and
autoantibodies against gangliosides were induced by
Pandemrix vaccination. Thus, in addition to a cell-
mediated immune response, post-vaccination narcolepsy
involves humoral autoimmunity.
WS4.25
Identification of a RANKL-Specific Gene
Set in Stimulated Foetal Thymic Organ
Culture
Rudolf Bichele, P€art Peterson & Martti Laan
Institute of Biomedicine and Translational Medicine, University of Tartu,
Tartu, Estonia
Medullary thymic epithelial cells (mTECs) express a large
variety of tissue-specific antigens and present them to
developing lymphocytes during the process of thymic
negative selection, thus preventing autoimmunity through
the regulation of T cell development. Mature mTECs are
crucial for proper induction of central tolerance, which is
why many recent studies have concentrated on cellular
signals driving mTEC maturation. It has been shown that
several receptors and ligands of the TNF superfamily
(TNFSF) are needed for proper mTEC development.
However, knowledge of their exact roles in regulating
gene expression of thymic epithelial cells is rather limited.
The aims of this study were to identify genes induced by
RANK, TNFR1, CD40 and LTbR signalling in the
thymus and in particular to identify genes specifically
induced by RANK-RANKL signalling, due to its key role
in mTEC maturation. Thymic lobes of embryonic day 16.5
mice were removed and cultured for 6 days in the presence
of 20-deoxyguanosine to deplete thymocytes. Thereafter,
the lobes were stimulated with selected TNFSF members
for 48 h. Material was collected and analysed using
Illumina BeadChip expression array to assess changes in
transcript levels. Selected genes were validated using
qPCR.
We found that different TNFSF ligands induced the
expression of tens to hundreds of genes, including Aire,
tissue-specific antigens and many thymic chemokines. We
observed largely overlapping lists of genes regulated by
various ligands, which suggests that single gene defects can
be compensated for by other signals and that a complex
regulatory network exists for target gene expression.
However, we identified 15 genes induced specifically by
RANKL, which, considering the central role of RANK
signalling in maintaining the thymic microenvironment,
are likely to play an important role in mTEC maturation
and regulate the induction of central tolerance.
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WS4.26
Antibodies Against Carbamylated Proteins
in Serum from Patients with Primary
Sj€ogren’s Syndrome
Brith Bergum1, Annelie Hellvard1, Roland
Jonsson1, Johan Brun2 & Piotr Mydel1
1Broegelmann Research Laboratory, Department of Clinical Science,
University of Bergen, Bergen, Norway, 2Department of Rheumatology,
Haukeland University Hospital, University of Bergen, Bergen, Norway
Sj€ogren’s syndrome (SS) is an autoimmune rheumatic
disease with organ-specific features, characterized by the
infiltration of mononuclear cells in the exocrine glands,
primarily the salivary and lachrymal glands. The presence
of autoantibodies towards intracellular Ro/SSA and La/SSB
antigens is commonly found and serves as diagnostic
criteria. In this study, we sought to evaluate the presence of
antibodies against carbamylated proteins (anti-CarP) in
patients with primary Sj€ogren’s syndrome (pSS).
Sera from 84 patients with pSS recruited from the
Rheumatology Clinic at the Haukeland University Hospi-
tal in Bergen, Norway, and 82 gender- and age-matched
healthy controls, recruited from the same geographical area
through the Haukeland University hospital Blood Bank,
were used in this study. All pSS patients fulfilled the
American-European Consensus criteria (AECC) for the
classification of SS. Samples were analysed for the presence
of IgG antibodies against carbamylated FCS by ELISA.
pSS patients had significantly increased level of aCarP
antibodies in the serum as compared to healthy controls.
Our results show that 26% of the serum of pSS patients
and 7% of healthy controls analysed were positive for IgG
anticarbamylated protein antibodies.
The reactivity against modified protein was over three
times more frequent in patients as compared to healthy
controls, indicating that the presence of anticarbamylated
protein antibodies may serve as an additional predictive or
diagnostic marker for Sj€ogren’s syndrome.
WS4.27
Sex-Biased Expression of Sj€ogren’s
Syndrome Susceptibility Genes
Jorge Ramırez, Gudny Ella Thorlacius, Thomas
Bergman, Susanna Brauner & Marie
Wahren-Herlenius
Karolinska Institutet, Stockholm, Sweden
Introduction: Sj€ogren’s syndrome is a chronic autoim-
mune disorder that mainly affects exocrine glands such as
lacrimal and salivary glands. The disease predominantly
affects women with a female-to-male ratio of 9–1, but the
molecular mechanisms that underlie this sex bias are not
well understood. Polymorphisms in several susceptibility
loci that associate with Sj€ogren’s syndrome have been
recently identified, including the MHC region, IRF5,
STAT4, IL12A, FAM167A/BLK and TNIP1 genes. In this
study, we investigated whether the expression of Sj€ogren’s
syndrome susceptibility genes is sex specific at steady state
by comparing expression in female and male mouse
immune cells.
Methods: Spleen and lymph nodes were recovered from
15 male and 15 female C57BL7/6 mice of 10 weeks of
age. RNA was extracted from the organ samples and
cDNA was obtained by reverse transcriptase conversion.
Quantitative PCR was performed for all samples, and
expression levels were normalized with GAPDH as
reference gene.
Results: The expression of five genes with the most
significant association with Sj€ogren’s syndrome was stud-
ied: IRF5, STAT4, IL12A, FAM167A, TNIP1 and BLK.
The analysis showed that the expression levels were not
significantly different between male and female mice at
steady state. Further, there was no substantial difference in
expression levels between the two tissues.
Conclusion: The sex bias observed in autoimmunity may
not be attributed exclusively to differential gene expression
at steady state. Rather, the molecular mechanisms regu-
lating the expression of these genes in specific triggering
situations might account for the sex skewing.
WS4.28
Identification of Molecules Targeted by
Ro52 Autoantibodies in the Development
of Congenital Heart Block
Kinga Tworus1, Sabrina Meisgen1, Cecilia
Mattson2, Peter Nilsson2 & Marie Wahren-
Herlenius1
1Karolinska Instutet, Stockholm, Sweden, 2Science for Life Laboratory,
Stockholm, Sweden
Introduction: Congenital heart block (CHB) is associated
with maternal anti-Ro52 autoantibodies, which are trans-
ported into the foetal circulation through the placenta and
lead to a block in the cardiac signal conduction at the
atrioventricular node. The mothers of affected infants are
often diagnosed with autoimmune disease such as Sj€ogren’s
syndrome or systemic lupus erythematosus. As CHB-
inducing antibodies bind the cardiomyocyte cell surface,
while Ro52 is an intracellular protein which has no or little
cardiac expression, it has been suggested that the maternal
autoantibodies bind a cross-reactive cell surface molecule
exposed in the foetal heart. The aim of the current study was
to establish methodology for the identification and confir-
mation of cross-reactive targets of the Ro52 autoantibodies.
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Methods: Multiplexed antibody-based protein profiling
and screening of protein components developed within the
framework of the human protein atlas project (PrESTs)
were performed for two mouse monoclonal antibodies that
induce CHB in an experimental transfer model and one
isotype-matched control monoclonal.
Results: An initial study with an 11,521 k PrEST array
detected 13 proteins bound by the CHB-inducing mono-
clonal Ro52 antibodies, but not the control antibody. One
PrEST, derived from the central (coiled-coil) part of
integrin-linked kinase (ILK) protein, was bound by both
CHB-inducing antibodies.
Conclusion: In conclusion, PrEST arrays could be an
auxiliary tool for screening and identifying cross-reactive
targets for normal and diseased states.
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Workshop 5. Allergy/Tumour
Immunology/Novel Concepts and
Technologies
WS5.1
The Role of Microfibrillar-Associated
Protein 4 in the Murine Model of Asthma
Bartosz Pilecki1, Anne Holm1, Anders Schlosser1,
Vicki Nielsen1, Helle Wulf-Johansson1, Jesper
Møller1, Niels Marcussen2, Jørgen Vestbo3,
Christopher Stevenson4, Uffe Holmskov1 &
Grith Sørensen1
1Institute of Molecular Medicine, Odense, Denmark, 2Department of
Pathology, Odense University Hospital, Odense, Denmark, 3Department of
Respiratory Medicine, Odense University Hospital, Odense, Denmark,
4Respiratory Disease Area, Novartis Horsham Research Centre, Horsham,
UK
Microfibrillar-associated protein 4 (MFAP4) is a matricel-
lular protein abundant in lungs. Its functions remain
largely unknown. However, due to the presence of an
integrin-binding site and structural similarities to many
proteins engaged in innate immune defences, MFAP4 is
thought to be an active modulator of immune response and
tissue remodelling.
The aim of the current study was to investigate a potential
role of MFAP4 in two distinct murine models of allergic
asthma.
BALB/c WT and MFAP4-deficient mice were sensitized
and subsequently challenged intranasally with ovalbumin,
or chronically challenged with house dust mite (HDM)
extract. Lung function measurements and airway hyper-
responsiveness (AHR) assessment were performed. Immune
cell infiltration and cytokine production were measured in
bronchoalveolar lavage (BAL) and lung tissue. Lungs were
processed for histology and evaluated for signs of inflam-
mation and airway remodelling.
In both models, treated MFAP4-deficient mice exhibited
lowered cell counts in BAL than the WT littermates,
corresponding to significantly diminished numbers of
infiltrating eosinophils. Accordingly, the production of
eosinophil chemoattractants CCL11 and CCL24 was
reduced in the airways of MFAP4-deficient mice. More-
over, MFAP4-deficient mice were partially protected from
allergy-induced mucus production, subepithelial fibrosis
and smooth muscle cell hyperplasia. Lack of MFAP4 in
chronically treated mice resulted in increased central
airway resistance, a representative for tracheal stiffness.
Obtained results show that absence of MFAP4 attenuates
allergy-induced airway remodelling and eosinophilia, but
contributes to stiffness in conducting airways. It indicates
that MFAP4 may serve as a potential therapeutic target in
the treatment for allergic asthma.
WS5.2
Does Cell Proliferation Contribute to the
OVA-Induced Increase of Lung Mast Cell
Progenitors in a Mouse Asthma Model?
Behdad Zarnegar, Joakim Dahlin, Annika Westin &
Jenny Hallgren Martinsson
Uppsala University, Uppsala, Sweden
Introduction: In patients with allergic asthma, mast cell
numbers are elevated in the lung. The increase in mast cells
can be recapitulated in experimental mouse models of
asthma. Earlier studies using an ovalbumin (OVA) model
of experimental asthma suggest that the increase in mast
cells is due to the recruitment of mast cell progenitors from
blood into the lung tissue. However, to what extent
proliferation of lung-resident mast cell progenitors is
contributing to the increase is currently unknown.
Methods: An experimental asthma model in which mice
were sensitized i.p. on day 0 and day 7 followed by OVA
aerosol challenge on days 17–19 was used. On day 20,
mononuclear cells were isolated from the lung following
enzymatic degradation and gradient centrifugation. Iso-
lated single cell suspensions were stained with antibodies
towards lineage markers, c-kit, ST2, integrin b7 and
CD16/32 to identify mast cell progenitors. In addition,
intracellular staining with the Ki-67 antibody to mark
proliferating cells was performed.
Results: OVA sensitization and challenge increased the
frequency and total number of lung mast cell progenitors
fivefold over only sensitized mice. Approximately 45% of
mast cell progenitors were Ki-67+ in OVA-sensitized mice.
After OVA sensitization and challenge, the percentage of
Ki-67+ mast cell progenitors was increased to about 70%
corresponding to an eightfold increase in total number of
proliferating mast cell progenitors.
Conclusions: Our data suggest that in situ cell proliferation
may add to remarkable increase in lung mast cell
progenitors.
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WS5.3
Insect Bite Hypersensitivity of Horses:
Induction of a Specific Antibody Response
in Horses After Oral Treatment with
Transgenic Barley Grain Expressing an
Insect Allergen
Sigrıdur Jonsdottir1, Sara B. Stefansdottir1,
Vilhjalmur Svansson1, Eliane Marti2, Einar
M€antyl€a3, Jon M. Bj€ornsson3, Audur
Magnusdottir3, Omar Gustafsson3 & Sigurbjo¨rg
Torsteinsdo´ttir1
1Institute for Experimental Pathology, University of Iceland, Keldur,
Reykjavik, Iceland,, 2Department of Clinical Research and Veterinary
Public Health, University of Bern, Bern, Switzerland, 3ORF Genetics,
Kopavogur, Iceland
Background: Insect bite hypersensitivity (IBH) is an IgE-
mediated dermatitis of horses initiated by bites of midges
of the genus Culicoides that do not exist in Iceland. The
prevalence of IBH is much higher in horses born in Iceland
and exported to the continent, compared to Icelandic
horses born in a Culicoides-rich environment. The specific
allergens causing IBH have been identified and expressed as
recombinant proteins in E. coli. The aim was to express
allergens in barley grain to use in oral immunotherapy
against IBH.
Methods: Cul n 2 was expressed in barley grain with the
Orfeus technique and in insect cells with the Bac-to-Bac
system. Cul n 2 transgenic barley flour of 50 g was mixed
in NaCl with hydroxyethylcellulose and two horses treated
six times orally with total 350 g of barley containing
35 mg rCul n 2 over a period of 4 months. Two control
horses were treated with unmodified barley. The horses
received the barley mixture in special hollow bits. The
mixture was slowly consumed in 4–5 h. Serum and saliva
samples were collected before and 2 weeks after each
treatment for the analysis of antibody responses in Western
blot (WB) and ELISA.
Results: The allergen Cul n 2, a hyaluronidase originating
from C. nubeculosus, was expressed in barley grain. When
tested in WB on rCul n 2 purified from insect cells, specific
IgG response could be detected in serum from the horses
treated with the transgenic barley. IgG subclasses were
tested in ELISA on rCul n 2 produced in E. coli. The
response was mainly of IgG4/7 subclass and to some extent
IgG1. No detectable IgG5 or IgG6 was induced and no
IgE.
Conclusion: Specific antibody response could be obtained
in horses using oral treatment with transgenic barley flour
expressing an allergen. Further studies will show whether
this approach is a useful alternative for the prevention and
treatment of equine IBH.
WS5.4
Vaccination of Horses Against Insect Bite
Hypersensitivity: Intralymphatic Injection
with Allergens in Alum or Alum and
Monophosphoryl Lipid A
Sigrı´dur Jo´nsdo´ttir1, Eliane Marti2, Vilhjalmur
Svansson1 & Sigurbj€org Torsteinsdottir1
1Institute for Experimental Pathology, University of Iceland, Keldur,
Reykjavik, Iceland, 2Department of Clinical Research and Veterinary
Public Health, University of Bern, Bern, Switzerland
Background: Insect bite hypersensitivity (IBH) is an IgE-
mediated allergic dermatitis of horses caused by bites of
insects of the genus Culicoides spp. (midges) that do not
exist in Iceland. All breeds of horses can be affected but
horses born in Iceland and exported to the continent are
more frequently affected than Icelandic horses born abroad.
We have isolated the respective Culicoides allergen genes
and expressed the proteins in E. coli.
Objectives: The objective was to compare two different
adjuvants for intralymphatic vaccinations using four
purified recombinant allergens with the final aim to
develop immunotherapy against IBH.
Methods: The allergens, rCul n 3, 4, 8 and 10, were
produced in E. coli and purified. Twelve healthy Icelandic
horses were vaccinated intralymphatically three times with
four recombinant allergens (10 lg/vaccination), six with
the allergens in alum and six with the allergens in alum
and monophosphoryl lipid A (MPL). Serum was collected
for the analysis of antibody response and the horses were
tested for allergy.
Results: Immunization with allergens in both alum and
alum/MPL gave strong specific IgG responses. The IgG
subclass antibodies induced against the four allergens were
mainly IgG1 and IgG4/7 and to some extent IgG5. There
was no detectable induction of IgE nor any indication of
IgE-mediated reaction as the horses did not respond to the
recombinant allergens in skin test and Culicoides extract
stimulation in a sulfidoleukotriene release test was nega-
tive.
Conclusions: Intralymphatic vaccination with small
amount of purified recombinant allergens in adjuvant
induced strong specific IgG response and not IgE. The
difference between alum and alum/MPL was not significant
but further experiments with analysis of the cytokine
profile and more horses are needed, as the results look
promising for the development of immunotherapy against
IBH.
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WS5.5
Culicoides Nubeculosus Hyaluronidase an
Allergen (Cul n 2) in Insect Bite
Hypersensitivity of Horses: Expression in
Insect Cells and Barley Grain and
Generation of Cul n 2 Specific
Monoclonal Antibodies
Sara Bjo¨rk Stefa´nsdo´ttir1, Sigrıdur Jonsdottir1,
Vilhjalmur Svansson1, Eliane Marti2, Einar
M€antyl€a3 & Sigurbj€org Torsteinsdottir1
1Institute for Experimental Pathology, University of Iceland, Keldur,
Reykjavik, Iceland, 2Department of Clinical Research and Veterinary
Public Health, University of Bern, Bern, Switzerland, 3ORF Genetics,
Kopavogur, Iceland
Background: Hyaluronidase from biting midges, Culico-
ides spp, is one of the allergens causing insect bite
hypersensitivity (IBH), an IgE-mediated dermatitis of
horses. Culicoides spp. are not indigenous to Iceland and the
prevalence of IBH is very high in horses born in Iceland
and exported to the continent. The hyaluronidase from
C. nubeculosus has been isolated and expressed in E. coli, its
allergenicity established and the allergen termed Cul n 2.
The objective was to express in insect cells and in barley
the most important allergens causing IBH with the final
aim of developing an immunotherapy against the IBH.
Methods: Monoclonal antibodies (mAb) were generated
against E. coli-produced Cul n 2 using the hybridoma
technique. rCul n 2 was expressed in insect cells with the
Bac-to-Bac system (Invitrogen). rCul n 2 was expressed in
barley grain with the Orfeus technique [Magnusdottir A.,
et al. (2013) Trends Biotechnol. 31:572–80]. Protein
detection was carried out with SDS-PAGE electrophoresis,
Coomassie staining and Western blot.
Results: The allergen Cul n 2 was expressed in insect cells
using baculovirus. Cul n 2 was also expressed in barley
grain. Third-generation seeds contain 1 mg rCul n 2 per
10 g grain and are available in a seed bank for future
production. The Cul n 2-specific mAb binds to the E. coli
expressed Cul n 2 as well as rBac-Cul n 2 and barley
produced rCul n 2. IgG from horses vaccinated with
E. coli-produced rCul n 2 in adjuvant bound to both rBac-
Cul n 2 and rCul n 2 from barley.
Conclusion: It is of importance to express, in insect cells,
the allergens that cause IBH for monitoring the immune
response following immunotherapy. Barley seeds are an
excellent source of recombinant proteins, ideal for their
stable storage.
WS5.6
Lower IL-21 Levels at Birth are Associated
with Parental Allergic Heredity
Claudia Carvalho-Queiroz1, Teresa Horn1, Julia
Bitmann1, Caroline Nilsson2 & Eva Sverremark-
Ekstr€om1
1Stockholm University, Stockholm, Sweden, 2Sachs’ Children and Youth
Hospital, Stockholm, Sweden
Children are born with an immature immune system that
develops during their first years of life under the influence
of environmental factors. In some individuals, non-hazard-
ous antigens induce IgE production and cause allergic
disease. The prevalence of allergy has increased during the
last decades. A reduced exposure to microbial products is
thought to be a contributing factor. In an attempt to better
understand how an immune response could relate to allergy
development during childhood, we studied the cytokine
profiles of children from a well-characterized allergy cohort
comprising a group of 281 children followed from the
third trimester of pregnancy until 10 years of age. Parental
allergy (heredity), IgE-sensitization and manifest allergic
disease have been thoroughly recorded throughout the
study (up to 10 years). Plasma cytokines were measured at
0 (birth), 2, 5 and 10 years of age. Results from 105
children (37% of the cohort) showed that as expected, the
children with both allergic parents presented with signif-
icantly higher levels of IL-4, IL-13 and IL-17A in their
plasma at birth, when compared to children without
allergy heredity. In contrast, children without allergic
parents had significantly higher concentration of IL-21 in
plasma at birth, when compared to children with allergic
heredity. Interestingly, the IL-21 levels increased at 5 years
on children with allergic heredity when compared to
children with no allergic heredity. Cytokine analyses in
relation to allergic outcomes will be performed. As the role
of IL-21 in inhibiting IgE production has been described,
our results so far indicate that IL-21 regulatory effects were
diminished already at birth on children born from allergic
parents. However, an increase in IL-21 levels later in life
even in children with allergic heredity suggests that other
factors could influence an immature immune system. Some
of these factors are currently under investigation.
WS5.7
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Insect Bite Hypersensitivity of Horses:
Intralymphatic Immunization of Foals
with Baculovirus Vectors Expressing
Culicoides Allergen
Lilja Thorsteinsdottir1, Sigrı´ður Jonsdottir2,
Sigurbj€org Torsteinsdottir2 & Vilhja´lmur
Svansson2
1Institute for Experimental Pathology, University of Iceland, Keldur,
Reykjavık, Iceland, 2Institute for Experimental Pathology, Reykjavık, Iceland
Background: Insect bite hypersensitivity (IBH) is a
recurrent seasonal allergic dermatitis of horses, a reaction
to biting midges, Culicoides spp. The incidence of IBH is
very high in horses born in Iceland and exported to the
continent. The aim of the project was to develop
baculoviral vectors for immunotherapy of IBH.
Methods: Two recombinant baculoviral vectors (rBac)
were constructed with the allergen gene Cul n 2, a
hyaluronidase from C. nubeculosus. Four foals were vacci-
nated 59 in the submandibular lymph node two with each
vector and then all subsequently boosted with E. coli-
produced Cul n 2 in monophosphoryl lipid A/alum
adjuvant. Gene expression in insect cells and equine
kidney cells was tested in Western blot (WB) and
serological response in WB and ELISA.
Results: We constructed two baculoviral vectors, rBac-Cul
n 2 with the Cul n 2 under the polyhedrin promoter and
rBac-EHV-2-gB-Cul n 2, with the glycoprotein B (gB)
from the equine herpesvirus 2 (EHV-2) under the polyhe-
drin promoter and with a mammalian expression cassette
containing cytomegalovirus promoter, intron A, the Cul n
2 allergen and poly A. After inoculation of rBac-EHV-2-
gB-Cul n 2, the Cul n 2 was expressed in equine cells,
whereas no expression was obtained with the rBac-Cul n 2
vector. However, Cul n 2-specific antibody response was
not detected in rBac-EHV-2-gB-Cul n 2-vaccinated foals
but only a low response in foals vaccinated with rBac-Cul n
2. After protein boost, antibody response was similar in all
foals.
Conclusions: The allergen Cul n 2 was expressed in equine
cells after inoculation with the baculoviral vector rBac-
EHV-2-gB-Cul n 2. However, the vector did not induce
detectable antibody response in contrast to the control
rBac-Cul n 2 vector. Further studies will show whether the
recombinant Bac vectors can be employed in IBH immu-
notherapy.
WS5.8
The IL6R Expression is Downregulated by
miR-451 in Tumour Progression
Dong Liu1, Cong Liu2, Xiyn Wang2, Sigurdur
Ingvarsson3 & Huiping Chen2
1Department of Radiology, Tongji Medical College, Huazhong University of
Science, Wuhan, Hubei, China, 2Department of Medical Genetics,
Huazhong University of Science and Technology, Wuhan, Hubei, China,
3Institute for Experimental Pathology, Reykjavik, Iceland
IL6 was originally identified as a B cell differentiation
factor. It is a multifunctional cytokine that regulates the
immune response, haematopoiesis, the acute-phase response
and inflammation. IL6 is produced by various types of cells
and influences various cell types and has multiple biolog-
ical activities through its unique receptor system. IL6
exerts its biological activities through IL6R. IL6R is
involved in IL6-STAT3-HIF signalling pathway, which
plays a role in cell growth and carcinogenesis. The miR-
451 was found to be frequently downregulated in tumours,
indicating that miR-451 could play an important role in
carcinogenesis. This study uncovered the mechanism by
which the miR-451 functions as a tumour suppressor. The
target genes of miR-451 were determined using target
gene prediction software. Then, the miR-451 mimics were
introduced into RKO and Hela cells, respectively. The
proliferation and invasion of cells were monitored by MTT,
cell cycle and in vitro extracellular matrix invasion assays.
Also, the angiogenesis of HUVEC cells transfected with
miR-451 mimics was examined. Subsequently, IL6R, a
predicted target gene of miR-451, was studied by real-time
PCR, Western blotting and siRNA technologies. The
mRNA and protein levels of IL6R gene were found to be
downregulated in the RKO and Hela cells transfected with
miR-451 mimics. Consequently, the cell proliferation was
inhibited. Also, the invasion of RKO cells was suppressed.
Furthermore, the angiogenesis of HUVEC cells transfected
with miR-451 mimics was assayed and the decreased
angiogenic ability was detected compared to the controls.
All these results were validated by IL6R siRNA experi-
ments. The IL6R gene is a target gene of miR-451. The
miR-451 behaves as a tumour suppressor, probably by
targeting the IL6R pathway.
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WS5.9
NK Cells and ALL: A Rat Model of T Cell
Lymphoblastic Leukaemia
Margherita Boieri1, Amanda Sudworth1, Lise
Kveberg2 & Marit Inngjerdingen2
1University of Oslo, Oslo, Norway, 2Rikshospitalet, Oslo University Hospital,
Oslo, Norway
Natural killer (NK) cells play a central role in tumour
immunosurveillance and exert both direct and indirect
effects by killing transformed target cells and by producing
cytokines to regulate the immune system. Despite this,
many cancer cells escape NK immunosurveillance and
appear to be resistant to NK-mediated cytotoxicity. Several
studies have demonstrated that acute lymphoblastic
leukaemia (ALL), and in particular T cell-derived leukae-
mias, are among these.
We have established a rat model of ALL, utilizing a
primary T cell leukaemia isolated from PVG rats (Roser;
Roser et al., 1975). To study the effect of the leukaemia on
the functionality of NK cells, we have combined in vitro
assays and in vivo experiments to investigate changes in the
phenotype and in the functionality of NK cells in the
context of ALL.
We tested in vitro the ability of rat NK cells to form
conjugate, to kill and/or to produce cytokines in response
to Roser leukaemia cells. We found that NK cells form few
conjugates with Roser leukaemia cells, and poorly killed
the leukaemic blasts in a 4-h 51Cr release assay. However,
addition of IL-2 to the co-cultures of NK cells and Roser
leukaemia cells improved the killing activity towards the
Roser leukaemia cells. The production of IFN-c by NK
cells was not affected by the presence of Roser leukaemia
cells in the culture. We also investigated changes in NK
phenotype upon exposure to Roser leukaemia cells, but
found no difference in the NK phenotype after co-culture.
In order to define the mechanism of reduced NK
functionality, Roser leukaemia cells have been tested for
the expression of known ligands for the NK activating
receptor NKG2D and the supernatant of NK-Roser
leukaemia cells co-culture has been screened for the
presence of soluble NKG2D ligands and other known
immunosuppressive factors.
WS5.10
Disease Relapse After Tyrosine Kinase
Inhibitor Treatment Discontinuation in
Chronic Myeloid Leukaemia is Related to
Both Low Number and Impaired Function
of NK Cells
Mette Ilander1, Ulla Olsson-Str€omberg2, Hanna
L€ahteenm€aki1, Tiina Kasanen1, Perttu
Koskenvesa1, Stina S€oderlund2, Martin H€oglund2,
Berit Markev€arn3, Anders Sj€alander4, Kouros
Lofti5, Claes Malm5, Anna Lubking6, Marja
Ekblom6, Elena Holm6, Mats Bj€oreman7, S€oren
Lehmann8, Leif Stenke8, Lotta Ohm8, Henrik
Hjorth-Hansen9, Susanne Saussele10, Francois-
Xavier Mahon11, Kimmo Porkka1, Johan Richter6
& Satu Mustjoki12
1Hematology Research Unit Helsinki, Helsinki, Finland, 2Department of
Hematology, Uppsala University Hospital, Uppsala, Sweden, 3Department
of Hematology, Umea University Hospital, Umea, Sweden, 4Department of
Public Heath and Clinical Medicine, Umea, Sweden, 5Department of
Hematology, Linkoping University Hospital, Link€oping, Sweden, 6Skane
University Hospital, Lund, Sweden, 7University Hospital, €Orebro, Sweden,,
8Division of Hematology, Department of Medicine, Karolinska University
Hospital, Stockholm, Sweden, 9Department of Hematology, St Olavs
University Hospital, Trondheim, Norway, 10III. Medizinische Klinik,
Universit€atsmedizin Mannheim, Universit€at Heidelberg, Mannheim,
Germany, 11Inserm U1035, Universite Bordeaux Segalen, Bordeux,
France, 12Hematology Research Unit Helsinki, University of Helsinki and
Helsinki University, Helsinki, Finland
Chronic myeloid leukaemia (CML) is caused by a translo-
cation in the haematopoietic stem cell resulting in BCR-
ABL1 oncokinase. The inhibition of BCR-ABL1 with
tyrosine kinase inhibitors (TKIs) has significantly
improved the prognosis of CML.
Recent reports suggest that approximately 40% of CML
patients who have achieved optimal therapy response
(sustained complete molecular remission) are able to stop
TKI treatment without disease relapse. However, there are
no predictive markers for successful therapy discontinua-
tion. Therefore, we set up an immunological substudy in
the ongoing pan-European EURO-SKI stopping study. We
aimed to identify predictive biomarkers for relapse/non-
relapse after TKI discontinuation, to understand more on
the mechanisms of immune surveillance and to study the
effects of TKI treatment on the immune system.
Basic lymphocyte analysis was performed at the study entry
and at 1, 6 and 12 months after the TKI discontinuation
(currently 94 patients included in the substudy). In 43
patients, more detailed immunophenotypic and functional
analyses were performed at the same time points.
Interestingly, patients who were able to maintain remission
had increased NK cell counts already before stopping the
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treatment compared to patients who relapsed. Further-
more, the phenotype of NK cells was more cytotoxic
(CD57+CD16+CD62L-), and also their function (degran-
ulation and direct cytotoxicity) was better in patients who
did not relapse. No differences were observed in the
function or the numbers of T cells at the time of treatment
discontinuation. However, the Th1 type of cytokine
secretion by CD8+ T cells enhanced after the treatment
discontinuation in patients who were able stay in remis-
sion.
In conclusion, the NK cell number and their function may
predict disease relapse after TKI discontinuation. This may
have impact on the future stopping trials. In addition, it
further illustrates the importance of the immune system in
the successful long-term treatment of CML.
WS5.11
Chronic Lymphocytic Leukaemia Cells
with Trisomy 12 Home to the Bone
Marrow in a CXCR4-Independent Manner
Evelyn Hutterer1, Sylvia Ganghammer1, Elisabeth
Hinterseer1, Gabriele Brachtl1, Daniela Asslaber1,
Peter Krenn1, Tamara Girbl1, Petera Berghammer1,
Roland Geisberger1, Alexander Egle1, Antonella
Zucchetto2, Valter Gattei2, Alexandre Chigaev3,
Richard Greil1 & Tanja Hartmann1
1LIMCR/PMU/PLUS, Salzburg, Austria, 2SOECS/CRO, Aviano, Italy,
3Department of Pathology and Cancer Center/UNM, Alburquerque, NM,
USA
Trisomy 12 (tri12) defines a subgroup among CLL patients
with specific clinical features, which is associated with
increased expression of the negative prognostic marker
CD49d, the a-subunit of the VLA-4 integrin. VLA-4 is
crucially involved in homing of CLL cells to bone marrow
(BM). This process is thought to depend on inside-out
activation of VLA-4 upon CXCL12–CXCR4 interaction
augmenting the arrest of the cells on the VCAM-1
presenting endothelium. The interplay between VLA-4
and CXCR4 in tri12 CLL was investigated by a combi-
nation of cytometrical, videomicroscopical and in vivo
assays. High expression of CD49d was accompanied by
lower levels of CXCR4 in tri12 CLL. Short-term adoptive
transfers of CLL cells to immune-deficient mice were
performed to analyse their homing capacity. BM homing
depended on functional VLA-4 expression. However, while
this homing could be diminished by inhibition of the
CXCL12-CXCR4 axis in non-tri12 CLL cells, tri12 CLL
cells homed independently of these signals. Migration
assays under shear flow were used to test whether VLA-4
could undergo CXCL12-induced activation and support
the adhesion of CLL cells to a VCAM-1 substrate. While
CXCL12 enhanced arrests of non-tri12 CLL cells, tri12
CLL cells did not rely on this chemokine. Analysing VLA-
4 conformations upon chemokine stimulation in real-time,
CXCL12 was found to fail to induce inside-out activation
of VLA-4 in tri12 CLL. Our results suggest that tri12 CLL
use a different pathway for integrin activation and provide
a mechanistical basis explaining, at least in part, the
peculiar clinical features of tri12 CLL.
WS5.12
The Spiegelmer NOX-A12 Mobilizes CLL
Cells from Lymphoid Organs and Prevents
Their Recirculation
Elisabeth Hinterseer1, Tamara Girbl1, Evelyn
Hutterer1, Petra Berghammer1, Sylvia
Ganghammer1, Eveline Anke Sifft1, Josefina
Pinon-Hofbauer1, Alexander Egle1, Anna
Kruschinski2, Richard Greil1 & Tanja Nicole
Hartmann1
1LIMCR/PMU/PLUS, Salzburg, Austria, 2NOXXON Pharma AG, Berlin,
Germany
NOX-A12 is a novel Spiegelmer-based antagonist of
CXCL12, a stromally expressed chemokine involved in
chronic lymphocytic leukaemia (CLL) cell trafficking to
and retention within bone marrow (BM) and other
lymphoid organs.
Here, the in vivo efficacy of NOX-A12 to mobilize CLL cells
from their protective lymphoid microenvironment to the
peripheral blood, thereby potentially sensitizing them to
cytotoxic agents, and to prevent their recirculation, was
investigated.
Using the Tcl1 transgenic transplantation model that
mimics human CLL, NOX-A12 demonstrated even at low
doses (10 mg/kg) a considerable potential to mobilize CLL
cells and other lymphocytes as relative CLL cell and
absolute lymphocyte blood counts raised within 1 h up to
200% and reached a peak after 6 h. Higher doses lead to a
prolonged mobilization duration. Short-term adoptive
transfers of human CLL cells into immune-deficient mice
revealed a reductive effect of NOX-A12 treatment on CLL
cell recirculation to BM in the majority of clinical CLL
subgroups. Next, CXCR4 surface levels of CLL cells before
injection and after cell had homed to BM were determined.
Homed CLL cells expressed increased CXCR4 surface levels
and CXCR4 levels were further increased upon CXCL12/
CXCR4 inhibition with NOX-A12.
Summarizing, our data demonstrate a high efficiency of
NOX-A12 to mobilize CLL cells and to prevent their
recirculation into protective lymphatic organs. Abrogating
CXCL12/CXCR4 signalling in combination with chemo-
therapy may provide an attractive approach for the
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treatment of CLL, which is currently evaluated using the
Tcl1 transgenic transplantation model.
WS5.13
Cell Surface Transport Undercover: The
Expression of the Soluble and Surface-
Bound NKG2D-Ligand ULBP2 is
Dependent on Endosomal Regulation
Franziska Katharina Uhlenbrock1, Michael
Hagemann-Jensen2, Stephanie Nina Kehlet2, Lars
Andesen2, Silvia Pastorekova3 & Søren Skov2
1Institute for Veterinary Disease, Copenhagen, Denmark,, 2Laboratory of
Immunology, Section for Experimental Animal Models, University of
Copenhagen, Copenhagen, Denmark, 3Department of Molecular Medicine,
Institute of Virology, Bratislava, Slovak Republic
Soluble ULBP2 is a marker for poor prognosis in several
types of cancer. In the present study, we demonstrate that
both soluble and cell surface-bound ULBP2 is transported
via a so far unrecognized endosomal pathway. ULBP2
surface expression, but not MICA/B, could specifically be
targeted and retained by affecting endosomal/lysosomal
integrity and PKC activity. This novel pathway was
identified through screening experiments by which meth-
ylselenic acid (MSA) was found to possess remarkable
NKG2D-ligand regulatory properties: MSA induced
MICA/B surface expression but on the contrary, MSA
dominantly blocked endosomal transport of ULBP2
through a sustained PKC inhibitory activity. Notably, by
targeting this novel pathway, we could specifically block
the production of soluble ULBP2 from different, primary
melanomas. Our findings strongly suggest that the
endosomal transport pathway constitutes a novel therapeu-
tic target for ULBP2-producing tumours.
WS5.14
The Role of NK Cells in T Cell Acute
Lymphocytic Leukaemia
Amanda Sudworth, Margherita Boieri, Lise
Kveberg & Marit Inngjerdingen
Oslo University, Oslo, Norway
NK cells have an important role in protecting the body
from cancer development. However, in cancer patients, NK
cells have demonstrated decreased function. The purpose of
this study was to get a better understanding on how NK
cell function changes during T cell ALL progression in the
rat. To test this PVG, RT7b rats were injected with Roser
leukaemia and sacrificed at various time points. Flow
cytometry was utilized to measure differences in NK cell
subsets, maturation level, activation markers and func-
tional ability of NK cells with ALL compared to healthy
controls. We have previously characterized a NKR-
P1Bbright subset found in the blood as terminally differ-
entiated effector NK cells. We found that the percentage of
NKR-P1Bbright cells in blood decreased around day 14,
which is the same time point in which low levels of
leukaemia cells can be detected. At the same time, there is
an increase in CD11b+CD27- mature cells. These results
suggest that the NK cells are affected by the leukaemia
cells by day 14 with an increase in mature cells and most
likely the activation and subsequent death of the NKR-
P1Bbright subset. A decrease in NK cell function was
measured after day 20. By this time point, the ALL cells
were the most numerous cells in the blood. This suggests
that NK cell function decreases as the leukaemic burden
increases.
WS5.15
Surface-Mediated Priming During In Vitro
Dendritic Cell Generation
Alexander Sauter1, Yvonne Sch€on2, Aurora
Martinez1, Joachim P. Spatz2 & Silke Appel1
1University of Bergen, Bergen, Norway, 2Max-Planck-Institute for
Intelligent Systems, Stuttgart, Germany
Introduction: Ex vivo-generated dendritic cells (DC) are
most commonly generated from monocytes by the addition
of IL-4 and GM-CSF using standard cell culture plastic
dishes. However, the effects of the plastic surface on the
developing DC have been poorly investigated so far. In this
work, we have compared a standard plastic dish with four
different, mainly non-adhesive, surfaces in order to eluci-
date the effect of the surface during the differentiation
process.
Methods: The five surfaces were either purchased or
prepared locally. Monocytes were isolated using the
Monocytes Isolation Kit II from Miltenyi Biotec and
cultured for 3 days in the presence of IL-4 and GM-CSF.
Time-lapse videos were recorded on three time points (one
each day), and the phenotype of the cells was analysed by
flow cytometry. The cytokine profiles were analysed in cell-
free supernatants using a 25-plex Luminex assay.
Results: Using non-adhesive surfaces did not alter the
production of most cytokines significantly. However, the
use of non-adhesive surfaces led to a significant reduction
in expression of CD14 and CD38 and a significant increase
in expression of CD86 compared to standard culture dishes.
Interestingly, the expression levels of DC-SIGN and PD-
L2 were also reduced significantly on cells cultured on non-
adhesive surfaces.
Conclusion: Although cytokine levels are only slightly
affected, standard cell culture dishes give rise to differences
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in the phenotype of monocyte-derived dendritic cells
compared to non-adhesive surfaces. The surface-mediated
priming should therefore be considered when aiming to
induce specific immune responses.
WS5.16
Method Development for the
Identification of HLA-DR-Bound Peptides
Tina Heyder1, Maxie Kohler1,Asa Wheelock1, Jan
Wahlstr€om1, Anders Eklund1, Roman Zubarev2,
Johan Grunewald1 & Jimmy Ytterberg2
1Department of Medicine, Karolinska Institutet, Stockholm, Sweden,
2Department of Medical Biochemistry and Biophysics, Karolinska
Institutet, Stockholm, Sweden
Introduction: The identification of HLA-DR-bound pep-
tides present a valuable tool to identify disease-specific
antigen(s) in chronic inflammatory and autoimmune
disorders. Our group has previously published a method,
where HLA-DR-bound peptides from the deep airways
could be identified from 800 million bronchoalveolar
lavage (BAL) cells pooled from 16 patients. Because BAL
from healthy non-smoking individuals typically only
contains 10–15 9 106 cells, our aim was to increase the
sensitivity in order to investigate individual subjects.
Methods: Cells were collected by bronchoalveolar lavage.
Crude membranes were isolated using differential centri-
fugation and solubilized using non-ionic detergents. HLA–
peptide complexes were immunoaffinity-purified and the
peptides eluted using acidic conditions. Peptides were
analysed using on-line nanoLC-MS/MS (Q-Exactive), fol-
lowed by identification by searching the Human IPI
database using the Mascot search engine.
Results: The enrichment for HLA-DR complexes prior to
immunopurification reduced the amount of non-specific
peptides identified in the samples. As expected, the
number of peptides and proteins identified was highly
dependent on the number of cells used for the purification.
While we identified 606 peptides from a sample with
85 9 106 cells, we only found 44 peptides from
10 9 106 cells. The majority of identified peptides
matched specific regions on the protein sequences and
formed overlapping clusters, which potentially correspond
to the HLA binding pockets. The peptide lengths, with a
median of 15 amino acids, were consistent with literature.
Comparing samples from different patients showed differ-
ences in both protein and peptide level. Some of these
differences could be correlated with the HLA type of the
patient.
Conclusion: The improved method will enable us to
compare peptide repertoires of BAL cells between patients
and healthy individuals. Further investigations will be
performed to validate the identified peptides regarding
disease specificity and binding prediction. Such peptides
may trigger pathogenic T cell responses and could become
tools for antigen-specific immunotherapy.
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Workshop 6. Infectious Diseases and
Vaccination/Immune Intervention and
Therapy
WS6.1
A Single Point Mutation in the spxB Gene
of Streptococcus pneumoniae
Dramatically Alters the Interaction with
Macrophages and Increases the Severity
of Infection
Martin Norman, Anna Syk, Jenny Fernebro,
Marilena Gallotta, Susan Farmand, Andreas
Sandgren, Staffan Normark & Birgitta Henriques-
Normark
Karolinska Institutet, Stockholm, Sweden
Streptococcus pneumoniae is a common colonizer of the human
nasopharynx, especially in preschool children. At least 93
different serotypes have been identified, of which some
such as serotype 1 are associated with a high invasive
disease potential. An important virulence factor for
S. pneumoniae is pyruvate oxidase, which is responsible for
the production of hydrogen peroxide and is encoded by the
spxB gene. Hydrogen peroxide allows S. pneumoniae to
outcompete other bacterial species such as Haemophilus
influenzae and Neisseria meningitidis during colonization of
the nasopharynx.
Mutations which disrupt the expression of the spxB gene
alter the interaction between S. pneumoniae and host cells.
In vitro data for both human and murine macrophage cell
lines showed a reduction in the binding of S. pneumoniae
strains with impaired spxB function compared to strains
with the wild-type gene. There was also a reduction in the
subsequent phagocytosis of the spxB mutant strains. In vivo
experiments support this finding that in an intraperitoneal
infection model, C57BL/6 mice infected with a strain with
impaired spxB function had a shorter survival time than
mice infected with the wild-type strain. Furthermore, mice
infected with the mutant also had higher bacterial titres at
the time of sacrifice. To mimic systemic disease, mice were
infected intravenously with wild-type and spxB mutants of
serotypes 1 and 4. For both strains, bacterial titres were
consistently higher throughout the infection for the spxB
mutants than for the wild-type strains. Interestingly, for
serotype 1 but not for serotype 4, this translated into a
shorter median survival time. How the interaction between
the innate immune system and S. pneumoniae changes due
to mutations in the spxB gene still remains unsolved. It is
likely that the altered interaction is due to indirect effects
of an impaired spxB gene and not directly attributable to
hydrogen peroxide.
WS6.2
Obesity and Risk of Infection
Kathrine Agerga˚rd Kaspersen1, Ole Birger
Pedersen2, Mikkel Steen Petersen1, Henrik
Hjalgrim3, Bjarne Kuno Møller1, Cecilie Juul
Sørensen1, Sebastian Kotze1, Kristoffer Sølvsten
Burgdorf4, Henrik Ullum4 & Christian Erikstrup1
1Aarhus University Hospital, Aarhus N, Denmark, 2Naestved Hospital,
Naestved, Denmark, 3Statens Serum Institut, Copenhagen,
Denmark, 4Copenhagen University Hospital, Rigshospitalet, Copenhagen,
Denmark
Background: Obesity is associated with increased risk of a
range of diseases. However, the association of obesity with
risk of infection among otherwise healthy individuals has
not been established.
Methods: The project included 37,634 participants in The
Danish Blood Donor Study (DBDS), which was initiated 1
March 2010. All participants completed a standard
questionnaire on smoking status, alcohol consumption,
physical activity, diet and various body measurements, etc.
Obesity was defined according to body mass index (BMI)
using WHO definitions: BMI < 30 kg/m2 (reference) and
BMI ≥ 30 kg/m2 (obese).
Infections among participants were defined as relevant
ICD-10 codes of infections in the Danish National Patient
Registry and as relevant ATC-codes of antibiotics in the
Danish Prescription Registry.
To measure risk of infection, multivariable Cox propor-
tional hazards analyses with BMI, waist circumference,
prescription of antibiotics, age, current smoking status and
sex as predictors were performed with risk time defined as
time since inclusion.
Results: The participants provided a total of 105,833 risk
years and 1156 participants were admitted to the hospital
due to infection, while 15,723 received prescriptions of
antibiotics during 58,259 risk years.
Obesity was associated with an increased risk of all-cause
infection for both men (hazard ratio (HR) = 1.50,
P < 0.0001, 95% confidence interval (CI): 1.24–1.74)
and women (HR = 1.44, P = 0.004, CI: 1.12–1.84). The
effect of obesity was similar to that of current smoking
(men: HR = 1.26, P = 0.023, CI: 1.03–1.50; women:
HR = 1.37, P = 0.003, CI: 1.11–1.68). Similarly, obesity
was strongly associated with prescription of antibiotics
(men: HR = 1.21, P < 0.0001, CI: 1.13–1.31; women:
HR = 1.16, P < 0.0001, CI: 1.09–1.24).
For specific infections, obesity was most strongly associated
with risk of infection of the skin and subcutaneous tissue,
cystitis among women and abscesses.
Conclusions: In a large cohort of healthy individuals,
obesity was statistically significantly associated with an
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increased risk of infection, similar to the risk associated
with smoking.
WS6.3
The Danish Blood Donor Study: Nasal and
Throat Colonization with Staphylococcus
aureus Among Healthy Danish Blood
Donors
Joseph Khoa Manh Dinh1, Lise Erikstrup1, Cecilie
Juul-Soerensen1, Ole Birger Pedersen2, Robert Leo
Skov3, Mikkel Steen Petersen1, Ullum Henrik4,
Bjarne Kuno Møller1, Henrik Hjalgrim3, Svend
Ellermann-Eriksen1 & Christian Erikstrup1
1Aarhus University Hospital, Aarhus, Denmark, 2Naestved Hospital,
Naestved, Denmark, 3Statens Serums Institute, Copenhagen, Denmark,
4Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
Introduction: Staphylococcus aureus is a commensal but it is
also a potent pathogen that can cause a wide variety of
infections. Approximately 25–30% of the healthy adult
population are carriers of S. aureus. Colonization is a
complex interaction between the bacteria and the host
immune system and it is still incompletely understood.
The aim was to describe the prevalence of nasal and throat
colonization with S. aureus among healthy adults and
identify immunological predictors of colonization.
Methods: Our study will comprise 5000 participants from
the Danish Blood Donor Study. So far, 215 participants have
been swabbed from the nose and throat. Samples were
cultured on selective S. aureus ID chromogenic agar. To
enhance sensitivity, all samples negative for S. aureus in the
primary culture were subcultured from enrichment broth.
Identification of S. aureus was based on the selective chromo-
genic agar and confirmedwithMALDI-TOF (matrix-assisted
laser desorption/ionization-time-of-flight mass spectrome-
ter). Plasma and DNA is available from all participants.
Results: Preliminary results reveal a prevalence of 54%
carriers of S. aureus. The colonization rates are follows:
28% colonized in the anterior nares and throat concom-
itantly, 13% only colonized in anterior nares and 13% only
colonized in the throat. By using the enrichment broth, the
detection of S. aureus in the anterior nares and throat was
increased by 8% and 14%, respectively.
Summary: The prevalence of S. aureus colonization was
comparable with previous reports. Our results indicate that
the anterior nares and throat are equally colonized with
S. aureus in contrast to the report from recent studies. The
results also emphasize the importance of using an enrich-
ment broth in the detection of S. aureus. The participants
will be genotyped for relevant single nucleotide polymor-
phisms to identify predictors of colonization.
WS6.4
Mycobacterium marinum Virulence
Factors: Tuberculosis by Host
Immunomodulation
Bruno Luukinen1, Milka Hammaren1, Mika
R€amet1, Astrid Van der Sar2 & Mataleena Parikka1
1BioMediTech, Tampere, Finland, 2VU University Medical Center,
Amsterdam, Netherlands
Tuberculosis (TB) is an infectious disease caused by
Mycobacterium tuberculosis. This reemerging disease is carried
by one-third of the world’s population, and its medical
treatment is losing its grip, making the disease one of the
most prominent threats of the human kind. For these
reasons, the World Health Organization gives the highest
priority in fundamental research to better understanding of
the host–pathogen interaction. For this, a natural TB
model system of zebrafish and Mycobacterium marinum is
highly applicable. Even though much of TB’s infection
biology remains to be understood, the pathogen is known
to be able to persist in the host by evading and exploiting
the host immune system. Our recent results suggest that
different infection profiles are reflected by different adap-
tive immune response profiles: a well-controlled infection
is associated with an induced humoral Th2 response (type 2
helper cell), whereas its absence correlates with progressive
disease. In this project, we will use a M. marinum mutant
library generated recently by Dr. Astrid van Der Sar’s
research group (VU University Medical Center, Amster-
dam, Netherlands). By initial screening of virulence factor
mutants and by subsequent scrutinizing of mutants
causing altered balance of host Th response, the project
aims to characterize mycobacterial virulence factors acting
through host immunomodulation. Such factors could be
consistent drug targets by letting the adaptive immune
system from mycobacteria’s leash.
WS6.5
Immunomodulation of Latent
Tuberculosis in the Mycobacterial
Infection Model of Adult Zebrafish
Hanna Nisula, Mataleena Parikka & Milka
Hammaren
University of Tampere, Tampere, Finland
Tuberculosis is one of the deadliest bacterial diseases
worldwide. According to World Health Organization,
there were 8.6 million tuberculosis patient and altogether
1.3 tuberculosis-related deaths in 2012. Furthermore, it
has been estimated that up to 90% of the infected has
Scandinavian Journal of Immunology, 2014, 79, 424–478
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latent asymptomatic infection that can reactivate to
infective disease. Active tuberculosis is difficult to cure
and at the moment the standard antibiotic regimen lasts
for minimum of 6 months. Latent tuberculosis is even
harder to treat as there is an increased population of
dormant mycobacteria that replicate rarely and have
thickened cell wall.
Our research group has developed mycobacterial infection
model of adult zebrafish in which latent disease can be
spontaneously developed without the help of chemother-
apeutics. In this infection model, it is possible to test new
treatments for latent tuberculosis either by intraperitoneal
injection of drugs or by feeding fish per os. ‘Wake and
whack’ is one approach for treating latent tuberculosis,
where dormant mycobacteria are first sensitized with
immunosuppressants and then these newly reactivated
mycobacteria are killed with antibiotics. In this experi-
ment, we will use immunosuppressants such as dexameth-
asone and rolipram as reactivators of dormant mycobacteria
and common antituberculosis antibiotics such as isoniazid
and ethambutol. Our preliminary data indicate that adult
zebrafish is a promising model for preclinical testing of
latent tuberculosis treatments and that combining delicate
immunosuppression and effective antibiotic treatment can
improve the treatment outcome.
WS6.6
Tuberculosis Vaccine Antigen Screen in
the Adult Zebrafish Model
Kaisa Oksanen, Maarit Ahava, Henna Myllym€aki,
Eleanor Sherwood, Nicholas Halfpenny,
Mataleena Parikka & Mika R€amet
University of Tampere, Tampere, Finland
Tuberculosis remains a major global threat and an
improved vaccine to replace the current bacillus Cal-
mette–Guerin (BCG) vaccine is needed. Moreover, meth-
ods for boosting the immunity of people already vaccinated
with BCG are lacking. As a small, non-mammalian
vertebrate with a fully developed immune system, the
zebrafish (Danio rerio) is a new, attractive and affordable
model for vaccine research. Zebrafish can be vaccinated
against mycobacteriosis and experimental infection with
Mycobacterium marinum – a fish pathogen closely related to
Mycobacterium tuberculosis causing human tuberculosis – can
be used to evaluate the efficacy of vaccine candidates. This
project uses an adult zebrafish model for screening through
mycobacterial antigens shared by M. tuberculosis and
M. marinum for their protective effects against mycobac-
teriosis. The screening is performed using DNA-based
vaccination that represents an alternative for immunizing
against tuberculosis and a tool for vaccine antigen
screening. Antigens associated with different bacterial
metabolic states are included in the screen to specifically
target different infection phases. Our aim is to identify
antigens or combinations of antigens that efficiently induce
protection against mycobacteriosis. These antigens could
potentially be used as DNA- or peptide-based vaccines
themselves, or be used as a booster vaccine for BCG. Our
long-term goal is to find safe and effective ways to prevent
different forms of tuberculosis.
WS6.7
Correlation of Viral Load with Fibroindex
Stage of Chronic Hepatitis C Patients
Randa Issa1 & Maha Bassuoni2,3
1Institute of Genetic Engineering and Biotechnology, Cairo, Egypt,, 2Faculty
of Medicine, Cairo, Egypt, 3Molecular Diagnostics Department, Genetic
Engineering Research Institute, Menofya University, Menofya, Egypt
Introduction: Fibroindex was first described by Koda
et al. (1) as a simple, non-invasive indirect marker of liver
fibrosis; it was derived from the platelet count, AST, and
gammaglobulin measurements. Aim of the study: The aim
of the present study was to evaluate the fibrogenic marker:
fibroindex as a non-invasive marker of liver fibrosis in
chronic hepatitis C and to correlate its serum levels with
the stage of fibrosis assessed by histopathological staging of
liver biopsy and virological characteristics including HCV
RNA titres.
Patient and Methods: This study was carried out on 40
patients with evidence of chronic hepatitis C (positive HCV-
Ab and positive HCV RNA by PCR), and they were (35)
male and (5) female. All cases were selected from outpatient
clinic of the hepatology unit of research institute for tropical
medicine (2011). The patients had liver fibrosis from F1 to
F4. Patients with no advanced liver fibrosis (F1–F2) were
considered as control. Fibroindex was calculated according to
the equation described by related authors. (fibroin-
dex = 1.738  0.064 (platelets [9104/mm3]) + 0.005
(AST [IU/l]) + 0.463 (gamma globulin [g/dl])).
Results: The study revealed no significant correlation
between PCR with both liver biopsy and the fibroindex.
Also, there was no significant correlation between fibroindex
and liver biopsy. We obtained two cut-off values (0.88) and
(0.84) and compared these two cut-off values with the
respective original report in which they set two cut-off values
in order to determine whether significant fibrosis was present
(≥2.25) or not (≤1.25); we were not able to differentiate
patients with cirrhosis (F4) or significant fibrosis (F2, F3)
from those without significant fibrosis (F1).
Conclusion: Fibroindex had low specificity and positive
predictive value in identifying patients with significant or
severe fibrosis. In addition, its sensitivity was limited and
not sufficient too.
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WS6.8
Polysaccharide-Induced
Hyporesponsiveness to Pneumococcal
Conjugate Vaccines Depends on the Dose
and Type of the Polysaccharide
Hreinn Benonisson, Stefania Bjarnarson & Ingileif
Jonsdottir
Landspitali University Hospital, University of Iceland, Reykjavik, Iceland
Introduction: Pneumococcal polysaccharide (PPS) can
decrease antibody (Ab) response to a subsequent immuni-
zation with a pneumococcal conjugate vaccine (PCV). This
effect is evident from both experimental and clinical
studies. We assessed whether PPS-induced hyporespon-
siveness was dependent on PPS dose and serotype.
Methods: Neonatal mice were primed with ten-valent
PCV (PCV10), saline or 23-valent PPS (PPV23) at three
different doses and boosted 16 days later with PCV10.
PPS-specific Abs in serum were measured and PPS-specific
antibody-secreting cells (AbSC) enumerated in spleen and
bone marrow 6 weeks after the first immunization.
Results: PPV23 priming decreased the Ab response to
subsequent PCV10 immunization for serotypes 1, 4, 5, 9V
and 18C, but had no effect on responses to serotypes 7F and
14. The hyporesponsiveness was dependent on the PPV23
dose, and the lowest dose did not affect the response to 9V
and 18C. Priming with PPV23 also reduced the number of
AbSCs specific for three of four serotypes tested (1, 4 and
18C) in spleen and bone marrow.
Conclusion: PPV23 priming induced dose-dependent
hyporesponsiveness to PCV10, reduced AbSCs in spleen
and BM, resulting in long-lasting reduction in serum IgG
Abs specific for the majority of serotypes. The effect was
dependent on the type of polysaccharide; specifically, PPS
with a neutral charge had no effect.
WS6.9
Vitamin D3 Administration to MS
Patients Leads to Increased Serum Levels
of TGF-Beta
Merja Soilu-Ha¨nninen1, JuliaAivo1 & Arno
H€anninen2
1Turku University Hospital, Turku, Finland, 2University of Turku, Turku,
Finland
Background: Vitamin D deficiency has been identified as
an environmental risk factor for multiple sclerosis and low
serum levels of vitamin D correlate with increased risk of
MS relapses and disease progression. In healthy volunteers,
vitamin D supplementation (5000–10,000 IU/day) has
been associated with an increase in IL-10 production by
PBMC and reduced frequency of Th17 cells (Aideen et al.
2012). There are only few studies of effect of vitamin D
supplementation on immune responses in patients with
MS. Aims of the study: In this study, we investigated the
effect of weekly vitamin D or placebo supplementation on
the serum levels of LAP (latency-associated peptide of
TGF-b), IFN-c, IL-17A, IL-10, IL-2, IL-22, IL-9, IL-13,
IL-6, IL-4, IL-5, IL-1b and TNF-a.
Materials and Methods: This study was conducted on a
cohort of patients who participated in The Finnish Vitamin D
Study (Cholecalciferol as Add-on Treatment to Subcutane-
ously Administered Interferon beta 1-b for Treatment of MS),
a double-blind, randomized, parallel group 1-year multicentre
trial (Soilu-H€anninen et al. JNNP 2012). In this trial,
patients were randomized either to cholecalciferol 20,000 IU/
week of placebo capsules for 12 months. Serum samples were
obtained at screening and at 1, 2, 3, 6, 9 and 12 months. For
this study, we used samples taken at screening and at
12 months. Concentrations of LAP (TGF-b), IFN-c, IL-2, IL-
4, IL-5, IL-6, IL-9, IL-10, IL-13, TNF-a and IL-1b were
determined using commercial fluorescent bead immunoassay
kits (Human Th1/Th2/Th9/Th17/Th22 13plex Kit, and
Human LAP Simplex Kit, eBioscience, USA).
Results: LAP levels increased significantly in the vitamin
D-treated group from a mean of 47 (S.E. 11) to 55 (S.E.
14) nM in 12 months. Placebo treatment had no significant
effect on LAP levels. The levels of IFN-c, IL-17A, IL-2, IL-
10, IL-9, IL-22, IL-6, IL-13, IL-4, IL-5, IL-1b and TNF-a
did not change statistically significantly in either group.
Conclusions: The effect of vitamin D in MS may be
mediated by increased TGF-b levels.
WS6.10
Development of Anti-Idiotypic Antibodies
Towards the Beta Cell-Specific IC2
Antibody
Kathrine Louise Jensen1, Christina Engmose1, Lina
Akesson2, Ingrid Kl€oting3, Kare Engkilde1 &
Carl-Henrik Brogren1
1Rigshospitalet, Copenhagen, Denmark,, 2University Hospital Malm€o,
Malm€o, Sweden, 3Department of Laboratory Animal Science, University
of Greifswald, Karlsburg, Germany
A major objective in diabetes research is to identify factors
that can prevent beta cell death. An attempt of using anti-
idiotypic antibody-mediated immunotherapy for the pre-
vention of type 1 diabetes has been performed in the NOD
mice model of the disease. Anti-idiotypic antibodies
towards GAD65 antibodies were shown to significantly
delay the onset and reduce the incidence rate of diabetes in
the mice model. Increased levels of GAD65 autoantibodies
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are well known in the development of type 1 diabetes, but
the lack of beta cell specificity of GAD65 anti-idiotypic
antibodies means that the search for beta cell-specific
immunotherapy in type 1 diabetes continues. NKT cells
have been shown to be important in the regulatory
mechanisms preventing diabetes in vivo and the beta cell-
specific monoclonal rat antibody IC2 has been shown to
inhibit the cytokine (IL-2) secretion of these cells in vitro.
Therefore, anti-idiotypic antibodies towards IC2 might
have higher therapeutic potential in the prevention or cure
of type 1 diabetes compared to the anti-idiotypic antibod-
ies against anti-GAD65.
We have successfully developed syngenic IC2-specific anti-
idiotypic antibodies through rat–rat hybridoma fusions.
Initially, immunizations of BB/BBDR+/+ rats with IC2
were performed, to develop an ELISA assay for the
detection of the IC2-specific anti-idiotypic antibodies as
well as to define the immunogenicity of IC2. A second
round of immunizations was used for the hybridoma
fusions followed by limiting dilution cloning for propa-
gation of the hybridoma cultures towards monoclonality.
Large-scale production of the antibodies was carried out in
CELLine tanks, and purification was performed through
immunoaffinity chromatography. Finally, characterization
of ten of the anti-idiotypic antibodies has been initiated
with the intention of choosing which to use for in vivo
testing in diabetes prevention of the diabetes-prone BB rat.
Further characterization will have to be done, but our data
entail promising results in regard of the in vivo potential of
the IC2-specific anti-idiotypic antibodies.
WS6.11
Development of Antidrug Antibodies in
Multiple Sclerosis Cohorts in Europe –
Overview of Interferon Beta and
Natalizumab Cases Tested for ADA in
Different Countries
Jenny Link1, Michael Auer2, Claudia Sievers3, Poul
Erik Hyldgaard Jensen4, Clemens Warnke5,
Kathleen Wolffram5, Ryan Ramanujam1, Bernd
Kieseier5, Per Soelberg Soerensen4, Raija
Lindberg3, Florian Deisenhammer2, Pierre
D€onnes6, Andy Lawton7, Julie Davidson7 & Anna
Fogdell-Hahn1
1Karolinska Institutet, Stockholm, Sweden, 2Innsbruck Medical University,
Innsbruck, Austria, 3University Hospital Basel, Basel, Switzerland,
4Copenhagen University Hospital, Copenhagen, Denmark, 5D€usseldorf
University Hospital, D€usseldorf, Germany, 6Scicross, Sk€ovde, Sweden,
7Glaxo Smith Kline, Uxbridge, UK
A joint effort from academia and industry resulted in 2012
in a collaboration called ABIRISK (Anti-Biopharmaceuti-
cal Immunization: prediction and analysis of clinical
relevance to minimize the RISK) that was funded by IMI
(Innovatives Medicines Initiative) and EFPIA (European
Federation of Pharmaceutical Industries and Associations).
One of the tasks of this collaboration was to set up and
initiate the use of a common database platform (Tran-
SMART) and to start loading data from all laboratories
within this collaboration that analyse antidrug antibodies
(ADAs) against biopharmaceuticals used in either multiple
sclerosis (MS), rheumatoid arthritis, inflammatory bowel
disease or haemophilia A.
The aim was to set up the TranSMART platform for
querying, analysing and storing retrospective data within
ABIRISK. This project is well underway and the first
retrospective data cohorts have been loaded. The task of
curating data and uploading it is in progress and MS
cohorts with retrospective data from five countries (Swe-
den, Austria, Switzerland, Germany and Denmark) have
been loaded, are on the way to be loaded or are nearly
finished preparing data for upload into TranSMART.
Altogether, these uploads contain over 12,000 patients
with over 33,000 test results from serum samples and their
information can be queried for information regarding
ADAs for future analyses.
Questions like ‘howmany patients in each country have been
tested for ADA?’ will be comparedwith regard to population
size, treatment use and expected MS population size.
Difference in ADA positivity between countries and if this
correlates with age and gender will be determined. Health-
care-related issues like the use of different treatment prepa-
rations, ADAanalysismethods and sampling routineswill be
analysed. Early results from these analyses will be presented.
Work Package 4 within ABIRISK would like to acknowl-
edge the contribution of IDBS (ID Business Solutions) to
the curation and hosting of ABIRISK data.
WS6.12
Neither Interferon Beta Nor Natalizumab
Treatment Influences Serum Anti-HHV-6
IgG Levels
Elin Engdahl & Anna Fogdell-Hahn
Karolinska Institutet, Stockholm, Sweden
Background: Multiple sclerosis (MS) is an inflammatory,
demyelinating disease of the central nervous system. It is a
complex disease where both genetic and environmental
factors contribute to disease susceptibility. Human her-
pesvirus 6 (HHV-6) has been associated with MS disease
activity. The first-line treatment of MS is interferon beta
(IFN-b), but the exact mechanism by which its beneficial
effect is achieved is not clear. Another treatment is
natalizumab, a monoclonal antibody directed against
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VLA4 that blocks CD4+ T cells from entering into the
CNS. Previous studies have observed that 1 year of IFN-b
treatment can reduce HHV-6 prevalence in PBMC and
that natalizumab-treated MS patients have higher levels of
anti-HHV-6 serum IgG compared to untreated MS
patients, suggesting that both treatments might influence
immune surveillance of HHV-6.
Aim: In order to further investigate the role of two
commonly used MS treatments on a virus associated with
MS disease, we studied the effect of IFN-b and natalizumab
on antibody levels against HHV-6.
Material and Method: Serum IgG antibody response
against HHV-6 was investigated in nine treatment na€ıve
relapsing–remitting MS patients who initiated IFNb-1a
(s.c) treatment and seven MS patients who initiated
natalizumab treatment. Antibody levels were measured
with ELISA before treatment start (nIFNb = 9,
nnatalizumab = 7) and after 6 months (nIFNb = 8),
12 months (nIFNb = 7, nnatalizumab = 7), 18 months
(nIFNb = 4) and/or 24 months (nIFNb = 4) of treatment.
Results and Conclusion: Neither INFb nor natalizumab
treatment altered the anti-HHV-6 IgG levels significantly.
A high interindividual variation of the anti-HHV-6 IgG
levels was observed, and we stress the importance of
longitudinal studies when investigating treatment effects.
WS6.13
Withdrawn
WS6.14
Combined Balneo- and NB-UVB Therapies
Suppress T Lymphocytes in Psoriatic Skin
Lesions
Gudmundur Bergsson1, Eva €Osp Bj€ornsdottir1,
Jenna Huld Eysteinsdottir1,2, Bjarni A.
Agnarsson3,4, Jon Hjaltalın Olafsson4,5,6, Barður
Sigurgeirsson6, Asa Brynjolfsdottir2, Steingrımur
Davıðsson2,5 & Bj€orn Runar Luðvıkssson1,6
1Department of Immunology, Landspitali University Hospital, Reykjavik,
Iceland,, 2The Blue Lagoon Clinic, Grindavik, Iceland, 3Department of
Pathology, Landspitali University Hospital, Reykjavik, Iceland, 4Faculty of
Medicine, University of Iceland, Reykjavik, Iceland, 5Department of
Dermatology, Landspitali University Hospital, Reykjavik, Iceland,
6Huðlæknast€oðin, Kopavogur, Iceland
A controlled balneo- and narrow band ultraviolet B (NB-
UVB) therapy in the Blue Lagoon is a commonly used
psoriasis treatment, which can suppress circulating T cells,
reduce skin inflammation and improve quality of life. This
study compares two treatment regimens, that is, bathing in
geothermal seawater, that is, Blue Lagoon, combined with
NB-UVB therapy and NB-UVB therapy alone, in sup-
pressing epidermal T lymphocytes. Patients with psoriasis
were recruited and treated for 6 weeks, five individuals for
each regimen. Disease severity was recorded and skin punch
biopsies were obtained from lesions on enrolment and after
6 weeks of therapy. Punches were sliced using a microtome
and sections stained with antibodies specific for CD3-,
CD4- and CD8-positive T lymphocytes. Numbers of
lymphocytes were counted in three separate fields from
each section. The combined therapy reduced CD3-, CD4-
and CD8-positive epidermal T lymphocytes by 71%, 65%
and 70%, respectively, and the monotherapy by 64%, 72%
and 73%, respectively. No difference in the efficacy to
reduce T lymphocytes was noted between the two
treatment regimens. The observed reduction in epidermal
T lymphocytes is in agreement with our previous data,
which demonstrates reduction in circulating T lympho-
cytes after 6 weeks of either combined or monotherapy.
Interestingly, the percentage of patients who achieved
PASI 75 and PASI 90 was greater after the combined
therapy (73.1% and 42.3%) than NB-UVB monotherapy
(16.7% and 0%) with P < 0.05 in all comparisons. Taken
together, the data support previous observations regarding
the role of T lymphocytes in the pathogenesis of psoriasis
and further strengthens the importance of epidermal T
lymphocytes within the pathology and treatment of
psoriasis.
WS6.15
Withdrawn
WS6.16
Health-Related Quality of Life of
Individuals with Mannan-Binding Lectin
Deficiency (MBLD)
Hildur Ey Sveinsdottir1, Margret Arnardottir1,
Helga Bjarnadottir2, Helga Jonsdottir1 & Bjorn
Runar Ludviksson2
1University of Iceland, Reykjavik, Iceland, 2The National University Hospital
of Iceland, Reykjavik, Iceland
Background: Mannan-binding lectin (MBL) and ficolin-3
are initiators of the lectin pathway that is important for
clearance of pathogens and apoptotic cells through com-
plement activation. MBL deficiency (MBLD) has been
associated with infectious complications but its clinical
relevance in adults is unclear.
Health-related quality of life (HRQOL) of individuals with
chronic illnesses has been well documented but very few
have studied the impact of MBLD on HRQOL. Measuring
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HRQOL has become an important foundation in clinical
research to evaluate the burden of illness for individual/
families and communities, to predict health outcomes and
to evaluate the result and efficiency of medical and nursing
interventions.
Objective: The aim of the study was to measure HRQOL
of individuals with previously defined MBL deficiency.
Methods: A total of 64 individuals previously defined as
MBL deficient (≤50 ng/ml) were contacted and 43 agreed
to participate. The participants answered a health-related
quality of life questionnaire Short Form-36 as well a
detailed questionnaire focused on pulmonary and gastro-
intestinal infections. Also, all participants were briefly
interviewed to obtain further data about their health. For
comparison, 63 adult individuals were randomly selected
from the general population and served as control subjects.
Results: The results demonstrate that individuals with
MBLD are prone to a variety of recurrent and severe
infections. Results also indicate that individuals with
MBLD experience depression, anxiety and social isolation.
Repeated or constant pain and fatigue was also common
among the individuals.
Conclusion: MBL-deficient individuals suffer from recur-
rent and severe forms of infections as well as a range of
clinical symptoms. This suggests that the burden of MBLD
in daily life may be considerable which warrants further
exploration.
WS6.17
From Genetic Variations to Biomarkers
Sahl Khalid Bedri1, Mattias Bronge1, Katarina
Fink1, Wangko Lundstr€om2, Anna Glaser1, Hans
Gr€onlund1 & Jan Hillert1
1Karolinska Institutet, Stockholm, Sweden, 2Wangko, Stockholm, Sweden
Multiple sclerosis (MS) is one of the leading causes of
neurological disabilities in Scandinavia. MS is a chronic
inflammatory complex disease in which both environmen-
tal and genetic factors are involved. The aim of this project
is to study the expression of MS risk genes during
natalizumab treatment in serum, plasma and cerebrospinal
fluid (CSF) and the clinical outcome, with the goal to
identify biomarkers that can assist with treatment decisions
and prognosis.
This is going to be done using two approaches, a narrow
but more selective and specific approach where we are
selecting to measure the expression of four soluble
receptors, soluble interleukin-7 receptor alpha (sIL7Ra),
soluble interleukin-6 receptor (sIL6R), soluble gp130
(sgp130) and soluble interleukin-2 receptor (sIL2R), using
enzyme-linked immunosorbent assay (ELISA). We will also
use a wider approach measuring the concentrations of a
larger group of proteins, first 384, then potentially more,
selected from the more than 15,000 expressed proteins of
the Human Protein Atlas (HPA, www.proteinatlas.org)
using an advanced technique called antibody suspension
bead array. Selection of the analysed proteins is guided by
the updated MS risk-associated genes. These two
approaches for analysis will be performed in 3–4 serial
serum and/or plasma samples from 90 MS patients treated
with natalizumab and in paired CSF samples before and
during treatment from 26 patients.
In addition, correlations between candidate MS biomarkers
and clinical information and treatment outcomes will be
studied. This project has the potential to provide us with
biomarkers for monitoring MS patients, which will help to
provide MS patients a better quality of life.
WS6.18
Intradermal Administration of Interferon
Beta Induces Dermal Dendritic Cell
Activation
Christina Hermanrud & Anna Fogdell-Hahn
Karolinska Institutet, Stockholm, Sweden
Background: The skin contains a dense network of
dendritic cell (DC) subtypes, and it is unclear how these
DCs are influenced by interferon beta (IFN-b) adminis-
tration. There are indications that drug administration
through the skin impact neutralizing antidrug antibody
(NAb) development. We hypothesize that skin DCs are
affected differently by different IFN-b preparations and
that activation of these cells also correlates with
individual variation determining the risk of developing
NAb.
Objective: To assess the effect of IFN-b administration to a
human ex vivo skin model on the migration and maturation
of skin DCs comparing different preparations and charac-
terizing donor variations.
Methods: Human skin was obtained from healthy subjects
undergoing abdominal reduction surgery. The skin was
injected intradermally with 50 ll of PBS, IFN-b-1b, or
IFN-b-1a (s.c. or i.m.). A biopsy was sampled from each
injection site and cultured. After 3 days, the crawl-out
cells were analysed by FACS or prepared for mixed
lymphocyte reaction (MLR) or T cell stimulatory assay.
Results: Intradermal injection with IFN-b-1a and IFN-b-
1b enhanced the maturation status of CD14+ and CD1a+
dermal DC crawl-out cells as demonstrated by a significant
upregulation of activation markers CD86 and HLA-DR. The
MLR demonstrated that the crawl-out cells from IFN-b-1a
(i.m. and s.c.)-injected skin had an enhanced capacity to
induce T cell proliferation compared to IFN-b-1b. Crawl-
out cells from IFN-b-1a (i.m. and s.c.)-injected skin
induced T helper (Th) 1 cytokine IFN gamma, whereas
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IFN-b-1b promoted the Th2 cytokine IL-4 in primed T
cells.
Conclusions: Intradermal injections of IFN-b modify DC
maturation and also programme DCs to promote T cell
proliferation and cytokine production differently depend-
ing on preparation. This partly explains the immunolog-
ically mechanism behind the differences in NAb
development depending on IFN-b preparation. Increased
understanding of how the immunology of the skin impacts
NAb development might lead to novel preventative
regimes to minimize the risk.
478 Abstracts
..................................................................................................................................................................
Scandinavian Journal of Immunology, 2014, 79, 424–478
